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Dissertation Synopsis
Objectives
The aims of this investigation are to (i) prepare hybrid quantum dot (QD)-polymer
complexes, (ii) manipulate structural and chemical properties of the hybrids and
characterize their effects on biocompatibility, and (iii) assemble diverse, heterostructured
complexes for enhancing and fluorescently tracking gene therapy.
Hypothesis
Controlling both the chemical functionalities and hierarchal nanostructuring of the QD-
polymer complex may enable the design of fluorescent, synergistic systems that are more
effective than their constituent components, therefore providing efficient solutions to
complex biological problems such as gene therapy.
Rationale
The properties of biological systems depend on the controlled assembly of highly
specialized materials into evolved nanostructures. Examples include DNA-containing
systems like viruses and chromosomes that demonstrate highly concerted interplay
between their material properties and structural organization. Therefore synthetic
systems designed to mimic their biological counterparts must possess similar synergies
between, and enable fine tunability of, their chemical functionalities and hierarchal
structuring. The use of QD-polymer complexes may enable integration of diverse
materials into ordered nanostructures whose biocompatibility and cellular interactions
can be manipulated by controlling the properties of the individual components.
Results
Preparation of the QD-polymer core included both aqueous synthesis of inherently water
soluble QDs and modification of commercially available hydrophobic QDs. Optically
active CdS nanocrystals were successfully synthesized using cationic polymers and
histidine oligopeptides, but high cytotoxicity and poor optical properties when integrated
with cells precluded their use in bioapplications. Commercially available CdSe-ZnS QDs
were made water--miscible by exchanging their hydrophobic surface ligand with
mercaptoacetic acid, and assembling cationic single-layer and anionic multi-layer
polymer-coated complexes. Layer-by-layer coating of QDs was robust enough to enable
integration of polymers with diverse chemical functionalities, independent of the
inorganic core.
Biocompatibility of the QD heterostructures integrated with diverse polymers was
investigated, and primarily depended on the chemical structure of the integrated
polymers. The QD cores did not cause significant toxicity, as was demonstrated by using
cores with different chemical compositions. Single layer complexes containing cations
with high charge densities were highly cytotoxic, while those coated with bio-derived
cations with low charge density were more biocompatible. These properties were
independent of the composition of the nanoparticle core. Cytotoxicity of the anionic
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multi-layer complexes depended on the chemical composition of both the anionic and the
cationic polymers, demonstrating that the composite properties of the heterostructures
depend on those of the individual polymers.
Cationic dextran coated QDs were selected to complex with DNA, due to the low
cytotoxicity and high transfection efficiency of the complex. The use of these complexes
yielded more than 15-fold higher levels of protein production than the use of equivalent
amounts of polymer, DNA and QD containing complexes simultaneously mixed
together, without first coating the nanocrystals with the polymer. Integrating
functionalized gene therapy polymers into the hybrid complex resulted in 2.5-fold
increase in protein production. Characterizing the basis of gene delivery enhancement
revealed that the cationic QD cores condensed DNA more effectively than their
unstructured and free polymer counterparts, forming beads-on-a-string morphologies
similar to nucleosomes. These heterostructures were used to continuously track the
delivery of DNA containing complexes from cellular internalization to protein
production, and used as different color labels for tagging the delivery of multiple genes.
Conclusions
Herein we demonstrated that: (i) water soluble QDs can be coated with oppositely
charged polyelectrolytes to assemble single-layer and multi-layer structures, (ii)
biocompatibility and cellular interactions of the hybrids depend primarily on the
chemical structure of the integrated polymers, and (iii) QD-polymer-DNA complexes
assemble into hierarchal structures that demonstrate better gene delivery properties than
their unstructured counterparts, enabling optical tracking of the delivery complex.
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1.1 Introduction to Quantum Dots
Colloidal semiconductor quantum dots (QDs) are single crystals that are a few
nanometers in diameter (< 15 nm), which demonstrate discretization of energy levels
(Section 1.1.1)1'5. They are generally composed of periodic groups of II-VI (e.g. CdSe)
or III-V (e.g. GaN) materials, although several other semiconductors may also be used.
They are too large to be atomic/molecular systems and too small to demonstrate bulk
properties, and therefore posses novel physical characteristics specific to their
intermediate size (Fig 1.1)6. Due to their large surface area to volume ratios, their
properties are dominated by the surface functionalities, and not their bulk
characteristics 7' . The optoelectronic properties and fine morphological control of the
QDs make them ideal candidates for use in highly interdisciplinary fields, including
applications to complex biological problems. In the subsequent sections the physics of
quantum confinement is discussed, followed by the optical properties of QDs, and some
current and future bioapplications.
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Figure 1.1 Size of quantum dots (QDs) relative to other biological elements. QDs are larger than atoms and
molecules, but smaller than cells and organelles. They are similar in size to proteins and biological
fluorophores (source: Quantum Dot Technologies, reference 6).
1.1.1 Brief Physics of Quantum Confinement
The small size of the quantum dots (less than Bohr radius) leads to three-dimensional
confinement of free elcectrons and holes, leading to discretization of their energy states,
different from the continuous energy states of the bulk material9 (Fig 1.2a)'0. This
discretization limits the mobility of the free charge carriers and leads to the development
of discrete conduction and valence bands"" ' J-3. As the size of the nanoparticle decreases,
the energy levels get further discretized and the band-gap between the conduction and
valence band increases 13 . Therefore, the energy of the band-gap can be controlled by
both, tuning the size of the QD, and using materials with different bulk band-gap values.
Conduction
band
Band gap
Valence
band
Energy
0
TIr
-if
0
Macroscopic Quantum dots
a crystal
Figure 1.2 Effect of the size of quantum dots (QDs) on the bandgap energy and fluorescence. (a)
Semiconductors have intrinsic bandgaps defined by the energy difference between the conduction band
(bonding orbitals) and the valence band (antibonding orbitals). As the QD size decreases, energy levels are
discretized, and the bandgap increases (reproduced based on reference 10). (b) Smaller QDs have larger
bandgaps, which causes blue shifting of the fluorescence. By varying the QD size, a rainbow of QD colors
can be prepared. (source: Quantum Dots Technologies, reference 15)
1.1.2 Optical Properties of QDs
Absorption of a photon of energy above the band-gap energy results in the creation of an
electron-hole pair (exciton) 7. The negatively charged electrons are excited from the
valence bands to the conduction bands, while positive holes are left behind, leading to
separation of charge. Radiative recombination of an exciton leads to the emission of a
photon'. Based on the energy released, the recombination may be in the visible spectrum
of light, and therefore detectable by the naked eye. Tuning both the size and composition
of the QD allows control of the band-gap energy levels, enabling preparation of QDs
with a spectrum of resolved emission. For example, the CdSe QDs have a Bohr radius of
approximately 5.4 nm and a bulk band-gap of 1.7 eV, corresponding to deep red
emission (-650 nm) 14. As the size of the QD decreases, the energy of the band-gap
I 0··
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increases and the emission spectra become more blue-shifted (Fig 1.2b) 5 . The emission
of the QD can be further enhanced by epitaxially growing a shell of higher band-gap
material around the semi-conductor core l68. This increases the brightness of the QD
emission, and eliminates the broad trailing red tails (700 - 800 nm) by decreasing the
number of surface defects which cause trapping and partial quenching of the released
photon. Thus epitaxial capping with a higher band-gap material enhances the brightness
of the QD by minimizing non-radiative recombination of the exciton pair, as
demonstrated by capping CdSe QDs with ZnS shells' 7 .
The optical properties of the QDs make them better fluorescent markers than their
organic counterparts19' 20. These include (i) absorption and emission characteristics, (ii)
stability and resistance to photobleaching, and (iii) bright fluorescence. As evidenced by
the absorption spectra (Fig. 1.3a)21, QDs have broad absorption generally in the UV
region, which allow excitation of multiple colors using a single UV source. They have
narrow, symmetric and finely resolved fluorescence spectra (Fig 1.3b) without the broad
trailing red tails characteristic of organic dyes1' 9 20. Therefore QDs are ideal probes for
simultaneous labeling of multiple targets; broad absorption enables excitation using a
single source while narrow, resolved emission enables distinct characterization of
multiple targets. QDs are very stable fluorophores; they are resistant to photobleaching
and maintain their fluorescence over extended periods of time and through repeated
exposure19,22'24. This allows their use as multi-dimension probes for z- and time-resolved
microscopy. Since both require repeated measurements over extended periods of time,
loss of fluorescence over the course of data collection may compromise the integrity of
the results. Therefore the use of QD enables reliable, extended characterization of multi-
dimensional systems. Lastly, QDs are much brighter than organic dyes with higher
quantum yields. They also have much longer fluorescence lifetimes . Combined, these
properties increase the signal to noise ratio of the image, enabling high sensitivity and
resolution. Therefore, small amounts of target molecule can be detected, allowing single
molecules to be labeled and tracked2 6.
1. 1.3 Potential for Biological Applications
QDs are well suited for biological applications; their small size enables efficient
conjugation to intracellular organelles and proteins and their optical properties allow
(i) immunolabelling and single molecule localization, (ii) optical multiplexing, and (iii)
continuous multi-tracking. Due to their bright and stable fluorescence, QDs have been
used for immunofluorescence staining of F-actin' 9, heat shock proteins2 7, and several
other cellular markers in live and fixed cells.2 528 30 They have been used for optical
multiplexing by the simultaneous labeling of multiple biomolecules based on color and
intensity 3 . QDs were used to produce optical barcodes in polystyrene beads that
encapsulate nanoparticles of different colors at varying ratios . Multi-peptide mediated
internalization was used to specifically incorporate multi-colored QDs into different
mammalian cells, generating a unique and spectrally resolvable code for each cell type33.
Different color QDs were modified with specific cell-recognition ligands for tumor and
normal cell types, and targeted cells in co-cultures3 4. QD surfaces were modified with
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organelle-specific targeting sequences, which selectively labeled cellular structures 3.
QDs are resistant to photobleaching, which enables continuous acquisition of high-
quality images over extended periods of time. This enables tracking of intracellular
structures and mechanisms, which may help elucidate cellular pathways and provide a
more fundamental, detailed understanding of cellular processes. Continuous, long term
visualization of cellular processes was demonstrated by preparing serotonin36 , glycine
receptor37 and epidermal growth factor-conjugated 38 QDs, and visualizing their
internalization and cellular transport through the cells. Continuous progression of
respiratory syncytial virus infection of Hep-2 cells was also visualized using QD-virus
conjugates39 . Real-time tracking of small, labeled molecules inside single cells was also
demonstrated by labeling mammalian cells with transferrin coated QDs22 .
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Figure 1.3 Optical spectra of CdSe-ZnS QDs as a function of their size. (a) As the size of the QD
decreases, absorbance becomes more blue-shifted, indicating higher energy absorption. All spectra are
highly defined and demonstrate indiscriminate, broad absorption in the UV region (< 350 nm). (b)
Fluorescence becomes more blue-shifted as the QD size decreases. All fluorescence spectra are narrow and
finely resolved. (source: Evident Technologies, reproduced with permission, reference 21)
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In addition to their optical and structural properties, QDs used for biological applications
should (i) be hydrophillic, (ii) allow integration of diverse chemical functionalities, and
(iii) be biocompatible and non-toxic to cells. Hydrophillicity is important since cellular
environments are aqueous, whereas commercially available QDs are produced in organic
solvents with hydrophobic surface coatings. Integration of various chemical
functionalities enables manipulation of the QD properties and tailoring for specific
cellular functions. However, this integration is challenging since most QDs have bulky,
organic ligancls on their surface that must be passivated or removed to allow covalent or
electrostatic interactions with biomolecules9 '22 (e.g. antibodies, localizing proteins).
Finally, biocompatibility is a significant concern, as leaching of metal ions from the QD
surface (e.g. Cd +) may result in cytotoxicity and mutagenesis 4 0 41. Therefore, hybrid QD
systems must be multi-functional if they are to be used as effective probes for
bioapplications.
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1.2 Introduction to Gene Therapy
Gene therapy is the delivery of exogenous nucleotide-based drugs to manipulate
endogenous protein levels, thereby regulating imbalances in the levels of functional
protein production42' 43. In the subsequent sections the potential of gene therapy, cellular
barriers impeding delivery, and the hierarchal nanostructuring of biological DNA
delivery vectors (virus) and DNA packing systems (chromosomes) are discussed.
1.2.1 Potential of Gene Therapy
The human genome is comprised of 3164.7 million nucleotide bases, less than 2% of
which account for the estimated 30,000 genes that encode for proteins 44. Advances in
human genome mapping and the molecular understanding of the fundamental disease
mechanisms has lead to the potential use of combinatorial nucleic-acid based
therapies. 45 46 Inherited and acquired genetic diseases can result from mutations in the
genetic sequence, which then causes modified gene expression and altered protein
production. Either an increase or a decrease in protein levels may manifest itself as
abnormal cellular activity, leading to diseased behavior. Return to normal protein levels
may nullify the effects of the disease, and restore the cell to its normal function; this can
include increasing suppressed protein expression or decreasing excessive protein
production (Fig 1.4)4 . Gene therapy holds great promise for the compensation of
deleterious genetic disorders.
Figure 1.4 Potential of gene therapy. (a) Cellular functions are controlled by their proteins, which are
encoded by the DNA. (b) Exogenous genetic material can be delivered to cells using gene delivery vectors
like viruses, which control the endogenous protein levels and manipulate the functions of the cell (source
figure reproduced from reference 47).
Therapeutic applications of gene therapy are still in the experimental phase 48. The first
clinical trials were conducted in 1990, where lymphocytes of patients suffering from a
form of severe combined immunodeficiency disease were isolated from the patient's
body, treated with a retrovirus carrying the therapeutic gene, and then returned 49
However, since then progress has been slow due to the complications associated with the
use of viruses as the DNA delivery platforms. Their use is plagued by potentially toxic
drv=
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immunological and inflammatory responses 5' ,51. Alternative synthetic systems are being
investigated, but their use is restricted due to low levels of gene product expression due
to impedance and arrest by the cellular barriers to gene delivery
1.2.2 Barriers to Gene Therapy
There are several barriers that impede the delivery of therapeutic nucleic acids from
outside the cell to the nucleus, where they can be transcribed 52. These include low
cellular uptake of the complex, limited endosomal escape, degradation by intracellular
non-specific nucleases, lack of nuclear targeting, restricted passage across the nuclear
membrane- and inefficient release of DNA from the deliverv comnlex (Fi 1 5_
Figure 1.5 Barriers to gene delivery. The first bottleneck is (a) efficient assembly of the DNA-vector
complexes, followed by (b) delivery of the complex to the cells, (c) cellular internalization of the
complexes, (d) endosomal escape of the complex, versus (e) endosomal degradation, (f) dissociation of the
DNA from the delivery vector, (h) nuclear localization of the gene, versus (g) degradation of the free
nucleic material, and (i) transport of the free nucleic material across the nuclear membrane and inside the
nucleus (reproduced with permission from Nature Publishing Group, reference 52).
Cellular internalization can occur via several mechanisms, the most common being non-
specific endocytosis, whereby the cell periodically samples its environment by non-
specifically engulfing the extracellular material. While these complexes are internalized
within the cell, they remain trapped in membrane-bound organelles (endosomes, and
lyzosomes) where they are eventually degraded, thus never reaching the nucleus.
Therefore, efficient endosomal escape of the complex is essential for mediating high
levels of gene delivery 53 . This may be achieved by disrupting the endosomal membrane
via association with the lipid bilayer54, or by causing osmotic swelling and rupture of the
endosome 55.
Once a material is released in the cytosol, it must be trafficked to the nucleus, where
gene transcription may occur. However, cytoskeletal elements (microfibers and
filaments) impede this diffusion, and cytoplasmic endonucleases act to degrade the
DNA52'56. Nuclear localization sequences, which consist of stretches of cationic amino
acids, aid in cellular trafficking and nuclear targeting57 . Fast and efficient transport of the
complex is necessary for high levels of sustained gene expression.
Upon reaching the nucleus, the complex must pass through the nuclear membrane and be
internalized into the nucleoplasm. The transport of DNA across the nuclear envelope
occurs through the nuclear pore which is approximately 55nm in diameter5 8. Particles
less than 25nm in diameter can diffuse through the membrane pores, while larger
particles enter via the formation of a nuclear pore complex59'60. The complex formation is
controlled by the presence of short stretches of basic amino acids, known as the nuclear
localization sequences. Once inside, the delivery vector must dissociate from the DNA to
allow transcription of the delivered gene and subsequent production of the protein6 1. If
the complex remains bound to the DNA it can not be transcribed by the enzyme and is
functionally inactive.
1.2.3 Viruses: Natural Gene Delivery Vectors
Several types of viruses can be used for nucleotide-based drug delivery, including
retrovirus, adenovirus, and adenoassosciate virus51. Among them, the most common one
is the adenovirus62 '64 , for which the structure and infection mechanism have been
extensively studied 65. Adenovirus is a non-enveloped, double-stranded DNA virus
approximately 150 MDa in mass66 '67. The capsid forms an icosahedron with 12 vertices
and 20 facets and has a diameter between 60 - 90 nm66'67. At each vertex are highly
negatively charged glycoprotein fibers approximately 35 nm in length which have
ligands grafted to their ends to serve as markers for receptor mediated endocytosis6 6. It
contains a linear genome of- 36 kbp that is stabilized by basic (cationic) proteins, and
forms the viral core6 6' 6 8.
While the details may vary, the overall infection mechanisms of different types of
adenovirus are similar69. The virus enters the cell via receptor-mediated endocytosis of
the fiber proteins, and in the endosome undergoes a series of cooperative structural
changes in the capsid68'7 0. The acidic environment of the endosome leads to structural
changes in the protein capsid. resulting in association of the proteins with the endosomal
membrane, and release the capsid-encapsulated DNA into the cytoplasm 7. The complex
is transported to the nucleus where it is internalized via the formation of a nuclear pore
complex 72.73. The DNA is released from the complexing proteins, and is ready for
transcription. Both the structural organization and the material properties of the virus are
precisely controlled to produce efficient gene delivery vectors.
While viruses achieve high efficiencies of gene delivery, there are several problems
assosciated with their use50 '51. They evoke inherent cytotoxic and immunogenic
responses, are prone to mutations, and have size limitations on the genes that they can
deliver. Furthermore, most viruses are not cell-specific and so, not cell selective.
Therefore, non-viral methods of gene delivery are being developed so that delivery
vector properties can be systematically manipulated to meet the specifications of the
application. Based on the viral mechanism, it is clear that both material properties and
17
internal nanostructure of the delivery vehicle are important for achieving high delivery
efficiency.
1.2.4 Chromosomes: Natural DNA Reservoirs
Human cells contain twenty three pairs of chromosomes, each between 1.7 and 8.5 cm
long, and 2 nm in diameter, totaling approximately 2 billion nm when completely
extended74. Since the nucleus is spherical, typically 5 - 20 plm in diameter, unstructured
packing of DNA within the nucleus may cause several problems: (i) physical
confinement of a large amount of DNA in a small nucleus, (ii) entanglement of the long,
thin DNA strands, and (iii) rigidity of the highly charged DNA backbone limiting the
ease with which DNA can be manipulated. To overcome these problems, highly efficient
condensing mechanisms have evolved that compact DNA, based on both electrostatic
interactions and ordered structuring of the nucleic acid and the complexing materials.
Several hierarchies of organization are necessary to effectively compact DNA75 76. The
first order of packing is the assembly of the fundamental unit of DNA condensing, the
nucleosome, which comprises of DNA and highly basic proteins called histones.
Between 150 and 200 basepairs of double stranded DNA wrap around the histone
octamer to form a complex approximately 11 nm in diameter, and 100 kDa in molecular
weight (Fig 1.6)76.77. A second histone (HI) fastens the DNA to the octamer histone
core 76' 77. Nucleosomes demonstrate characteristic beads-on-a-string morphologies, as
visualized using transmission electron microscopy. Condensed histone-DNA units are
connected by segments of uncomplexed, exposed linker DNA resulting in an
approximate packing ratio of 676. . The second order of packing is further condensation
of beads-on-a-string chromatin with the aid of the H 1 protein, to form chromatin fibers
30 nm in diameter 76' 78. Each helical turn of the chromatin fiber contains approximately
1200 basepairs of DNA, condensed into six nucleosomes. This results in an approximate
packing ratio of 4078. Finally, the DNA is further packaged by organizing into extended
and condensed loops, scaffolds, and domains, giving a packing ratio of between 10,000
and 50,00076,78.
DNA
/Hi Histone/\
I
Figure 1.6 Organization of chromatin. Coiling of approximately 150 basepairs of DNA around histone core
to form approximately 200 base pair nucleosome in a beads-on-a-string morphology (figures reproduced
based on reference 78).
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1.3 Specific Aims
The general aims of this dissertation were to (i) prepare hybrid quantum dot (QD)-
polymer complexes, (ii) manipulate hybrid structural and chemical properties and
characterize their effects on biocompatibility, and (iii) use diverse, heterostructured
complexes for gene therapy. This was accomplished by the following specific aims.
Aim 1: Prepare stable, hybrid QD-polymer cores
Aim l a: Synthesize CdS QDs in
aqueous solutions
i~~~~~~4
Use cationic polymers
as capping agents
I
Aim lb: Modify CdSe-ZnS QDs
with organic polymers
Optimize modification procedure to
make QDs hydrophillic
L
Use histidine
oligopeptides as
capping agents
Test photostability, biocompatibility
and tunability of synthesized QDs
I
1 [
I
Develop polymer coating techniques
to assemble anionic QD-polymer
complexes
Characterize optical properties and
morphology of modified QDs
Select QD core with better optical properties
and tunability for subsequent investigations
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Aim 2: Characterize biocompatibility of polymer coated QDs
I
Determine inherent biocompatibility of the QD core
J
Assemble single-layer systems with different polymers
Assemble multi-layer structures with different polymers
[
Characterize biocompatibility of composite complexes
and determine contribution of nanoparticle core and
coating polymer layers I
Aim 3: Investigate use of QD-polymer-DNA hybrid
Select QD-polymer cores mediating high levels
of protein production and low cytotoxicity
Characterize morphology of hybrid
complexes
Investigate effect and mechanism of
nanostructuring on gene delivery
1 I
1
f
Use as fluorescent probes for
constant monitoring of gene delivery
Use as labels for tagging multi-gene
systems
i 
]I
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Evaluate utility and potential of hybrid gene
delivery vehicles
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1.4 Specific Rationale
Polymer modified semiconductor QDs were used for assembling gene delivery
nanostructures since they (i) enable fine morphological control of the QD core, (ii)
posses inherent fluorescence of the QDs, and (iii) allow easy integration of diverse
chemical functionalities. These properties are important for the assembly of finely tuned
delivery vectors for mediating efficient gene delivery and tracking.
The small size and uniform size distribution make QDs ideal platforms for gene delivery.
They are similar in size and shape to histones, natural DNA condensing proteins, which
might help them effectively condense DNA. They are small enough to enable
hierarchical organization of the QD-polymer-DNA complexes, which may enhance
delivery properties due to nanostructuring. Their size may facilitate the assembly of
small complexes that can be efficiently endocytosed by the cells and encounter less
impedance during cellular trafficking. Furthermore, QD size, shape and size distribution
can be readily manipulated, allowing their morphology to be systematically varied for
optimization of the delivery properties of the hybrid complex.
The inherent fluorescence of QDs makes them excellent probes for optical
characterization of complex systems, and can be easily monitored using a fluorescence
microscope. Their fluorescence may be used to develop semi-quantitative models for
predicting protein expression, which could help determine therapeutic doses. QDs
demonstrate high photostability and do not hydrolyze or degrade in water, therefore
enabling multi-dimensional and continuous tracking of complexes. Continuous, time-
resolved three dimensional imaging may enable elucidation of gene delivery pathways
and identification of gene delivery barriers, aiding in the design of highly efficient gene
delivery vectors. QDs have highly resolved emission spectra and therefore multiple
colors can be used to tag different genes, enabling simultaneous characterization of
combinatorial, multi-gene systems.
Integrating the QDs with polymers can enable assembly of complexes with diverse
functionalities, including bio-derived and synthetic materials. The efficiency of different
materials in mediating gene delivery and their escape from or arrest by different cellular
barriers may be characterized. This can help identify materials best suited for avoiding
arrest by specific cellular barriers. Systematic integration of different materials with
complimentary functionalities may enable the assembly of highly synergistic gene
delivery systems, which mediate escape from different cellular barriers. Highly
characterized delivery systems also have the potential to be optimized for very specific
gene therapy applications.
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Chapter 2: Aqueous Synthesis of CdS Quantum Dots
24
Chapter Synopsis
Objective
The aim of this section was to synthesize and characterize optical properties and
biocompatibility of CdS quantum dots (QD), prepared in aqueous solutions using cationic
polymers and histidine oligopeptides of varying molecular weights and chemical
structures as the capping agents.
Hypothesis
Varying the chemical properties of the capping agents may enable synthesis of CdS QDs
with controlled optical properties and morphologies, which may be subsequently used for
bioapplications.
Rationale
The use of aqueous phase synthesis will enable production of inherently hydrophilic QDs
that can be used for biological applications, while providing an alternate technique that is
more environmentally benign than the organic synthesis. The use of cationic polymers
and histidine rich motifs has previously demonstrated stabilization of optically active
CdS QDs. However, no systematic investigation has been conducted characterizing the
effect of varying the polymer structure and molecular weight on the properties of the
synthesized QDs, and the interactions of the synthesized QDs with biological systems.
Results
The optical properties and morphology of the synthesized QDs depend on (i) the
molecular weight of the polymer, (ii) its mass concentration during synthesis, and (iii) the
molecular structure of the monomer. Cationic branched polyethyleneimine (bPEI)
polymers with molecular weight exceeding 2 kDa effectively passivated optically active
CdS nanoparticles, within effective concentration ranges of the polymer. Increasing the
mass concentration within these effective ranges resulted in the synthesis of QDs with
blue-shifted and more defined absorbance and fluorescence spectra, indicating the
synthesis of smaller QDs with tighter size distributions. Increasing the molecular weight
of the polymer resulted in broadening of the effective concentration window over which
optically active QDs are prepared, moving it to higher concentrations, and enhancing the
brightness of QD fluorescence. Using linear PEI and polyallylamine (PAA), other
synthetic polycations, as the surface capping agents led to the synthesis of QDs with less
defined absorbance spectra, and with decreased fluorescence, as compared to those
synthesized using bPEI. All QDs had highly cationic surfaces and resulted in widespread
cytotoxicity and when incubated with COS-7 cells, therefore precluding their use for
bioapplications
Histidine oligopeptides with three or more covalently linked residues were effective
stabilizers for producing optically active CdS QDs. The number of covalently linked
histidine residues affected the morphology and optical properties of the synthesized QDs;
as the histidine chain length increased, the size of the QDs decreased, size distribution
became tighter, and the absorbance and fluorescence became more blue-shifted. The QDs
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had crystalline cores, as revealed by transmission electron microscopy. Integration of the
QDs with cells demonstrated poor optical resolution and aggregation of the particles in
solution.
Conclusions
Controlling the chemical properties of the capping agents enabled tailoring of the optical
properties of the QDs. However, these QDs were either cytotoxic or demonstrated poor
optical properties like photobleaching and aggregating in solution, and were therefore
precluded from further use as bioprobes.
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2.1 Background
Semiconductor QDs prepared using different synthesis techniques have varied structures
and properties; high quality II-VI nanocrystals, exemplified by CdS, have been prepared
in organic and aqueous environments using thermal decomposition and ligand
stabilization techniques' 3 . While nanoparticles produced in organic solvents at elevated
temperatures exhibit finely tunable optoelectronic properties (Fig 1.3), their surfaces are
capped with large, hydrophobic ligands which make them immiscible with polar and
aqueous solvents4 7. Therefore, they require extensive modification if they are to be
interfaced with aqueous environments common in biological applications . Organic
synthesis also generates large quantities of toxic, environmentally harmful organic waste.
Alternative aqueous synthesis methods that use benign conditions to produce water-
compatible QDs are currently under investigations -. Using these methods optically
active nanocrystals with varying core compositions, including CdSe 3 and CdS" 14, have
been successfully preparedl-. However applications of these QDs have been limited since
their optical properties, including the absorption and emission spectra, are neither as
finely tunable nor as resolved as of those produced in organic solvents.
Aqueous synthesis of CdS QDs has been previously demonstrated using a variety of
nanoparticle surface passivating agents, to produce intrinsically water-miscible
nanocrystals. Typical synthesis schemes include initial incubation of the cationic metal
precursor salts (e.g. CdCl2) with the stabilizing agent and rapid addition of the anionic
precursor salt (e.g. Na2S) to form nanoparticles' 2. The properties of the synthesized QDs
depend on the reaction conditions and the composition and concentration of the precursor
salts and the capping agents. Varying these conditions and materials, especially the
chemical structure of the stabilizers, has a significant effect on the optical properties of
the QDs. Synthetic and biological ligands and polymers have been tested as surface
passivators, including thiol-containing ligands, phytochelatin peptides 6 'l7 , cationic
polymers 4'1 8 '' 9 and dendrimers20'21. producing optically active CdS nanocrystals.
The use of two material groups as surface passivators for CdS QD synthesis, cationic
polymers and histidine oligopeptides, is particularly promising. Previous investigations
have demonstrated that cationic polymers with high charge densities, like high molecular
weight cationic branched polyethyleneimine and polyamidoamine (PAMAM)
dendrimers, are effective stabilizers for producing CdS QDs14"'8' 21. The surfaces of CdS
particles are anionic due to adsorption of negatively charged hydroxyl groups to the
cationic dangling cadmium bonds (Fig 2. la)2 2, to which the cationic polymers
electrostatically associate. Histidine oligopeptides were effective at mediating synthesis
of noble metal nanoclusters; silver, gold, platinum and copper nanoparticles were
previously synthesized using histidine amino acids and histidine-rich motifs23. Recent
work using yeast surface display demonstrated that histidine rich sequences promote
binding to CdS surfaces24. Nanoparticle stabilization is likely mediated by formation of
metal-imidazole bonds, formed by donating the electron pair of the imidazole ring to
stabilize the cations 2 5 (Fig 2.1b).
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Figure 2.1 Interactions of the metal ions with their environment. (a) Water coordinates with the cadmium
ions via the lone pair of electrons on the oxygen atom. The adsorbed water molecule loses a proton
rendering the surface of the semi-conductor negatively charged. (b) Nucleophillic imidazole ring of the
histidine amino acid coordinates and stabilizes the metal cations (Me++).
Herein we have used cationic polymers and histidine oligopeptides as capping agents for
producing CdS QDs. Cationic bPEI, linear polyethyleneimine (PEI) and polyallylamine
(PAA) were tested as capping agents (Appendix); bPEI is a highly branched structure
with primary, secondary and tertiary amines in its backbone, while IPEI and PAA are
linear polycations with secondary amines in the backbone and primary amines grafted to
the backbone, respectively. Histidine oligopeptides with varying number of covalently
linked histidine residues were also tested. Since the capping agents electrostatically
associate with the CdS nanocrystals, changing any parameters that might affect these
electrostatic interactions can affect the properties of the final QD produced. To the best of
our knowledge, no systematic investigation of the effects of varying the molecular weight
and structural architecture of these capping agents on the optical properties of the
nanoparticles has been previously demonstrated. Furthermore, biocompatibility of
polycation stabilized CdS nanoparticles with cells has also not been previously
characterized.
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2.2 Specific Aims
2.2.1 Cationic Polymer Mediated Synthesis
* Optimize experimental conditions (pH, temperature, salt concentration) for CdS QD
synthesis using bPEI polymer as the capping agent.
* Determine the effect of varying bPEI chain length on the size and optical properties
of the synthesized nanoparticle.
* Investigate the effect of varying polymer structure on the size and optical properties
of the synthesized QD, by testing bPEI, PEI and PAA as the capping agents.
* Test the biocompatibility of the "best" cationic QDs synthesized using cationic
polymeric surface capping agents.
2.2.2 Histidine Oligopeptide Mediated Synthesis
* Optimize experimental conditions (solution pH) for CdS QD synthesis using His 10
as the capping agent.
* Investigate the effect of varying the number of covalently linked histidine residues
(His 1, 3, 5, 10, 80 - 100) on the properties of synthesized QDs
* Test the biocompatibility of histidine-coated QDs synthesized using different length
histidine capping agents.
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2.3 Materials & Methods
2.3.1 Experimental Setup
Materials
CdCl2 and Na2S were purchased from Alfa Aesar. PAA, bPEI and PEI were obtained
from Sigma Aldrich. Histidine amino acid (Hisl) and polypeptide chain (pHis, 70-90
units) were obtained from Sigma Aldrich. Oligopeptide chains with 3, 5 and 10 histidine
units (His3, His5 and His10, respectively) were synthesized at the MIT Biopolymers Lab.
The pH of the solutions was adjusted by adding HCl and NaOH purchased from Sigma
Aldrich. All other reagents were also purchased from Sigma Aldrich.
QD Synlihesis
Stock solutions of 100 mM CdCI2 and Na2S were prepared in deionized water and further
diluted to 0.5mM in pH adjusted water (values discussed later)'2. Capping agent (CA)
solutions were prepared in deionized water at 10mg/mL. Varying volumes of CA were
added to 2mL of diluted CdC12 while stirring vigorously in a heated water bath
maintained at 80°C. The volumes were varied to obtain capping agent unit to cadmium
molar ratios over wide ranges, and was based on the molar concentration of the monomer
residues. and not that of the terminators polymer chains. CdCI2 and CA were equilibrated
for 10 minutes and followed by the rapid addition of 3mL diluted Na2S (in excess). The
solution was stirred on heat for 10 minutes, and cooled for 4 hours to allow the optical
properties to stabilize.
Particle Characterization & Size Estimation
The absorbance spectra of undiluted, particles were obtained using a UV/Vis
spectrometer (Beckman Coulter, DU 800). For fluorescence measurements, the samples
were diluted in equal volume deionized water, excited at 325nm (unless noted otherwise),
and their emission spectra obtained using a fluorimeter (Hitachi 2500). The peak
positions of the absorbance and fluorescence spectra were obtained by determining the
maxima of the corresponding curves. The nanoparticle size was estimated using the
effective-mass model including Coulomb interactions, which correlates the absorbance
fronts to the CdS particle size26. Surface charge of the nanoparticles was determined in
deionized water, using the Smoluchowski method (ZetaPals Analyzer, Brookhaven).
TEM Characterization
Nanoparticles were purified to remove excess reactants by ultrafiltration through
microsep centrifugal columns (Pall, 3 kDa and 30kDa cutoff). The purified QD's were
diluted in deionized water and adsorbed on carbon coated copper grid (Ladd Research
Industries) for 20 minutes, rinsed with water, dried, and imaged using a JEOL 2010 at an
accelerating voltage of 200 kV.
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Incubating Cell with QDs
Cos-7 cells were cultured in DMEM/F-12 medium supplemented with 10% fetal bovine
serum and 1%/ Penicillin/Streptomycin/Amphotericin B. They were incubated at 37 C in
5% CO. For QD incubations, cells were plated at a density of about 75,000 cells per well
in a 24-well plate, and allowed to grow overnight. Prior to incubation with QDs, cells
were incubated in serum-free medium (0.5 mL per well). QD complexes were introduced
and the cells were incubated for 2 hrs following they were supplemented with fresh,
complete medium.
Fluorescence Imaging
The cells were imaged using an inverted IX51 Olympus microscope with GFP (ex
450/40, em 525/'50), TRITC (ex 535/50, em 610/75) and DAPI (ex 360/40, em 460/50)
filters. Images were obtained using SimplePCI software.
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2.4 Results & Discussion: Cationic Polymer Mediated
Synthesis
The use of synthetic polycations, bPEI, IPEI and PAA, to synthesize CdS QDs was
investigated. First, reaction conditions including temperature, pH, salt and surfactant
concentration were optimized, using bPEI as the capping agent. The effect of varying the
molecular weight (MW) of bPEI on the absorbance and fluorescence properties of the
QDs was characterized. Next, QDs were prepared using PEI and PAA as the capping
agents. and their optical properties were characterized and compared to the properties of
QDs synthesized using bPEI. Lastly, biocompatibility of the "best" QDs synthesized
using bPEI, PEI and PAA was determined.
2.4.1 Optimizing Synthesis Conditions
The effect of varying reaction temperature on the optical properties of bPEI capped CdS
QDs was determined by synthesizing nanoparticles in deionized water at 25°C, 50'C and
80°C (Fig. 2.2). QD were synthesized by equilibrating CdCI2 (dissolved in water) with
bPEI (25 kDa) for 10 mins, followed by rapid addition of Na2S (dissolved in water). The
particles were aged for 4 hours after synthesis, and optical properties were characterized.
The absorbance spectra (Fig 2.2a) of QDs prepared at all three temperatures are similar in
shape and intensity of absorption. They are very well defined with two distinct absorption
peaks, one at 320 nm and the other at 345 nm. These peaks are due to the discretization of
energy levels as a result of quantum confinement of CdS (Section 1.1.1). Visual
characterization of fluorescence under a UV lamp demonstrated a significant difference
in the brightness of the QDs synthesized at different temperatures; those produced at 80
°C were bright blue, while those synthesized at 25 C were faint blue-green. Subsequent
characterization of the QD fluorescence spectra (ex. 325 nm) yielded similar results (Fig
2.2b); the emission peaks of all three QDs were between 450 - 460 nnm, those produced at
80 C being slightly more blue-shifted (445 nm) than those produced at 50 °C (453 nm)
and 25 C (456 nm). There was a significant difference in brightness, with QDs produced
at 80 °C being more than 1.5-fold brighter than those produced at 50 °C and 25 °C. This
enhanced fluorescence may be due to more efficient capping of the QD by the polymer at
higher temperatures, leading to a decrease in the number of surface defects27 . Since QDs
synthesized at 80°C have the brightest fluorescence, all subsequent syntheses were
carried out at that temperature. unless stated otherwise.
The effect of solution pH on the optical properties of the QDs was determined by
synthesizing QDs in pH adjusted solutions; precursor salts were dissolved in 0.63, 1.25
and 2.5 mM HC1 or NaOH solutions. Synthesis was conducted as before and the
absorbance spectra obtained 4 hours after synthesis (Fig. 2.3). QDs produced in pure
water have the split-peak absorbance profiles, but as the precursor salt solutions become
increasingly acidic or basic, the peaks flatten out and the absorbance spectra lose their
definition. At high HCI concentrations, all quantized absorbance is lost and the spectra
resembles that of unstructured, bulk CdS. Visual characterization of the QD fluorescence
showed a decrease in fluorescence brightness and red-shifting of the emission color with
pH adjustment of the precursor salt solutions. The data demonstrate that QDs with the
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best optical properties are synthesized in unadjusted deionized water, and that the
addition of acid or base compromises the optical quality of the QD produced. Therefore
all subsequent reactions for cationic polymer synthesis were conducted in plain deionized
water, unless stated otherwise.
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Figure 2.2. Characterizing the optical properties of bPEI capped CdS QDs synthesized at varying
temperatures. (a) Absorbance spectra of the nanoparticles prepared at different temperatures are similar in
shape and peak positions, and demonstrate the characteristic split-peak absorbance. (b) Fluorescence
spectra become significantly brighter and slightly blue-shifted with increasing synthesis temperatures.
The effect of salt concentration on the optical properties of the QDs was determined by
characterizing nanoparticles prepared by dissolving the CdCl2 and Na2S in 1.25, 2.5 and 5
mM NaCl. Analyzing the absorbance spectra (Fig. 2.4) revealed that the addition of salt
resulted in loss of definition as the peaks flattened out. Visual characterization of the
fluorescence revealed that QDs synthesized in increasingly higher salt concentrations had
- .4
progressively decreased fluorescence. These data demonstrate that addition of salt to the
reaction solutions is detrimental to the optical properties of the synthesized QDs. Since
the associations between the QD and the capping agent are electrostatic, and addition of
salt causes charge shielding, presence of salt may decrease the strength of interactions
between the QD surface and the cationic polymer resulting in inefficient passivation of
the QD surface, leading to poor optical properties. All subsequent syntheses were
performed without the addition of salt, unless stated otherwise.
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Figure 2.3 Absorbance spectra of CdS QDs synthesized in acidic and basic buffers, at 80 °C using bPEI as
the capping agent. The absorbance becomes less defined as acid or base are added to the synthesis solution.
The effect of surfactant concentration on the optical properties of the synthesized QDs
was determined by supplementing the precursor salt solutions with polyethylene glycol
(PEG) at concentrations ranging between 0.25 and 6.25 tM. The absorbance spectra of
QDs prepared at varying PEG concentrations (Fig 2.5) are similar, with no significant
differences between the peak positions and absorption profiles. Visual characterization of
the QD fluorescence did not reveal any differences between the color and the brightness
of the QDs synthesized at varying PEG concentrations. Therefore, the addition of PEG
does not affect the optical properties of the synthesized QDs within the concentrations
tested. Subsequent syntheses were conducted without the addition of the surfactant,
unless stated otherwise.
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Figure 2.4 Absorbance spectra of CdS QDs synthesized in buffers with varying NaCI concentration, at 80
"C using bPEI as the capping agent. The addition of salt appears to have no effect on the absorbance
properties of the synthesized QDs.
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Figure 2.5 Absorbance spectra of CdS QDs synthesized with varying concentrations of polyethylene glycol
surfactant, at 80 "C using bPEl as the capping agent. Addition of the surfactant does not appear to have a
significant effect on the absorption properties.
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The data presented in this section demonstrates that within the ranges investigated,
optimized QDs were synthesized at 80 "C in deionized water, without the addition of
acid, base, salt, or surfactant. All subsequent cationic polymer syntheses were carried out
at these optimized conditions, unless stated otherwise.
2.4.2 Investigating the Effect of Chain-Length
The effects of varying the concentration and molecular weight of the capping agent on
the optical properties of the synthesized QDs were investigated. QDs were synthesized by
equilibrating CdC12 (dissolved in water) with bPEI (25 kDa) for 10 mins, followed by
rapid addition of Na2 S (dissolved in water). Increasing concentrations of bPEI (25 kDa)
ranging between 2.5 and 1250 gtg/L, were added to the cadmium salt solution. The
particles were aged for 4 hours after synthesis, and optical properties were characterized
(Fig. 2.6). At low concentrations ofbPEI (2.5 pg/mL) the spectra are relatively flat and
featureless, indicating the absence of quantum confinement of CdS. Furthermore, after
mixing the reactants a fine, yellow precipitate formed that eventually settled down to the
bottom of the reaction vessel. The particles were likely large aggregates of bulk CdS that
formed due to insufficient polymer to mediate synthesis of finely dispersed QDs. As the
concentration of bPEI was increased (25 to 250 jtg/mL), the absorption spectra became
more defined and distinct peaks corresponding to exciton absorptions were visible. The
peaks also become more blue-shifted, indicating a decrease in particle size 27 . The CdS
solution remained visibly clear, and the large, yellow aggregates did not form. At very
high bPEI concentrations (1250 plg/mL), the absorption spectra became unfeatured again,
as the profile assosciated with quantized absorption was lost. However, the yellow
precipitate did not form, indicating that CdS did not aggregate. This suggests that when
the polymer concentration was very high, the nanoclusters formed did not demonstrate
fluorescence in the visible region. These data demonstrate that there is a range of
concentrations (concentration window) between which the polymers act as effective
capping agents to produce optically active CdS quantum dots. By varying the
concentrations within these ranges, the optical properties of the QDs can be manipulated.
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Figure 2.6 Absorbance profiles of QDs synthesized at 80 "C, with varying concentrations of 25kDa bPEI.
At very low and high bPEI concentrations, optically active QDs with well-defined absorption spectra are
not prepared. There is a range within which bPEI acts as an effective capping agent; increasing the
concentration of bPEI within this range causes blue-shifting of the absorbance spectrum.
To determine the effect of the molecular weight of the polymer on the optical properties
of the synthesized QDs, effective concentration windows of 2, 10, 25 and 70 kDa bPEl
were determined. Synthesis was conducted at polymer concentrations ranging between
2.5 and 1250 Jtg/mL, and the positions of the first QD absorption peaks were determined
(Fig 2.7). Blue-shifting of the first peak from the bulk value (-460 nm) reflects a
decrease in particle size, indicating effective capping2 . CdS treated with 2 kDa bPEI did
not demonstrate any blue-shifting, and visual inspection revealed the formation of yellow
precipitate that lacked fluorescence. The use of bPEI polymers (> 2kDa) within the
respective effective concentration windows resulted in blue-shifting of the absorbance
fronts. Using 10 kDa bPEI as the capping agent at concentrations between 2.5 and 250
ptg/mL produced optically active QDs, while higher molecular weight polymers were
effective at higher doses. 10 kDa bPEI passivated QDs demonstrated the most blue
shifting at lower bPEI concentrations than those prepared using 25 and 70 kDa polymers.
However, the maximum value of the blue-shift was approximately the same for all three
higher molecular weight bPEI's. This suggests that a critical minimum size of polymer is
needed, beyond which bPEI can act as an effective stabilizing agent. Above this size (> 2
kDa), the maximum blue-shifting of the peak position is approximately the same for all
polymers, but observed at different polymer concentrations. Smaller chain length
polymers also have smaller effective concentration windows and appear to form the most
blue-shifted QDs at lower concentrations than large molecular weight polymers.
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Figure 2.7 First absorption peak position as a function of bPEI molecular weight and concentration.
Polymers greater than 2 kDa are capable of producing optically active QDs. Increasing the molecular
weight of the polymer broadens the effective concentration window.
The effects of chain length on the optical properties of the synthesized QD may be
explained by considering two different factors that affect QD stabilization: electrostatic
association of the cationic polymer chain with the anionic nanocrystal, and the molar
concentration of the polymer. Since bPEI chains likely interact with the growing QDs by
I f i I
weak electrostatic interactions, increasing the polymer chain length reinforces these
interactions by enabling multiple electrostatic interactions, making the binding stronger.
For very short chain lengths the binding may not be strong enough to enable effective
passivation of the QD surfaces, resulting in the formation of CdS aggregates without
quantum confinement. As the chain length increases the binding is reinforced, resulting in
stronger interactions between the QD and the polymer, therefore facilitating the synthesis
of optically active CdS QDs. This effect is likely more pronounced at smaller chain
lengths, since progressively increasing the polymer chain length may have diminishing
enhancement on the polymer-QD binding. However, as the chain length of the polymer is
increased, its molar concentration decreases, at constant mass concentrations. Therefore
fewer chains are available to bind to the QDs. This could cause the effective
concentration window to broaden and move to higher concentrations, and explain why
maximum blue-shifting occurs at higher mass concentrations. While the binding between
each polymer chain and QD increases in strength with increasing molecular weight of the
polycation, there are fewer chains available to bind to the QDs. This mechanism predicts
that once the higher molecular weight polymers bind to the QDs, the association will be
very strong and the particles will be more effectively stabilized than by smaller molecular
weight polymers.
Stronger interactions between the passivating polymer and the QD surface may lead to
reduction in the number of defects on the QD surface, resulting in brighter fluorescence27
This hypothesis was tested by comparing the fluorescence of QDs synthesized at the
same mass concentration (125 pg/mL) using bPEI of different molecular weights (Fig
2.8). The sample prepared using 2 kDa bPEI did not show any fluorescence, while those
prepared using 10, 25 and 70 kDa bPEI showed increasingly brighter fluorescence. The
positions of the peak maxima were similar, located between 525 - 535 nm. This data
further supports that higher molecular weight bPEI binds more tightly to the surface of
the QDs, than does lower molecular weight bPEI.
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Figure 2.8 Fluorescence spectra of QDs synthesized using different molecular weights bPEI, at the same
mass concentrations. As the molecular weight of the QD-capping polymer increases, the fluorescence of
the nanoparticle becomes brighter and more blue-shifted.
The data presented in this section demonstrates that both the mass concentrations and the
chain length of the capping polymer have a significant effect on the optical properties of
the synthesized QDs; bPEI polymers with low molecular weights (< 2 kDa) are not
effective capping agents, while higher molecular weight polymers are effective within
defined concentration ranges. As the molecular weight of the polymer increases, this
effective window increases and moves to higher mass concentrations. QDs produced
using higher molecular weight capping agents demonstrate brighter fluorescence than
those prepared using low molecular weight ones.
2.4.3 Determining Effect of Molecular Structure
The effect of varying the molecular structure of cationic polymers was investigated by
using lPEI (25 kDa) and PAA (19 kDa) as capping agents. QD were synthesized by
equilibrating CdCl1 (dissolved in water) with the capping agent for 10 mins, followed by
rapid addition of Na2S (dissolved in water). The particles were aged for 4 hours after
synthesis, and optical properties were characterized. The effective concentration ranges
of the PEI and PAA were determined by synthesizing QDs at polymer concentrations
ranging between 2.5 and 1250 jtg/mL, and analyzing the positions of the first absorption
peak of the synthesized QDs (Fig. 2.9). Both polymers demonstrate blue-shifting of the
absorption peaks but to different extents, when present above a critical minimum
concentration. Maximum blue-shifting of IPEI capped QDs (350 nm) is less than that of
PAA capped QDs (325 nm), and both occur at approximately the same concentration of
the polymer (250 tg/mL), under the conditions tested. Therefore PEI forms QDs that
are larger in size than those produced by using PAA. The absorbance fronts of PAA
capped QDs show similar blue-shifts as those synthesized with similar molecular weight
bPEI (25 kDa, 325 nm), and therefore likely produce QDs similar in size. Both lPEI and
PAA have broader effective concentration ranges than bPEI, indicating that they are not
as effective as bPEI in mediating the synthesis of very small nanoclusters. This may be
due to the rigidity of their linear polymer backbones which limit their wrapping around
CdS nanoparticles. It could also be because the branched polymer has higher
hydrodynamic radius, enabling more efficient encapsulation of the QDs. This data
demonstrates that the optical properties of the QDs depend on both the chemical and
molecular structures of the polymer.
To further investigate the optical properties of the lPEI and PAA capped QDs,
absorbance and fluorescence spectra of QDs synthesized using IPEI and PAA at 125
mg/mL were analyzed (Fig. 2. 10). The absorbance spectra (Fig 2.1 Oa) have one peak
each; PEI stabilized QDs have an absorbance peak at 340 nm, while PAA terminated
QDs have a peak at 320 nm. They do not have the split-peak absorbance characteristic of
bPEI passivated CdS QDs. However their peaks individually correspond to those
obtained using bPEI (320 and 345 nm). It is possible that association of the secondary
amine with the CdS results in the more red-shifted peak at -340 nm (PEI, bPEI), while
association of the primary amine with the CdS QDs results in the formation of the more
blue-shifted peak at -325 nm (PAA, bPEI). Furthermore, lPEI capped QDs have sharp
absorbance profiles, whereas PAA coated QDs show a trailing rise. This suggests that the
QDs obtained using lPEI are more homogenous in size than those obtained using PAA.
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Analysis of the fluorescence spectra (Fig 2.1 Ob) reveals that IPEI coated QDs are not as
brightly fluorescent as PAA coated QDs, and both are less bright than bPEI capped QDs
(Fig 2.8). This further suggests that linear IPEI and PAA do not passivate the QD surface
as strongly as bPEI.
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Figure 2.9 First absorbance peak positions of QDs synthesized using IPEI and PAA as a function of
polymer concentrations. Both polymers are capable of mediating optically active CdS QD synthesis.
However, the absorption peaks are not as blue-shifted as those obtained when bPEI is used as the capping
agent.
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Figure 2.10 Optical properties of CdS QDs prepared using IPEI and PAA as the capping agents. (a)
Absorbance spectrum of the IPEI capped QDs is more defined and red-shifted than that of the PAA capped
QDs. (b) Fluorescence spectra of PAA capped QDs is significantly brighter and slightly blue-shifted than
that of the IPEI capped QDs.
The data presented demonstrates that the molecular structure of the polymer has a
significant effect on the properties of the synthesized QDs. QDs obtained using bPEI are
small with a sharp, well defined absorbance and bright fluorescence. QDs prepared using
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IPEI have well defined absorbance, but are not as bright. QDs prepared using PAA are
small and bright, but do not have well defined absorbance spectra. The "best" QDs are
those produced using bPEI, IPEI and PAA as the capping agents, synthesized at polymer
concentrations of 125 pg/mL.
2.4.4 Biointegration of cationic QDs
The surface charge of QDs capped with bPEI was characterized prior to integration with
cells. The zeta potentials were determined by measuring the electrophoretic mobility of
QDs in deionized water, prepared using bPEI (2, 10, 25 and 70 kDa), IPEI and PAA at
polymer concentrations of 125 mg/mL (Fig 2.11). The surface potential of all optically
active QDs are positive; samples synthesized with 2 kDa bPEI form large aggregates that
do not have a well defined surface charge, while nanocrystals produced with bPEI > 2
kDa, IPEI and PAA are cationic. This demonstrates that the surfaces of the optically
active QDs are coated with the cationic polymers.
Cellular interactions of the cationic polymer coated CdS QDs were probed by
characterizing the treated cells with microscopy (Fig 2.12). Cellular morphologies were
analyzed using light microscopy (left panel), cytotoxicity was determined by treating
with propidium iodide (PI) (red, middle panel), and complex uptake was monitored by
localizing the fluorescence of the nanoparticles (blue, right panel). PI is a cell
impermeant dye that undergoes 50-fold enhancement in fluorescence when it binds to
single-stranded DNA, and is therefore an indicator of dead or dying cells with
compromised cellular membranes and dissociated DNA. Cells treated with bPEI, IPEI
and PAA passivated QDs were small and rounded with fragmented membranes, lacked
distinct cellular organelles, and stained densely with PI, indicating widespread cell death.
There were low levels of blue fluorescence in the cells, indicating limited QD-complex
uptake or poor optical stability. These data demonstrate that the cationic QDs tested were
highly cytotoxic, and their subsequent use for bioapplications was not pursued.
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Figure 2.11 Zeta potentials of CdS nanoparticles synthesized using cationic polymers. All samples except
those prepared using bPEI 2 demonstrate positive zeta potentials, indicating that the surfaces of the QDs are
coated with cationic polymers. CdS treated with 2 kDa bPEI (bPEI 2) are neutral, likely due to the
aggregation of CdS (as demonstrated previously).
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Figure 2.12 Cells treated with CdS nanoparticles synthesized using (a) bPEI, (b) IPEI, (c) PAA and (d)
untreated cells. The fragmented morphology of the cells (left panel) and the intense PI staining (middle
column) demonstrate that cationic polymer capped CdS QDs are highly cytotoxic. Faint blue fluorescence
(right column) show QDs associating with cells.
2.5 Results & Discussion: Histidine Mediated Synthesis
The use of histidine oligopeptides to passivate CdS nanoparticles was investigated.
Synthesis conditions were reoptimized and the effects of varying peptide chain length on
nanoparticle optical properties, size and morphology were characterized.
Biocompatibility of histidine-passivated QDs was tested by incubating the "best"
nanoparticles with COS-7 cells.
2.5.1 Optimizing Synthesis Conditions
The reaction conditions of histidine oligopeptide mediated CdS QD synthesis were
optimized by varying the temperature and the pH of the reaction. QDs were synthesized
by equilibrating CdC12 (dissolved in water) with the capping agent for 10 mins, followed
by rapid addition of Na2S (dissolved in water). The particles were aged for 4 hours after
synthesis, and optical properties were characterized. Preliminary investigations
demonstrated that varying the temperature had the same effect on histidine-oligopeptide
mediated synthesis as it did on bPEI mediated synthesis (Fig 2.2); synthesis at higher
temperatures yielded QDs with better optical properties. Therefore synthesis was
conducted at 80 C. However, varying the pH of the precursor salt solutions had a very
different effect on the optical properties of the histidine-oligopeptide passivated QDs than
it did on bPEI capped QDs. Since histidine moieties likely mediate synthesis by a
different mechanism than bPEI QDs, a different response to solution pH is expected.
Histidine oligopeptides likely mediate synthesis by stabilizing the cationic metal ion with
the lone electron pair of the imidazole ring forming metal cation-imidazole bonds 2' (Fig
2.lb).
To determine the effect of varying precursor salt solution pH on the optical properties of
the QDs, nanoparticles were prepared using salts dissolved in pH adjusted water, with 10-
mer histidine oligopeptide (His 10) as the capping agent. Cadmium salts were dissolved
in pH 3, 5 and 7 solutions, and sulfide salts were dissolved in pH 7, 9 and 11 solutions,
and the absorbance of the synthesized QDs was characterized (Fig. 2.13). QDs prepared
from precursor cadmium salts dissolved in mildly acidic to neutral pH buffers (pH 5 - 7)
have more defined absorbance spectra than those prepared using cadmium salts in low
pH, highly acidic buffers (pH 3). Conversely, the absorbance spectra of QDs synthesized
with the sulfide salt dissolved in buffers at higher pH values (pH 7 - 9) show better
absorbance profiles than those prepared using sulfide salts in buffers at low pH values
(pH 5). Visually characterizing the fluorescence of the QDs under a UV lamp (Table 2.1)
demonstrated that QDs with more defined absorbance profiles have brighter, more blue-
shifted fluorescence. Therefore QDs produced from cadmium salts dissolved at pH 5 or
7, and sulfide salts dissolved at pH 9 or 11 produced QDs with bright blue, fluorescence.
However, if both the salt solutions had high pH (pH 7 and 11), the QDs precipitated out
of solution. Therefore the best combination of cadmium/sulfide solution pH was 5/11,
since it produced QDs with good absorption profiles, bright fluoresce, and high water
stability. All subsequent histidine-mediated syntheses of CdS QDs were conducted at
80°C, with the cadmium and sulfide salts dissolved in water with pH adjusted to 5 and 11,
respectively, without the addition of salts or surfactants.
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Figure 2.13 Absorption spectra of CdS QDs synthesized with the cadmium and the sulfide salts dissolved
in different pH buffers (pH cadmium salt / pH sulfide salt), using His 10 as the capping agent. QDs with the
defined absorbance profiles are prepared when sulfide salt is dissolved in high pH solutions (pH 11). The
pH of the cadmium solution does not appear to have a significant effect on the absorbance properties of the
synthesized QDs.
2.5.2 Investigating Histidine Oligopeptide Mediated Synthesis
The effect of varying the concentration of histidine peptides on the optical properties of
the synthesized CdS QDs was investigated (Table 2.1). QD were synthesized by
equilibrating CdC12 (dissolved in water) for 10 mins. with histidine oligopeptide,
followed by rapid addition of Na 2S (dissolved in water). The particles were aged for 4
hours after synthesis, and absorbance and fluorescence spectra of the nanoparticles
synthesized at different Hisl 0 concentrations were obtained. The spectra were
representative of nanoparticles synthesized using peptides with three or more histidine
residues. Concentration of the histidine peptide was expressed as the molar ratio of
histidine residues to cadmium ions, to enable investigation of the effect of covalently
linked histidine residues in the capping agent chain, on the optical properties of the
synthesized QD.
The absorbance spectra of CdS nanoparticles (Fig 2.14a) synthesized using varying
concentrations of His10 become more defined as the concentration of the peptide
increases (from 0 to 12). In the absence or very low concentrations of histidine peptides
(ratio between 0 and 2), spectra with low levels of broad absorption increasing
monotonically at wavelengths less than 500nm, are observed. This supports that non-
crystalline, non-homogeneous aggregates form in the absence of a stabilizer27 . As the
concentration of stabilizers is increased (ratio 4 and above), the absorbance spectra
become more defined. Distinct absorption peaks between 300nm and 500nm emerge,
indicating the formation of crystalline particles with progressively smaller sizes and
tighter size distributions. The peak positions of the absorbance fronts blue-shift with
increasing peptide concentrations, from 333nm at a ratio of 2, to 310nm at a ratio of 12.
pH of CdCI2
pH of Na2S 3 5 7
7 blank green green/blue
9 orange blue blue
11 blue blue blue (ppt)
Table 2.1 Fluorescence ofCdS QDs synthesized with the cadmium and the sulfide salts dissolved in
different pH buffers, using His 10 as the capping agent. Fluorescence is most blue-shifted when sulfide
salts are dissolved in high pH solutions (pH 1 1), and cadmium salts are dissolved in neutral pH solutions.
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Figure 2.14 Optical properties of CdS QDs prepared at varying concentrations of the HislO0 capping
oligopeptide. (a) Absorbance spectra become more defined and blue-shifted with increasing concentrations
of the oligopeptide. (b) Fluorescence spectra become slightly more blue-shifted with increasing
concentrations of Hisl 10 peptide.
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This blue-shift indicates increased quantum confinement of the energy levels which is
indicative of a decrease in the size of the synthesized nanoparticle. Analyzing the
fluorescence spectra (Fig 2.14b) reveals that in the absence of a terminator (ratio 0), the
samples demonstrate no detectable fluorescence. As the concentration of the histidine
peptide increases, the fluorescence of the particles becomes brighter and more blue-
shifted. At low doses of HislO (ratio 2), the particles display broad, dull fluorescence
between 400 nm to 600nm, with a peak at 498 nm. As the concentration of His 10 is
increased, the fluorescence intensity of the particles increases, and the peaks become
blue-shifted, to 442 nm (ratio 12). This may be due to a decrease in particle size as more
capping agent is available to passivate the nanoparticles with the peptide chain. The
decrease in nanoparticle size with an increase in terminator concentration may be
explained by probing the growth mechanism of the nanoparticles2 3'27. Growth of the QD
is in competition with termination due to binding with the histidine peptide. As the
concentration of the stabilizer increases, growth is hampered and the termination is
facilitated resulting in a shift of the equilibrium toward termination. This results in the
synthesis of smaller nanoparticles.
The effects of varying the chain length of the histidine peptides on the optical properties
of the QDs were also investigated. QDs were synthesized at different molar ratios of
histidine units to cadmium using histidine amino acid (Hisl), oligopeptides with 3, 5 and
10 histidine residues (His3, His5, His 1O), and poly histidine (pHis, 70-90 units), as the
capping agents. The absorbance spectra were obtained and used to determine the position
of the first absorbance fronts (Fig. 2.15a). CdS particles synthesized using histidine
amino acid did not have absorbance fronts (448-457 nm) that were significantly more
blue-shifted than those observed in bulk CdS (-450 nm)2 8. Visual inspection of the
solution revealed that CdS precipitated out as yellow aggregates. Nanoparticles prepared
using pHis had very blue-shifted absorbance fronts (308-331 nm) and did not produce the
yellow precipitate. As the number of covalently linked histidine units in the peptide
increases, the absorbance fronts became more blue-shifted. This effect was more
pronounced at shorter chain length oligopeptides, and diminished significantly as the
peptide length exceeded ten residues. At corresponding molar concentration of histidine
units to cadmium, QDs capped with peptides of higher chain lengths demonstrated more
blue-shifted absorbance spectra, indicating production of smaller sized nanoparticles.
Fluorescence of the nanoparticles was also obtained and used to determine the position of
the fluorescence fronts (Fig. 2.15b). Nanoparticles prepared using His1 showed no
detectable fluorescence. As the chain-length of the peptide increased, the position of the
fluorescence peak at the corresponding molar concentration of histidine units to cadmium
became more distinct and blue-shifted. His3 capped QD showed fluorescence at 547 nm
- 527 nm, while pHis capped nanoparticles had peaks at 469 nm - 415 nm.
The blue-shifting of the absorbance and fluorescence spectra indicate the synthesis of
smaller nanoparticles as the number of covalently linked histidine residues in the capping
agent increases. Increasing the chain length may change the dynamic binding strength of
the peptide to the cadmium ions on the surface of the growing nanoparticle. Data in
literature suggests that histidine imidazole ring coordinates the divalent metal cations via
labile electrostatic interactions (Fig 2. lb)25. At any given time, dynamic equilibrium is
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maintained between the associated and dissociated molecules. If several histidine
residues are covalently linked, the probability of association between the chain and the
growing crystal increases, since there are multiple possible association sites.
Furthermore, as some of the chains coordinate cadmium, other non-associated histidine
residues are brought in close contact with the surface of the growing nanocrystal, thus
facilitating attachment. Thus several covalently linked histidines may reinforce labile
imidazole-cadmium bonds, facilitating stronger binding between the terminator and the
growing nanocrystals, and resulting in early termination 24. This hypothesis is further
supported by the diminishing decrease in particle size as the chain length is increased;
cooperativity effects are greatest at short chain lengths, and become less pronounced as
the chains elongates.
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Figure 2.15 Optical first peak positions of CdS QDs as a function of histidine oligopeptide chain length
and concentration of capping agent. (a) Absorbance and (b) fluorescence peaks are blue-shifted as the
number of covalently linked histidine residues in the capping oligopeptide increases, and as the
concentration of the peptide is increased.
The nanoparticle sizes scale as a function of the concentration and length of the capping
agents, and were determined using the position of the absorption fronts (Table 2.2)26. The
particle sizes decrease with increasing concentrations of the stabilizer. As the amount of
i·
E
E
His lO is increased from histadine to cadmium ratio 2 to 12, the size of the particles
decreased from 2.60 nm to 2.36 nm. Increasing the number of histidine residues in the
terminator also decreases the particle size; the size of His3 capped nanoparticles ranges
between 3.40 nm - 2.98 nm, while pHis capped QDs range between 2.58 nm - 2.34 nm.
While the nanoparticle size decreases with an increase in both, the histidine peptide dose
and chain length, the latter appears to have a greater effect on controlling the particle
size.
concentration Particle Diameter (nm) (0.2)
ratio His1 His3 His5 Hisl0 pHis
2 5.10 3.40 2.74 2.60 2.58
4 5.42 3.12 2.71 2.47 2.41
6 5.31 3.09 2.60 2.47 2.36
8 5.26 3.11 2.59 2.39 2.36
10 5.17 2.98 2.60 2.36 2.36
12 5.07 2.98 2.60 2.36 2.34
Table 2.2 Sizes of CdS QDs synthesized using histidine oligopeptides of different lengths, and at different
concentrations. As the number of covalently linked histidine residue and the concentration of the capping
agent increase, the sizes of the synthesized QDs decrease.
The morphology, crystallinity and size of the QDs were further probed by using
transmission electron microscopy (TEM) to characterize QDs prepared using His3 and
pHis peptides, at a ratio of 6:1 (Fig. 2.16a & b). The QDs are spherical in shape and
appear as discrete particles, not visibly aggregated. There are visible differences between
the two samples; those produced using His3 are larger (3.9nm ± 1.lnm) and have greater
size variations than those produced using pHis (2.9 nm ±0.6 nm). These trends are in
accordance with those inferred from the blue-shifts of the absorbance and fluorescence
fronts (Figure 2.14), and the respective sizes are similar to those calculated using the
absorbance fronts (3.1 nm and 2.4 nm respectively, Table 2.2). High resolution TEM
images determined the lattice spacing and crystalline structure of the QDs (Fig. 2.16c).
The lattice spacing of the QDs imaged are 3.1 A (left) and 2.7 A (right), and correspond
to cubic CdS, which has lattice spacings of 3.16 A3 and 2.73 A29. Cubic packing has been
previously observed in CdS nanoparticles synthesized in aqueous solutions, and is
different from the hexagonal packing observed in bulk CdS29 . This demonstrates that the
histidine polypeptides do not act exclusively as passive surface coatings, but may be
involved in the nucleation and stabilization of the QDs.
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Figure 2.16 Transmission electron microscopy (TEM) images of CdS QDs prepared using histidine
oligopeptides. QDs prepared using (a) His 3 as the capping agent are larger and more polydisperse than
those prepared using (b) His 10 as the capping agent (scale bar 20 nm). (c) High resolution TEM images
reveal lattice fringes, which demonstrate the crystallinity of the QDs core (scale bar 5 nm).
2.5.3 Biointegration of histidine mediated QDs
Cellular interactions of the histidine oligopeptide passivated CdS QDs were probed by
characterizing cells treated with nanoparticles synthesized using His3, His5, Hisl0 and
pHis, at histidine to cadmium molar ratios of 10:1 (Fig 2.17). Cells were incubated with
QDs for 1 hr, and imaged 12 hours post treatment. Cellular morphologies were analyzed
using light microscopy (left panel), and QD uptake was monitored by localizing the
fluorescence of the nanoparticles (blue, right panel). The cells are spread out with intact
cellular and nuclear membranes and distinct cellular organelles, indicating that the QDs
are not highly toxic. However, fluorescent imaging reveals that the QDs have poor
optical properties; the fluorescence diminishes within a few hours post treatment and the
particles aggregate in solution, as demonstrated by the diffuse blue fluorescence (right
panel). Therefore their subsequent use for bioapplications was not pursued.
Figure 2.17 Cells treated with CdS QDs prepared using (a) His 3, (b) His 5, (c) His 10, and (d) untreated
controls. The cells (left panel) are not curled up and fragmented, but extended and sprouting processes, and
therefore viable. Faint blue fluorescence (right column) indicates the presence of QDs which are aggregated
in solution.
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2.6 Summary & Conclusions
2.6.1 Cationic polymer-mediated synthesis
* Both mass concentrations and chain lengths of the capping polymer have an effect
on their QD-passivating properties.
o bPEI (> 2 kDa) produce optically active CdS nanoparticles
o polymers have effective concentration ranges within which they mediate
synthesis of CdS QDs
o increasing molecular weights result in increasing the effective
concentrations range of the polymer
o higher molecular weight polymers yield QDs with brighter fluorescence
· Molecular structure of the polymer affects the optical properties of QDs.
o bPEI coated QDs are small with tightly controlled size distribution, have
sharp, well defined absorbance and bright fluorescence
o IPEI passivated QDs have well defined absorbance and tight size
distributions, but are larger and not as bright
o PAA terminated QDs are small and bright, but do not have well defined
absorbance spectra or controlled size distributions
· QDs prepared using the cationic polymers have positive surfaces
· Cationic QDs are all highly cytotoxic. and therefore not suitable for
bioapplications.
2.6.2 Histidine oligopeptide-mediated synthesis
* Histidine oligopeptides with 3 or more covalently linked residues can be used as
effective stabilizers to produce optically active CdS QDs.
· Number of covalently linked histidine residues affects the properties of the
synthesized QDs.
o the size of the synthesized particle and the particle size distribution
decreases with increasing chain length
o absorbance and fluorescence become more blue-shifted with increasing
chain length
* CdS QDs have crystalline cores and cubic packing.
· Histidine mediated CdS QDs can not be used as bioprobes since they do not
demonstrate good optical properties when incubated with cells, and aggregate in
solution.
Therefore the use of aqueous-based QDs as bioprobes was not pursued further, and the
use of commercially available QDs was investigated.
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Chapter 3: Layer-by-Layer Modification of CdSe/ZnS &
GaN Nanocrystals
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Chapter Synopsis
Objective
The aim of this section was to deposit oppositely charged polymer layers on the surface
of quantum dots (QDs), demonstrate use of the charged complex as building blocks for
assembling hierarchal structures, and test versatility of the technique by using
nanoparticle cores and polyelectrolytes with different chemical compositions.
Hypothesis
Coating QDs with polymers may enable functionalization of their surfaces and
manipulation of their chemical properties, enabling assembly of diverse nanoparticle-
polyelectrolyte hybrid complexes stable enough to be integrated into ordered arrays.
Rationale
The use of QDs for biological applications requires modification of the nanoparticle with
diverse functionalities to allow tailoring of QD-cellular interactions for specific
applications. Electrostatic layer-by-layer deposition of oppositely charged
polyelectrolytes is a fast, versatile technique that enables integration of multiple
functionalities and has been demonstrated for nanomaterials such as gold nanoparticles.
Assembling the QD-polymer complexes into ordered structures will demonstrate stability
and manipulability of the hybrids.
Results
Here we optimize a procedure for CdSe-ZnS QD surface ligand exchange by displacing
hydrophobic trioctyl phosphine oxide (TOPO) ligands with mercaptoacetic acid (MAA),
enabling the QDs to be dispersed in water. Surface potential measurements revealed that
the QD-MAA were anionic, and subsequent coating with cationic polyallylamine (PAA)
polymer rendered them positively charged. The single-layer, cationic QD-polymer
complexes were subsequently coated with another layer of anionic polvinylsulfonate
(PVSA) polymer, resulting in a second surface charge reversal. Analyzing the absorbance
spectra and morphologies of the heterostructures revealed that the optical properties did
not change significantly, and that the QDs were individually coated.
Integration of polymer coated QDs into ordered heterostructures was also demonstrated.
Cationic QD-PAA and anionic QD-MAA selectively adsorbed to oppositely charged
substrates, and were sequentially deposited on anionic hyaluronic acid (HA) patterned
glass substrates to form glass/HA/QD-PAA/QD-MAA bilayers. Charged QDs show
preferential binding to oppositely charged islands, and not to the uncharged, non-
adhesive glass substrates. These patterns were stable, reproducible over multiple length
scales, and showed high fidelity.
The robustness of the layer-by-layer modification technique was tested by coating GaN
QDs with different cationic and anionic polyelectrolytes. Monitoring the surface charge
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revealed characteristic surface charge reversals, and deposition on patterned substrates
demonstrated selective adsorption on oppositely charged substrates.
Conclusions
Layer-by-layer deposition of polyelectrolytes on QDs enabled surface functionalization
of nanoparticles, while preserving the properties of the individual, inorganic QD cores.
These hybrids were stable enough to be integrated into ordered heterostructures, and the
technique was versatile enough to enable incorporation of nanoparticles and polymers
with diverse chemical compositions. These hybrids may be tailored for bioapplications.
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3.1 Background
Commercially available high quality CdSe-ZnS QDs with finely tunable morphologies
and optical properties are prepared in organic solvents, with bulky, organic surface
capping ligands like trioctyl phosphine/trioctyl phosphine oxide (TOP/TOPO)1'2. QDs
coated with these ligands are hydrophobic and therefore not miscible with aqueous
environments, limiting their applications; biointegration of QDs requires easy suspension
of the nanocrystals in aqueous solutions, and ready integration with functionalized
materials 9 . Several modification schemes render the TOPO-coated QDs soluble in
water: (i) exchanging the hydrophobic surface ligand, (ii) encapsulating QD-TOPO
complexes in amphiphillic functionalized materials, or (iii) hybrid combinations of the
two techniques. Some common techniques used to make hydrophobic QDs water
compatible, their advantages and limitations, and ease with which diverse functionalities
can be integrated are discussed in the subsequent sections.
The most common method of rendering QDs miscible in water is by replacing the
hydrophobic TOPO with hydrophilic ligands. TOPO molecules passivate the QD surfaces
by coordinating the lone pair of electrons of phosphorous, with the dangling surface
metal cations (Fig. 3.1 a)l° . However, these interactions are labile with the coupling
between TOPO molecules and the metal surfaces in dynamic equilibrium 4. The
introduction of a second ligand which binds to the dangling surface metal cations more
strongly than the TOPO phosphine moiety results in displacement of TOPO, and
association of the new ligand. Thiol-, imidazole- and other phosphine-containing ligands
demonstrate high affinity for the metal nanocrystals, and effectively displace the TOPO
molecules4 " .12. However, the ability of these modified QDs to remain suspended in
water depends on the hydrophillicity of the functionalities attached to the metal-
coordinating moieties; polar, charged side groups facilitate dispersion of the QD-ligand
complexes aqueous environments, and render them dispersible and stable in water (Fig
3.1), while amphiphillic or hydrophobic functionalities can cause aggregation' 3 . Several
ligands have been used for TOPO ligand displacement, of which the thiolated-
carboxylates4 are the most common. These bifunctional ligands have a nucleophillic thiol
on one end that coordinates with the dangling surface metal cations, and a charged
hydrophilic carboxylate on the other end that renders the modified QDs water soluble.
While this technique is quick and inexpensive, the thiol-cadmium interactions are also
labile and the ligands bound to the surface are in dynamic equilibrium with the solution 4.
Repeated modifications and extended exposure to aqueous environments causes
aggregation of modified nanoparticles. This aggregation (Fig 3.2)1415 is due to depletion
of the surface ligands and the formation of disulfide bonds between them, and
compromises the structural and optical integrity of the QDs. The use of polydentate
ligandsl6 7 to coordinate with the metal cations has been investigated, and while they
bind more strongly to the QD surface, such materials require preparation and
modification procedures that are time and resource consuming.
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Figure 3.1. Displacement of TOPO from the QD surface, and suspension of the modified QD in solution
depends on the chemical properties of the displacing ligand. If the ligand has a strong nucleophillic moiety
(b, c), it can replace TOPO from the QD surface by coordinating with the metal cation. However, if it does
not have such a functionality, then the QD will remain passivated with TOPO (a). The stability of the
modified QDs in aqueous solution depends on the ability of the modifying ligand to cause repulsion
between the QDs, to overcome intrinsic van der Waals forces. Ligands with strongly charged moieties (b)
enable QDs to remain individually suspended in solution, while those capped with uncharged ligands (c)
aggregate in solution.
Coating and encapsulating hydrophobic QDs with functionalized materials has been
previously demonstrated. Amphiphillic materials including phospholipid micelles' 8 ,
organic dendrons 19'20, simple and block co-polymers 21 have all been used to produce
water-miscible QDs. The lipophillic regions of the amphiphillic materials associate with
the organic ligands through hydrophobic interactions, while the hydrophilic regions
coordinate with water to facilitate suspension in aqueous solutions. While the individual
hydrophobic interactions coordinating the amphiphillic material to the QD-TOPO cores
are weak, they are collectively reinforced forming stable envelopes around the inorganic
core. These modified QDs remain suspended over extended periods of time, and can
undergo chemical modification without aggregating. Diverse chemical functionalities
integrated in the hydrophilic region of the amphiphillic coating can help produce water
miscible QDs with varied surface functionalities. However preparation of functionalized
materials requires several modifications steps that are time and resource intensive, and
encapsulating the bulky hydrophobic QD-ligand significantly increases the size of the
modified nanoparticle complex.
Hybrid techniques combining ligand exchange and QD encapsulation have also been
demonstrated, the most common involving the growth of silica shells around modified
QD cores (Fig 3.3) 22 . The hydrophobic QD surface ligands are first exchanged with thiol-
containing silane (e.g. mercapto-trimethoxysilane) followed by cross-linked of the silanes
to form a siloxane shell. Diverse chemical functionalities can be incorporated into the
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shell to tailor the surface chemistry, including amino, phospho- and polyethylene glycol
moieties. However, this method is very labor intensive involving extensive QD
modification and the synthesis of functionalized materials. Furthermore, the polymer
shells dissolve after extended exposure to aqueous environments .
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Figure 3.2 Aqueous instability of QDs coated with thiol-containing ligands. Nucleophillic thiols coordinate
with metal cations forming labile thiol-metal bonds. However, oxidation of the thiols leads to the formation
of disulfide bonds, which leave the surface of the QDs unpassivated. These uncoated nanoparticles oxidize
in solution and aggregate due to high van der Waals forces (reproduced from reference 14 with
permission).
In addition to the aforementioned techniques, layer-by-layer deposition of
polyelectrolytes on particle surfaces for coating colloids, microparticles24 ,2' and gold
nanoparticles26 has been previously demonstrated. This technique entails electrostatically
depositing layers of oppositely charged polyelectrolytes on functionalized particle
surfaces, leading to the assembly of multi-layered structures (Fig 3.4)5". Each step in the
deposition cycle is characterized by charge reversal due to the overcompensation of
charge neutralization, characteristic of electrostatic layer-by-layer assembly systems27
This is a simple and versatile technique that enables integration of several functionalities,
but was not used to modify QDs at the time this research was initiated, likely due to the
r
small size, high surface curvature and difficult surface chemistries
manipulation, making it tedious and time-consuming 28' 29.
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Figure 3.3 CdSe-ZnS QD stabilization by silanization. (a) Silane-containing thiols displace TOPO from the
nanoparticle surface. (b) Silanes are polymerized to form primary siloxane shells. (c) Additional silanes
with versatile surface chemistries are subsequently incorporated and cross-linked with the primary siloxane
core (reproduced from reference 22 with permission).
Herein we (i) optimized a method for exchanging the QD hydrophobic ligands to make
the modified nanoparticles miscible with water, (ii) developed surface coating techniques
using layer by layer deposition of polymers on QDs to tailor nanoparticle surface
chemistries, (iii) integrated the QDs into ordered heterostructures to demonstrate their use
as building blocks, and (iv) tested the robustness of the technique by integrating QDs and
polyelectrolytes of varying compositions. This technique can enable ready assembly of
multi-layered structures with diverse chemical properties that can be integrated with
biological systems.
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Figure 3.4 Layer by layer deposition of polyelectrolytes on QD surfaces. Hydrophobic TOPO is displaced
using MAA, which renders the QDs water miscible and anionic. These QDs are subsequently coated with
cationic and anionic polymers, resulting in the assembly of hybrid nanocomplexes (reproduced from
reference 15 with permission).
3.2 Specific Aims
Optimize CdSe-ZnS Modification Protocol
· Select TOPO-exchange ligand for passivating CdSe-ZnS QD surfaces thereby
enabling suspension in aqueous solutions.
· Determine the effect of temperature, resuspension buffer and purification techniques
on the optical properties and miscibility of the modified QDs.
Demonstrate layer-by-layer deposition of polyelectrolytes on QD
surfaces to assemble multi-layered structures.
· Prepare and characterize single- and multi-layer structures with alternating charges
· Determine the effect of polymer coating on the optical properties and morphology of
the QD.
Manipulate QD-polymer hybrids
· Assemble bi-layers of oppositely charged QDs on patterned substrates to produce
ordered structures.
· Test the reproducibility and fidelity of electrostatically assembled structures.
Test Versatility of the Technique
* Investigate robustness of the coating technique by integrating inorganic cores and
organic polyelectrolytes of varying composition.
· Assemble and characterize bi-layers of oppositely charged QDs on patterned
substrates.
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3.3 Materials & Methods
3.3.1 Experimental setup
Materials
CdS-ZnS QDs were purchased from Evident Technologies. Polyelectrolytes were
purchased from Sigma Aldrich and Fluka Chemicals. All chemicals were purchased from
Sigma Aldrich at reagent grade.
Characterizing Physical Properties
The absorption spectra of undiluted particles were obtained using a UV/Vis spectrometer
(Beckman Coulter, DU 800). Surface charge of the polyelectrolyte coated QDs
suspended in 50 mM NaCl in deionized water was determined using the Smoluchowski
method (ZetaPals Analyzer).
,Slubstrate Patterning with HA
The hyaluronic acid (HA) patterned glass slides were prepared as described
elsewhere3 "'31. Polydimethylsiloxane (PDMS) stamps were prepared by casting against
silicon masters fabricated using photolithography. The stamps and the glass surfaces were
both plasma cleaned for 2 mins (model PDC-001, Harrick Scientific Inc.), the slides were
spin coated (model CB 15, Headaway Research, Inc.) with 5 mg/mL of HA and brought
into conformal contact with the PDMS stamp. The HA was allowed to evaporate
overnight before the stamp was peeled off and freshly exposed patterned surfaces were
washed three times by immersing in deionized water. A thin film of QDs-PAA (cationic)
was deposited on the substrate for 30 minutes and excess QDs were removed by washing
the substrate with deionized water. A subsequent layer of QDs-MAA (anionic) was
similarly deposited on QDs-PAA coated surfaces, and the sample washed and allowed to
air dry.
Microscopic Characterization
Fluorescence images were obtained using an Olympus microscope (IX51) with GFP (ex
450/40, em 525/50) and TRITC (ex 535/50, em 610/75) filters using SimplePCI software.
Fluorescence was quantified using Scion Image software. The AFM was operated in the
tapping mode at a scan rate of 0.5 Hz using 300 kHz (MikcoMasch) tips. Images were
taken on a NanoscopeIV (Digital Instruments) and data was manipulated using
Nanoscope IV (version 6) software (Veeco Instruments Inc.).
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3.3.2 Experimental design: CdSe-ZnS QD Modification
Optimizing QD Ligand Exchange Protocol
(1) Select surface modification ligand (MAA,
MEA, MEtOH, Cystine)
, o
L
t
(2) Determine optimal modification temperature
(30 C, 50 C, 80 C)
(3) Test different resuspension buffers of varying
pH (2 - 12) and salt concentrations
I
]
(4) Optimize secondary purification of QD-ligand
from organic impurities
(5) Select optimal
conditions
Optimizing QD polymer coating Protocol
(1) Determine effective concentrations and purification
protocols for cationic polymer coated QD-ligand
(2) Test coating with bPEI of varying molecular weights
(0.7, 2, 10, 25 & 75 kDa)
(3) Determine effective concentrations and purification
protocols for anionic polymer coated QD-polymer
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Integrating Modified QDs into Devices
(1) Coat CdSe-ZnS QDs with cationic PAA
and anionic PVSA
[
(4) Repeat for GaN QDs to test robustness of 1
the technique
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(2) Characterize QD properties (surface
charge, absorbance, morphology)
(3) Test electrostatic deposition & device
assembly
I
I
3.4 Results & Discussion
3.4.1: Optimizing CdSe-ZnS Modification Protocol
Surface ligand exchange of TOPO capped CdSe-ZnS QDs with different mercapto-
containing molecules was investigated. Ligand exchange was optimized by varying the
temperature, pH of the resuspension buffer, and the modification protocol. The effects of
varying modification parameters on the ease of suspension in aqueous solutions and on
the fluorescence properties of the modified QDs were characterized.
Selecting ligand for QD surface passivation
The first step in making QDs water-miscible was to exchange the bulky, hydrophilic
TOPO group with another ligand that is: (i) strongly nucleophillic to coordinate with the
dangling surface metal cations, (ii) hydrophilic to enable suspension in aqueous
environments, and (iii) self-repellent to prevent aggregation of the QD in solution. For
this exchange, thiol-containing ligands were tested since the sulthydryl is strongly
nucleophillic, and such ligands conjugated with different pendant functionalities are
readily available. Ligands tested included mercapto acetic acid (MAA), mercapto
ethylamine (MEA), mercapto ethanol (MEtOH) and cysteine (Cys).
Modification of hydrophobic TOPO capped CdSe-ZnS QDs with MAA, MEA, MEtOH
and Cys was carried out, and stability in aqueous solutions was investigated. QDs were
modified by suspending in chloroform, mixing with ligands reconstituted in DMSO (if
necessary), sonicating at 80 °C, precipitating with ethanol, and resuspending in deionized
water. The ease with which the modified QDs resuspended in water, and the intensity of
their fluorescence when observed under a UV lamp, were used as indicators of QD
stability in the aqueous environments (Table 3.1). QDs treated with MAA were the
easiest to resuspend, showed the least amount of aggregation, and demonstrated the
brightest fluorescence of all modified QDs. MEA treated QDs also resuspended easily,
but were not as brightly fluorescent as MAA-treated QDs, and settled out of solution a
few hours post-treatment. MEtOH and Cys treated QDs did not resuspend but remained
aggregated and demonstrated very limited fluorescence.
The difference in the ease of resuspension and the optical properties may be attributed to
both, the inherent properties of the QDs, and the surface passivation ability of the
exchange ligands, which depends on the chemical functionalities of their pendant chains.
QDs suspended in solution are subject to both attractive and repulsive forces, and
whether they aggregate or remain finely dispersed depends on which forces dominate ' .
Their small sizes leads to the development of large van der Waals forces, causing
hydrophobic attraction between the QDs. However, the surfaces of the nanoparticles are
highly negatively charged due to adsorption of hydroxyl molecules to the dangling bonds
of the surface metal cations (Fig 2. la, Section 2.1). The presence of the polar/charged
pendant chains of the thiol-containing ligand, or the bulky organic side group of TOPO
lead to electrostatic or steric repulsion between the suspended QDs, thus facilitating
dispersion in the solvent. If the pendant chains are not strongly charged, as in the case of
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MEtOH and Cys, the modified QDs do not have enough repulsion between them to
enable dispersion in water, and therefore aggregate. However, if the ligands are
functionalized with highly charged moieties, as are MEA and MAA, there is sufficient
repulsion between nanoparticles to enable dispersion in aqueous solutions. Therefore
MAA and MEA treated QDs resuspend in water, while MEtOH and Cys treated QDs
aggregate. Furthermore, MAA is anionic which may enhance the inherent negative
charge of the QD and enable the modified QD to remain suspended in aqueous
solutions'° . MEA is positively charged, which may compete with the inherent negative
charge of the QD and therefore produce modified QD that are not as stable as those
treated with MAA.
Surface Ligand Suspension Fluorescence
MAA clear high
MEA clear medium
MEtOh aggregated low
Cystiene aggregated low
Table 3.1 Testing different thiol containing ligands as stabilizers for QD. MAA stabilized QDs are the
easiest to resuspend, and the brightest in solution, when compared to QDs treated with MEA, MEtOH and
cysteine.
To test the differences in surface charges of MAA and MEA treated QDs, their
electrophoretic mobilities were measured over a range of values between pH 2 and 7 (Fig
3.5). MAA treated QDs were predominantly negative over the entire range, while MEA
treated QDs went from being positively charged to negatively charged at an approximate
isoelectric point of 5.5. Since the pH of the resuspending deionized water was
approximately 5.0, QD-MAA are expected to be highly negatively charged (-40 mV),
while QD-MEA are only slightly positively charged (10 mV). This further demonstrates
that the difference in stability of the MAA and MEA treated QDs was due to differences
in electrostatic surface potentials. Based on the data presented, MAA was selected as the
TOPO displacement ligand for all subsequent modifications.
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Figure 3.5 Surface zeta potentials of MAA and MEA treated QDs over a range of pH values. MAA
passivated QDs are highly negative at all pH values above 3, while MEA passivated QDs undergo charge
inversion at approximately pH 5.5. (Error bars between 2 - 7 mV)
Optimizing ligand exchange
Once the exchange ligand was selected, the exchange protocol was optimized to allow
assembly of stable, finely dispersed QDs. The first step was to vary the temperature of
the sonicating water bath to determine its effect on the dispersion and fluorescence of the
modified QDs (Table 3.2). QDs modified at higher temperatures (80 "C) were more
readily dispersed, and had brighter fluorescence than those modified at lower
temperatures (50 and 30 'C). Therefore higher temperatures are better for surface ligand
exchange reactions. Since association of TOPO with the QD is a labile equilibrium
reaction, increasing the temperature likely increases the rate at which the ligands
dissosciate/assosciate with the surface 4. However, once TOPO dissociates, it is likely that
MAA associates with the QDs instead of TOPO, since the former is available in excess
and has a higher affinity for the metal cation than TOPO. Therefore increasing the
temperature shifts the equilibrium towards MAA binding to the QD surface, and all
subsequent ligand exchange reactions were carried out at 80 "C.
Temperature ("C) Suspension Fluorescence
30 aggregated low
50 clumpy medium
80 clear bright
Table 3.2 Investigating the effect of temperature on QD ligand exchange. QDs modified at high
temperatures (80 "C) are easier to resuspend in solution and have brighter fluorescence than those modified
at low and moderate temperatures (30 and 50 "C).
The second step in optimizing the exchange protocol was to vary the pH values of the
QD-MAA resuspension buffers. Excess MAA and TOPO were removed by precipitating
the ligand exchange solution with ethanol, centrifuging to pellet the displaced QD-MAA,
and removing the supernatant. The pellet was subsequently resuspended in pH adjusted
water, and the fluorescence of the solution characterized (Fig 3.6). The results
demonstrate that increasing pH results in enhancement of fluorescence and blue-shifting
of the emission peak. This effect is very pronounced at low pH values, and becomes less
significant at higher pH values; the fluorescence reaches 90% of its maximum value
when QD-MAA are suspended in pH 9 solution. Addition of small amounts of salt to the
pH adjusted water further facilitated QD-MAA resuspension, without affecting their
fluorescence. Therefore, high pH buffers prepared at low concentrations were tested as
resuspension solutions. Tris base buffer (50 mM, pH 9)26 demonstrated excellent
resuspension and bright fluorescence of the modified QD-MAA, and was therefore
selected as the resuspension buffer and used for all subsequent modifications.
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Figure 3.6 Varying pH of the resuspension buffer of MAA modified QDs. QDs resuspended in high pH
solutions (> 9) demonstrate significantly brighter fluorescence.
The final step in optimizing the ligand exchange was purification of the QD-MAA from
residual organics. If this is not performed, too many organic impurities remain in the
solution causing it to turn cloudy. If the QD-MAA solution is purified too many times
then the MAA ligand is stripped from the QD surface causing the QDs to aggregate.
Since both of these can interfere with subsequent QD coating with polyelectrolytes, it is
important to optimize the separation procedure. The QD-MAA suspended in tris buffer
were precipitated with twice the volume equivalent of isopropanol (polarity index 3.9).
Ethanol does not precipitate the QD-MAA from tris solution since it is highly polar
(polarity index 5.2), and therefore not strong enough to displace QD-MAA. The volume
of isopropanol is critical, since too little does not displace the QD-MAA, and too much
results in aggregation of the QDs, likely due to stripping of MAA from the QD surface.
The displaced QDs were centrifuged briefly, the supernatant removed, and QD-MAA
resuspended in tris-base buffer. The purified QDs were subsequently modified by coating
with cationic polymers.
3.4.2 Demonstrating layer-by-layer deposition of polyelectrolytes
on QD surfaces to assemble multi-layered structures
The protocol26 for layer-by-layer (LbL) coating of CdSe-ZnS QDs (3.2 nm, green) was
optimized and surface charge, optical properties and morphology of the complex were
characterized.
Optimizing polymer deposition technique
Preparing disperse, individually wrapped, cationic polymer coated QD-MAA required
optimization of the coating and purification procedures. The first step was to determine
optimal concentrations of the QD-MAA and cationic polymers. QD-MAA were
suspended in aqueous solutions at 30 - 50 jpg/mL, as determined using optical
measurements (Appendix I). More concentrated QD solutions resulted in aggregation
when added to the cationic polymer, and lowering the QD concentration increased the
purification time. High concentrations of the polyelectrolyte were necessary since it must
be in excess to over-compensate for the anionic QD-MAA. Branched polyethyleneimine
(bPEI, 25 kDa) was used coating polymer, and solutions were maintained at 10 mg/mL;
lower concentrations resulted in QD clumping while higher concentrations made some
polymer solutions very viscous.
Next. QD-MAA were rapidly mixed with 10 mg/mL polymer solution. It was important
to add the QD-MAA to the polymer so that the latter is always in excess, which
facilitated individual coating of the particles. The QD-MAA/cationic polymer solutions
were vigorously vortexed, and incubated on benchtop for 20 minutes to ensure complete
electrostatic association between the QD and the polyelectrolyte. The excess polymer was
removed using Amicon filters (100 kDa cutoff), according to manufacturer's protocols.
Several other purification methods were tested (centrifugation, dialysis, mircospin
columns and gel filtration) but none were successful as they caused aggregation of the
QDs.
The effect of varying molecular weight on the ability of the polymer to coat QDs was
also investigated. Cationic bPEI polymers of different molecular weights (0.7, 2, 10, 25
and 75 kDa) were used to coat QD-MAA surfaces, and the ease of resuspension and
fluorescence were characterized (Table 3.3). QD-MAA coated with bPEI with a
molecular weight of 10 kDa or greater did not aggregate after purification and exhibited
bright fluorescence. However, QD-MAA coated with bPEI less than 10 kDa did not
resuspend well after purification, and had very weak fluorescence. The data demonstrates
that larger molecular weight polymers are more efficient at coating and stabilizing QD-
MAA surfaces than shorter chain polymers. Since individual electrostatic interactions are
weak, increasing the chain length may facilitate multiple interactions thereby reinforcing
the electrostatic interactions. This can make it easier for high molecular weight polymers
to overcompensate for charge neutralization, mediating assembly of positively charged
polymer coated QD that are stable in water27. For all subsequent modifications, polymers
with molecular weights between 10 to 70 kDa were used.
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MW bPEI Suspension Fluorescence
700 aggregated bright
2,000 aggregated bright
10,000 clear bright
25,000 clear bright
70,000 clear bright
Table 3.3 Effect of polymer chain length on the coating QD-MAA. Polycationic bPEI coated QD-MAA are
stable in solution when coated with high molecular weight polymers (> 2 kDa).
The final step was to test assembly of multiple layers. The QD concentrations were
further reduced to keep the solution from turning turbid due to aggregation and cross-
linking of highly cationic QDs and anionic polymers. Purified QD-bPEI were suspended
at a concentration of 5 ~pg/mL. These were added to 10 mg/mL anionic PVSA polymer. It
is important to maintain the anionic polymers in significant excess, to ensure that the
cationic QDs are individually coated and to minimize cross-linking. The cationic QD
solution was mixed slowly with the anionic polymers while vortexing to facilitate
electrostatic interactions. The solution was incubated on the bench top for 20 minutes,
and excess anion was removed by purifying through Amicon filter (100 kDa), as
described previously. All subsequent QD modifications were made according to this
optimized procedure, unless stated otherwise.
Characterizing properties of QD-polymer complexes
Once the procedure for polymer coating the QDs was optimized, surface charge, optical
properties and morphology of the modified nanoparticles were analyzed. QDs were
sequentially coated with cationic polyallylamine (PAA, 19 kDa) and polyvinylsulfonic
acid (PVSA, 25 kDa). The surface charge of modified QDs suspended in 50 mM NaCl
solutions was determined by measuring their electrophoretic mobility (Fig 3.7). Zeta
potentials of two different sized CdSe-ZnS QD, green 3.4 nm (solid bars) and red 7.2 nm
(hatched bars), were measured. The zeta potential of bare mercaptoacetic acid modified
QDs are -29.5 mV (green) and -37.5 mV (red), likely due to the presence of anionic
MAA and hydroxyl molecules adsorbed to the dangling surface zinc ions'0 . The PAA
coated QDs are 23.6 mV (green) and 31.6 mV (red), while the PVSA coated ones are -
53.8 mV (green) and -84 mV (red). Both QD complexes show characteristic patterns of
surface charge reversals caused by excess polymer deposition due to overcompensation
of charge neutralization. These values are in agreement with those of other
polyelectrolyte-coated colloidal systems found in the literature26 . The absolute values of
surface charges appear to be higher for the larger red (7.2 nm) QDs, particularly for the
PVSA coat. This may be due to their lower surface curvature which allows the stiff
polymer chains to fold around the nanoparticles more easily, and therefore facilitate
polyelectrolyte adsorption'3 . The data demonstrate that polyelectrolyte deposition on QDs
was successful.
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Figure 3.7 Zeta potential of polyelectrolyte coated QDs. Polymer treated QDs show characteristic surface
charge reversals; QD-MAA are highly negative, polycation coated QD-MAA-PAA are positive, and
polyanion coated QD-MAA-PAA-PVSA are highly negative (reproduced with permission from reference
33).
Next, the effect of the polymer coating on the absorption properties of the QDs was
investigated. The absorption spectra of red and blue QD-MAA, -PAA, -PVSA and QD-
TOPO (in DMSO) were obtained (Fig 3.8). For both red and green QDs, the positions of
the first observable peak (607 nm and 508 nm, respectively) shift slightly after MAA
exchange, and remain blue shifted after polyelectrolyte adsorption. As expected, the
dominant shifts for both modifications occur after MAA exchange, as previously
reported"1,12. The shifts are attributed to the differences in ligand binding affinities; the
thiol-zinc bond is stronger than the TOPO-zinc bond, and may cause distortion of the
energy levels, leading to reorganization of the electronic density and increase in the
confinement energy, thus resulting in a slight blue-shift. While photooxidation may also
cause a blue-shift, it is unlikely to be the cause since the peak positions and QD optical
densities remained constant for several days post modification. Other than peak positions
shifts, the overall shape of the spectra was unchanged; there is no observable peak
broadening which suggests that the structure of the QDs is preserved throughout the
several processing steps and there is no clumping or fragmentation. Therefore the
polyelectrolyte deposition does not appear to be detrimental to the absorbance properties
or size homogeneity of the QDs.
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Figure 3.8 Absorbance of red (light) and green (heavy) polymer coated QDs is not affected by coating with
polyelectrolytes. The shapes of the absorbance spectra remain the same, with slight blue shift in of the first
absorbance peak, attributed to the displacement of TOPO by MAA (reproduced with permission from
reference 33).
The size and morphology of the modified QDs were further investigated using
transmission electron microscopy (TEM) to visualize red QDs modified with MAA, PAA
and PVSA coatings (Figure 3.9). The dense cores of the nanoparticles are approximately
7nm in diameter, and their sizes and shapes do not vary after polyelectrolyte deposition.
This reinforces that the QDs do not photooxidize or fragment due to polymer coating, and
that the blue shifts in the absorption spectra (Figure 3.8) are likely due to tighter thiol-
zinc bonding. The QDs do not aggregate but remain distinct, which indicates that the
polyelectrolytes form layers around individual particles. While the deposited layers are
too thin to be visualized directly 32, their presence is supported by the existence of a halo
around the PVSA coated QDs (Figure 3.9c) which is not visible in the MAA treated QDs
(Figure 3.9a). There is also an apparent increase in the interparticle spacing as additional
polymer layers are deposited on the QD surface. Therefore the overall morphology of the
nanoparticles is preserved, and they appear to be individually coated by the polymers.
Figure 3.9 TEM images of(a) MAA capped, (b) PAA, and (c) PVSA coated red QDs. The morphology
and size of the QDs is not affected by polyelectrolyte deposition. The QDs do not aggregate but remain
individually dispersed. (scale bar 25 nm) (reproduced with permission from reference 33).
3.4.3 Manipulating QD-polymer hybrids
The ability of polymer-coated QDs to selectively assemble into hybrid heterostructures
was investigated. The specificity of charge interactions was determined by quantifying
the fluorescence of anionic (QD-MAA) and cationic (QD-PDMC) nanoparticles
deposited on positive and negative substrates (Fig 3.10). Anionic and cationic substrates
were prepared by spin coating hyaluronic acid (HA, 1MDa) and bPEI (70 kDa) on
plasma cleaned glass surfaces, incubating overnight, and removing the excess, unbound
polymer by rinsing three times with deionized water. The QD-layers were imaged using
fluorescence microscopy, and the fluorescence intensity was quantified using Scion
Image software (Fig 3.10). Approximately 10-fold more cationic red QDs deposited on
anionic substrates than did anionic red QDs (40 vs. 4), and 6-fold more cationic green
QDs deposited on anionic substrates than did anionic green QDs (115 vs. 20). Similarly,
9-fold more anionic red QDs deposited on cationic substrates than did cationic red QDs
(180 vs. 20), and 3.5-fold more anionic green QDs deposited on cationic substrates than
did cationic green QDs (170 vs. 50). Therefore both anionic and cationic, red and green
QDs preferentially deposited on oppositely charged substrates, with low levels of non-
specific binding.
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Figure 3.10 Characterizing specificity of binding of polyelectrolyte coated QDs to oppositely charged
substrates. Red and green, cationic and anionic QDs show preferential adsorption to oppositely charged
substrates, with very low levels of non-specific binding.
Anionic (QD-MAA, green) and cationic (QD-PAA, red) QDs were electrostatically
adsorbed onto anionic polymer (HA) patterned substrates, and visualized using
fluorescence microscopy (Fig 3.11). Patterned substrates were prepared by spin coating
HA on plasma cleaned glass substrates, bringing them in conformal contact with
polydimethyl siloxane (PDMS) moulds, allowing HA to evaporate overnight, peeling off
the stamp and washing off the excess, unbound polymer prior to QD deposition 30' 3 1. Thin
films of cationic and anionic QDs were sequentially deposited on the anionic, HA
patterned substrates for 30 mins and excess, unbound QDs were washed off by rinsing
three times with deionized water. Glass substrates with three layers were imaged: (i)
patterned (anionic) HA layer adsorbed on glass, (ii) red (cationic) QD-PAA layer
electrostatically associated with the HA/glass substrate, and (iii) green (anionic) QD-
MAA layer assembled on the positive PAA-QD/HA/glass substrate. Fluorescence images
of the patterned bilayer images show excellent overlap between the green anionic (Fig.
3.11 a) and red cationic (Fig. 3.11 b) QD layers. The fluorescent areas are where QD
binding occurred, and the dark squares correspond to the non-adhesive glass surface. The
modified QDs selectively adhere to oppositely charged substrates but not to the untreated
glass, and do not wash off even after several rinses. The electrostatic forces are strong
enough to enable QD assembly on oppositely charged polyelectrolyte (HA) and QD
surfaces, even after washing. The films appear smooth and show conformal coverage
with very little clumping or pattern distortion, even after drying. The pattern fidelity is
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very high: the features have sharp edges, the layers are precisely aligned, and the patterns
are reproducible over large areas. The data demonstrates that the properties of the QDs
can be consistently and reproducibly controlled, and that the modified QDs are stable
building blocks for integrating into heterostructured complexes and devices.
Figure 3.11 Electrostatic deposition of polymer-coated cationic (green) and anionic (red) QD bilayers on
charged patterned substrates visualized through (a) green (FITC) and (b) red (TRITC) filters. Charged QDs
specifically bind to oppositely charged patterns (fluorescent regions), and not to the uncharged substrate
(dark regions) (reproduced with permission from reference 33).
Feature integrity and the height profiles were further characterized by imaging the QD
bilayers using atomic force microscopy (AFM, Fig. 3.12). The features appear to be the
same size (3pm squares) with an aspect ratio close to unity. There is some non-specific
adsorption on the untreated glass surface, which could be due to the residual debris from
the PDMS mold or the polyelectrolytes. The height difference between the bilayer and
the non-adhering regions, as indicated by the height profile (inset), is approximately 15
nm. The HA layer is approximately 3 - 6 nm in height 30'3 1 while the PAA and MAA
modified QDs are approximately 7 nm and 3 nm respectively, which implies that
monolayers of QDs may be deposited on the surface-.
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Figure 3.12 Electrostatic deposition of polymer-coated cationic (green) and anionic (red) QD bilayers on
charged patterned substrates visualized using atomic force microscopy. Patterns demonstrate high fidelity
and smooth coverage. Inset measures the height profile across the patterned feature, along the dotted line
(reproduced with permission from reference 33).
3.4.4 Testing Versatility of the Technique
The robustness of the layer-by-layer surface deposition technique was tested by
integrating inorganic QDs and polymers with different chemical compositions. Anionic
colloidal GaN QDs (3nm, blue) were produced in-lab without any surface passivating
layer, and were coated with cationic polydiallyldimethylammonium chloride (PDMC, 15
kDa) and anionic polyacrylic acid (PAAc, 16 kDa). The same coating methods optimized
for PAA coating of CdSe-ZnS QDs were used. Briefly, QDs were introduced into the
cationic polymer solutions, incubated on benchtop for 30 mins, and purified from the
excess unbound polymer by spinning twice through an Amicon filter (100 kDa). The
surface charges of the nanoparticles were characterized over a range of pH values (Fig.
3.13). Both uncoated (green) and anionic PAAc coated (red) GaN QDs are negatively
charged at all pH values above 4, while cationic PDMC coated QDs are positively
charged for all values tested (up to pH 12). This characteristic surface charge reversal is
due to excess deposition of polyelectrolytes, due to overcompensation of charge reversal,
as discussed previously. The data demonstrate that polyelectrolyte deposition on GaN QD
surfaces was also successful.
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Figure 3.13 Zeta potentials of polymer-coated GaN QDs over a range of pH values. Uncoated (UC) and
polyanion coated (PAAc) QDs are highly negatively charged above pH values of 4. Polycation coated
(PDMC) QDs are highly positively charged over the entire range tested. The curves were drawn in by hand
to guide the eye.
The controlled integration of polymer-coated GaN QDs into ordered arrays was also
investigated by adsorbing GaN nanoparticles on oppositely charge patterned substrates.
Patterned substrates were prepared by spin coating HA on plasma cleaned glass
substrates, bringing them in conformal contact with polydimethyl siloxane (PDMS)
moulds, allowing HA to evaporate overnight, peeling off the stamp and washing off the
excess, unbound polymer prior to QD deposition. Thin films of cationic GaN QDs were
deposited on the anionic, HA patterned substrates for 30 mins and excess, unbound QDs
washed off by rinsing three times with deionized water. Glass substrates with two layers
were imaged (Fig 3.14): patterned (anionic) HA layer adsorbed on glass, and blue
(cationic) GaN QD-PDMC layer electrostatically associated with the HA/glass substrate.
The fluorescent blue lines display where QD binding occurred, and the dark lines
correspond to the non-adhesive glass surface. The modified QDs selectively adhere to
oppositely charged substrates but not to the untreated glass, and do not wash off even
after several rinses. The electrostatic forces are strong enough to enable QD assembly on
oppositely charged polyelectrolyte (HA), even after washing. The films appear smooth
and show conformal coverage with very little clumping or pattern distortion, even after
drying. The pattern fidelity is very high: the features have sharp edges, the layers are
precisely aligned, and the patterns are reproducible over large areas. Therefore polymer
coated nanoparticles can be electrostatically manipulated, independent of their inorganic
core.
Figure 3.14 Electrostatic deposition of cationic polymer-coated GaN QDs on oppositely charged HA
patterned substrates. Cationic QDs bind specifically to the anionic HA patterns (blue fluorescence) and not
to the uncharged substrate (dark regions) forming features with high pattern fidelity (scale bar 50 pm).
The data demonstrates that layer-by-layer deposition of polyelectrolytes on QD surfaces
enables control of their surface chemistries, without affecting the morphology or optical
properties of the inorganic core. These polymer-coated QDs were stable enough to
electrostatically assemble into heterostructures, and the technique is robust enough to
enable integration of QD and polymers, independent of the chemical compositions.
3.5 Summary & Conclusions
3.5.1 Optimized CdSe-ZnS Modification Protocol
1. QD-TOPO were displaced with 10 x volume of ethanol and centrifuged at 10x kg
for 2 mins (manufacturer's protocol).
2. Supernatant was discarded and QD-TOPO resuspended in 10x (original volumes)
of chloroform (manufacturer's protocol).
3. Equivolume of MAA was added to the QD-TOPO solution, and sonicated at 80
°C for 30s.
4. QD-MAA were precipitated using equivolume ethanol and centrifuged at 10x kg
for 2 mins.
5. Supernatant was discarded and QD-MAA resuspended in 10 x (original volume)
50 mM tris-base buffer (pH 9).
6. QD-MAA were precipitated using 2x volume of isopropanol and centrifuged at
1 Ox kg for 2 mins.
7. Supernatant was discarded and QD-MAA were suspended in 10x (original
volume) 50 mM tris-base buffer (pH 9).
3.5.2 Demonstrating layer-by-layer deposition of polyelectrolytes
on QD surfaces to assemble multi-layered structures
· Optimizing polymer deposition technique
o QD-MAA were diluted to 30 - 50 mg/mL, added to equivolume 10
mg/mL cationic polymer solution (10 - 70 kDa), and incubated for 20
mins.
o QD-polymer were purified twice using Amicon columns (100 kDa).
o Cationic QD-polymer were diluted to 5 mg/mL and added to 10 mg/mL
anionic polymer (10 - 70 kDa), and incubated on benchtop for 20 mins.
o QD-polymer were purified twice using Amicon columns (100 kDa).
· Layer by layer deposition of oppositely charged polyelectrolytes on QD surface
was successfully demonstrated by characteristic surface charge reversals.
o Coated inorganic QD were not fragmented or degraded and retained their
optical properties and morphology.
o QDs were coated individually and did not form aggregates or clumps.
* Electrostatic assembly of charged QDs and oppositely substrates was demonstrated.
o Charged QDs were preferentially deposited on oppositely charged
substrates, with low levels of non-specific binding.
o Adsorption to charged, patterned substrates produced ordered,
heterostructured templates with high pattern fidelity and stability.
* Coating technique was robust enough to combine inorganic cores and organic
polyelectrolytes of varying compositions that could be integrated into ordered
nanostructures.
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Chapter 4: Effect of Surface Functionalization on
Biocompatibility of QDs
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Chapter Synopsis
Objective
The aim of this section was to investigate the biocompatibility of (i) uncoated quantum
dots (QD), (ii) single-layered QD-cation and (iii) multi-layered QD-anion complexes, and
determine the effect of varying individual core and polymer chemical compositions on
the cellular interactions of the hybrid complexes.
Hypothesis
Integration of different materials may allow manipulation of the cellular interactions of
the QD-polymer hybrids, enabling semi-rational design of complexes tailored for specific
bioapplications.
Rationale
Novel optoelectronic properties of QDs make them ideal candidates for bioprobes, but
their surfaces must be functionalized prior to biointegration. Layer-by-layer coating of
nanoparticles allows fast, easy and versatile surface modification of the nanoparticles,
while preserving their core properties. Integration of polyelectrolytes previously used for
biological applications may allow control of QD complex properties and enable design of
hybrids with specific properties.
Results
Incubation of uncoated nanoparticles including anionic CdSe-ZnS and GaN QDs, and
polystyrene nanoparticles with epithelial Cos-7 cells revealed that the nanoparticles are
not inherently cytotoxic, but demonstrate different degrees of cellular uptake. Coating
these nanoparticles with different cationic polymers forms complexes with varying
biocompatibilities; branched polyethyleneimine (bPEI), polyallylamine (PAA),
polydiallyldimethyl ammonium chloride (PDMC), polylysine (pLys) and polyarginine
(pArg) coated nanoparticles are highly cytotoxic, diethylaminoethyl dextran (dextran)
coated nanoparticles demonstrate dose dependent toxicity, and quaternized
hydroxyethylethoxy cellulose (cellulose) coated nanoparticles are non-toxic.
Multi-layered heterostructures were assembled by coating cationic QD-dextran cores
with different anionic polymers, and their biocompatibility was determined by incubating
with COS-7 cells. The complexes demonstrated varying levels of cytotoxicity that
depended on the chemical compositions of the anionic polymers; polyvinylsulfonic acid
(PVSA) and polyacrylic acid (PAAc) containing complexes were highly cytotoxic and
caused extensive distortion of cellular morphologies, while dextran sulfate (DS)
containing complexes had limited cytotoxicity and low cellular uptake. Further
investigations using QD-cation-DS multi-layered complexes with different cations
revealed that biocompatibility of heterostructures also depended on the chemical
composition of the integrated cations; PAA containing complexes remained highly
cytotoxic but bPEI and PDMC containing complexes demonstrated reduced toxicity
when coated with DS, as compared to their corresponding single-layer complexes.
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Conclusions
The overall biocompatibility of the multi-layered complexes depends primarily on the
chemical composition of all the integrated polymers, and is relatively independent of the
nanoparticle core. Therefore, rationally designed complexes with controlled properties
may be prepared.
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4.1 Background
Commercially available hydrophobic quantum dots (QDs) with excellent optical
properties can be made water miscible by exchanging the bulky, organic surface
passivating ligands with hydrophilic mercaptoacetic acid (MAA), producing anionic QD-
MAA cores (Chapter 3). Subsequent deposition of oppositely charged polyelectrolytes on
the QD-MAA cores results in the assembly of heterostructured complexes, which
maintain the structural integrity and optical properties of the inorganic core, while
enabling surface functionalization of the complex. The chemical compositions of both,
the nanoparticle core and the coating polymers may be varied, thus enabling the assembly
of complexes with diverse chemical functionalities that are tailored for specific
bioapplications. The chemical structures, properties, and biointegration of several
nanoparticle cores and cationic and anionic polyelectrolytes are discussed in the
following section.
4.1.1 Nanoparticle Cores
High quality QDs with finely resolved emission spectra, stable fluorescence, and uniform
morphology are exemplified by CdSe-ZnS nanocrystals' 4 . However, their use in
bioapplications raises concerns regarding the potential inherent cytotoxicity of the
nanoparticles 5-7. Several studies have demonstrated that uncapped CdSe or CdS QDs are
prone to surface oxidation, as indicated by the red-shift of the optical properties, and
deterioration of the crystallinity of the inorganic core5'8. Oxidation leads to the release of
free cadmium ions in solution (Fig 4.1) whose cytotoxic effects have been extensively
characterized 9"10. Capping the QDs with a layer of ZnS greatly decreases the cytotoxic
effects by limiting the release of cadmium ions, as indicated by preservation of the
optical properties and morphology of the CdSe core4'6 . In addition to the chemical
toxicity, the nanoparticles may also demonstrate indiscriminate cytotoxicity due to their
small size and high mass, which can cause perforation of the cell membranes and arrest
of cellular functions by complexing with the organelles and proteins5"s .
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Figure 4.1 Oxidation of the CdSe nanoparticle. The non-metal anions react to form oxides in the presence
of an oxidizing agent, leaving behind free cadmium ions (Reproduced based on schematic in reference 5)
To test the inherent cytotoxicity of the QDs due to their composition and size, CdSe-ZnS
(3 nm), GaN (3 nm) and polystyrene (PS, 20 nm) nanoparticles were used as the anionic
nanoparticle cores. GaN nanoparticles are similar is size, morphology and structure to the
CdSe-ZnS QDs: both are small, spherical, crystalline, anionic and composed of semi-
conductor materialsl2. However, the gallium-nitride bond is stronger and not as easily
hydrolyzed as the cadmium-selenide bond, therefore limiting the release of free metal
cations in solution3 . In addition free gallium ions are significantly less cytotoxic than
cadmium ions 3. 'Therefore the use of GaN nanoparticles should mimic any
indiscriminate, non-chemical cytotoxicity caused by CdSe-ZnS nanoparticles. The
structure and morphology of the PS nanoparticles us very different from those of CdSe-
ZnS QDs; they are larger, non-crystalline and composed of biologically inert organic
materials. Their surfaces are coated with carboxylic acid moieties to mimic the anionic
charge of the CdSe-ZnS QDs modified with MAA. These nanoparticles are known to
have very low inherent cytotoxicities, and therefore their use should enable direct
observation of the effects of nanoassembly of the polymers, on the cellular interactions of
the complexes.
4.1.2 Materials for QD Coating
Cationic and anionic polyelectrolytes with different chemical structures (Appendix II)
were used to coat the oppositely charged nanoparticle cores. Polymers selected for
polyelectrolyte coating were (i) highly charged to facilitate electrostatic interactions with
the oppositely charged nanoparticle-complexes, (ii) between 10 - 100 kDa in molecular
weight so that they were large enough to strongly bind to the nanoparticle, but small
enough to enable efficient separation of the unbound polymer from the complex (Section
3.4.2), (iii) commercially available and not requiring additional preparation for ease of
modification, and (iv) sufficiently hydrophilic to enable complex miscibility with
aqueous environments. Seven cations and three anions were selected, including synthetic
and biologically derived polymers with high and low charge densities. Their structures,
chemical properties, integration into layer-by-layer assemblies, and previous
bioapplications are discussed below. Charge densities are expressed as the number of
charges per monomer unit mass, and are inversely proportional to monomer molecular
weight; for monomers with the same number of charges, higher molecular weight units
have lower charge densities than lower molecular weight ones.
Cationic Polymers
The cationic polymers selected included three synthetic polymers, branched
polyethyleneimine (bPEI), polyallylamine (PAA) and poly diallyldimethyl ammonium
chloride (PDMC), and four bio-derived polymers, polylysine (pLys) and polyarginine
(pArg) polypeptides, amine-derivatized diethylaminoethyl dextran (dextran), and
quaternized hydroxyethylethoxy cellulose (cellulose). Their properties as discussed
below, and structures are illustrated in Appendix II.
Cationic bPEI is randomly branched with primary, secondary and tertiary amines
separated by ethyl moieties. When completely ionized, it has one charge per monomer
unit (44 amu). Since it has the lowest molecular weight monomer, it has the highest
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charge density of all polymers tested. PAA is a linear polymer with pendant methyl-
primary amine moieties grafted to the hydrocarbon backbone. It is completely ionized
with one charge per monomer unit (56 amu). PDMC is a stiff, linear polymer with
quaternary ammonium groups in rings that form part of the backbone of the polymer
chain. It is completely ionized, and has one charge per monomer unit (126 amu). The
linear polypeptides, pLys and pArg, have amide backbones, and primary amine and
guanidine moieties respectively in the pendant side chains. pLys has one charge per
monomer (129 amu), while pArg has two charges per monomer (157 amu); pArg has
approximately the same charge density as PDMC, while pLys has a lower charge density.
Dextran and cellulose are both linear, glucose based polymers modified with pendant
quatemized amines. They have one charge per monomer unit (424 and 539 amu,
respectively) and much lower charge densities than the other cationic polymers.
Therefore the polymers, in order of decreasing charge density, are bPEI, PAA,
PDMC/pArg, pLys, dextran and cellulose.
The cationic polymers selected were previously incorporated into electrostatic layer-by-
layer assemblies; bPEI was adsorbed onto poly-lactic-acid particles' 4 , PAA was
deposited on PS colloid particles 15, PDMC was coated on gold nanoparticles 16 , pLys was
deposited on condensed DNA particlesl7, and pArg 8 , dextran'9 and cellulose20 were
deposited on anionic thin films. They formed stable, electrostatically assembled
structures with finely controlled surface properties that were stable in aqueous
environments.
The polymers were also used for cellular delivery of biological materials; bPEI2 1,
PAA2 ,23 PDMC24 , pLys2 , pArg26 and dextran2 7 were complexed with DNA and
delivered to cells, yielding varying levels of gene-product. There was a tradeoff between
the efficiency of delivery and invoked cytotoxicity; optimized bPEI complexes yielded
the highest levels of gene delivery, but also caused highest levels of cytotoxicity. Varying
the polymer to DNA mass ratios greatly affected the delivery properties; an initial
increase in the amount of polymer yielded significant enhancement in the amount of gene
expression with low levels of cytotoxicity, but continued increase in the amount of
polymer resulted in decreased gene expression and elevated levels of cytotoxicity21. At
high polymer doses, the cationic polymers become increasingly cytotoxic; bPEI, PAA,
PDMC, pLys, pArg and dextran all demonstrated elevated cytotoxicity at high polymer
concentrations-. Cytotoxicity also increased with the charge density of the polymers21;
block-co-polymers of cationic bPEI and uncharged polyethylene glycol 28 (PEG),
demonstrate progressively increasing cytotoxicity as the ratio of the charged bPEI to the
uncharged PEG increases. Changing the molecular architecture also affected the
cytotoxicity of the polymers; dendrimer analogues of PEI, branched PEI, and linear PEI
demonstrated progressively decreasing levels of gene transfection and cytotoxicity at the
equivalent polymer to DNA mass ratios, indicating that ordered, highly branched
structures are more cytotoxic than their linear, unstructured analogues2 9. Therefore the
biocompatibility of the cationic polymer complexes depends on the chemical structure,
properties, and the effective dose of the polymers.
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Several mechanisms may account for the elevated cytotoxicity levels of the different
cationic polymers, including cell membrane perforation, endosomal rupture, and arrest of
anionic cellular proteins. Cationic complexes attach to and puncture cell membranes,
compromising their integrity and triggering cell death, as observed for amine-containing
dendrimers2 9. The small size and high positive charges facilitate binding of the
complexes to the anionic cell membranes. Endocytosed cationic bPEI-containing
complexes escape endosomal confinement by osmotic swelling and rupture; sequestering
of hydrogen ions by the polymer leads to an excessive influx of hydrogen and chloride
ions and water, leading to swelling and vesicle rupture21. However, endosomal rupture
also releases degradative enzymes into the cell cytoplasm, which can trigger cell death.
Anionic Polymers
Three anionic polymers were selected to coat the cationic QD-polymer complexes
(Appendix II); synthetic polyvinylsulfonic acid (PVSA) and polyacrylic acid (PAAc),
and bio-derived clextran sulfate (DS). PVSA and PAAc are linear polymers with pendant
sulfonate and carboxylate groups grafted to their backbones. They have one anionic
charge each per monomer unit (molecular weights 123 and 72, respectively), and have
high charge densities. DS is a glucose based polymer with anionic sulfate grafted to the
glucose ring backbone. It has three anionic charges per monomer repeat unit (molecular
weight 351), and therefore has similar charge density as PVSA and PAAc. These
materials have also been previously incorporated into layer-by-layer assemblies; PVSA
was deposited on the surface of PAA coated CdSe-ZnS QDs30 , PAAc was adsorbed onto
PAA coated PS particles', and DS was deposited on planar films. Delivery of anionic
polymers to cells with compromised cellular membranes has resulted in cytotoxicity; DS
added to lymphocytes caused gelatination of the cellular nuclei by extraction of histone
proteins by the anionic polymer and complexing of cationic histone-DS with anionic
DNA. The swelling pressure caused by these cross-linking gels results in the distortion of
cellular morphology, and the rupture of the cells3 '.
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4.2 Specific Aims
Uncoated & Single Layer Systems
· Test the biocompatibility of CdSe-ZnS-MAA, GaN and PS-COOH nanoparticles.
· Investigate cellular interactions of cationic polymer-coated nanoparticle complexes.
o Incorporate bPEI, PAA, PDMC, pLys, pArg, dextran and cellulose into
single-layer complexes.
o Characterize cationic QD complexes using zeta potentials.
o Determine biocompatibility of cationic complexes.
· Investigate the effect of varying the core composition on biocompatibility of the
complexes, by using CdSe-ZnS, GaN and PS nanoparticles as deposition platforms.
Multi-Layer Systems
· Investigate cellular interactions of anionic polymer-coated QD complexes.
o Deposit PVSA, PAAc and DS polymers on suitable QD-cation core.
o Characterize anionic QD complexes using zeta potentials.
o Determine biocompatibility of anionic complexes.
· Determine the effect of varying cationic polymers on the properties of the multi-
layered system.
o Assemble QD-cation-anion multi-layered systems using bPEI, PAA,
PI)MC and dextran as cations.
o Investigate the effect on biocompatibility
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4.3 Materials & Methods
4.3.1 Experimental design
QD-PE Modification
CdSe-ZnS core-shell QD were modified with mercaptoacetic acid, and coated with
cationic polymers, as described in section 3.4.1 and 3.4.2.
OD-PE Cell Incubation
Monkey kidney COS-7 cells maintained at 37 °C and 5% CO2, were cultured in
DMEM/F- 12 medium supplemented with 10% fetal bovine serum and 1%
penicillin/streptomycin/amphotericin B. Cells were seeded at a density of about 75,000
cells per well in a 24-well plate, and 30,000 cells per well in an 8-well collagen treated
cover-glass chamber, and allowed to grow overnight. QD-polymer complexes were
delivered to cells in serum-free medium for 2 hrs, and then replaced with fresh serum-
supplemented medium.
Cell viability quantification
QD-polymer treated cells were washed with phosphobuffered saline (PBS), incubated on
ice for 15 min with trypsin (2.5 mg/mL) and propidium iodide (PI, 5 tg/mL)
supplemented-PBS, and analyzed using a FACScan (Becton Dickinson) flow cytometer,
equipped with an argon ion laser. PI treated cells were detected using a PE/PI band-pass
filter (585/42). The cells were appropriately gated by forward and side scatter.
Normalized cell viability was determined as the percentage of viable cells, relative to
untreated cells exposed to the same conditions.
Zeta potential measurements
Surface electrophoretic mobilities of hybrid complexes were determined using a zeta
potential analyzer (ZetaPlus, Brookhaven) with a HeNe laser at 632 nm. Complexes were
dispersed in 50 mM NaCl in deionized water, and measurements were repeated three
times. The Smoluchowski method was used to calculate the zeta potentials.
Fluorescence microscopy imaging
Low magnification (40x) images were obtained using an inverted Olympus microscope
(IX51) with GFP (ex 450/40, em 525/50), TRITC (ex 535/50, em 610/75) and DAPI (ex
360/40, em 460/50) filters, using SimplePCI software.
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4.3.2 Experimental setup
Testing biocompatibility of inherent nanoparticle cores
Prepare CdSe-ZnS-MAA, GaN and PS-
COOH nanoparticles and test biocompatibility
I
Test biocompatibility of cationic nanoparticles: effect of varying polymer and core
compositions
1. Coat nanoparticles with bPEI, PAA,
PDMC, pLys, pArg, dextran and cellulose
I
dSe-ZnS 1 F 2b. GaN cores 2c. P'
res
cores
S cores
3. Characterize by determining zeta
potentials
4. Deliver to cells and characterize
cytotoxicity using visual assay
5. Determine cellular interactions by using
light and fluorescence microscopy
6. Quantify cytotoxicity using polymer
coated CdSe-ZnS QDs
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Test biocompatibility of anionic multi-layered systems: effect of varying anion
composition
1. Prepare QD-DEAE-anion nanoparticles
using PVSA, PAAc and DS
2. Deliver to cells and characterize results
using light and fluorescence microscopy
Determine if biocompatibility if independent of internal cation or depends on the
composite properties of both polymers
1. Prepare QD-cation-DS nanoparticles
using bPEI, PAA, PDMC and DEAE
. ..o .....
2. Deliver to cells and characterize results
using light and fluorescence microscopy
I
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4.4 Results & Discussion
Cellular interactions of (i) uncoated, (ii) single layer cationic, and (iii) multi-layered
anionic complexes with COS-7 cells were investigated. COS-7 cells are immortalized
African green monkey kidney epithelial (fibroblast) cells that grow in monolayers. They
were selected because they are robust, have easily characterizable morphologies, actively
endocytose extracellular materials, and are very well characterized. The effects of
varying the compositions of the nanoparticle core and coating polymers on
biocompatibility and cellular morphology were determined.
4.4.1 Uncoated & Single Layer Systems
Prior to biointegration, the surface charges of modified CdSe-ZnS (green, 3.4 nm), GaN
(blue, 3 nm), and PS (green, 20 nm) nanoparticles suspended in 50 mM NaCl were
determined using zeta potential measurements (Fig 4.2). The surfaces of all three
nanoparticles were highly anionic. Modified CdSe-ZnS QDs and PS nanoparticles had
carboxylic acid moieties grafted to their surfaces, which contributed to the negative
surface charge. GaN nanoparticles were negatively charged likely due to the adsorption
of anionic hydroxyl molecules to the dangling bonds of the surface gallium atoms, as
observed for other metal nanoparticles (Fig 2.1a)32. Therefore any differences in cellular
interactions were not due to variations in surface charges of the nanoparticles.
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Figure 4.2 Zeta potential of CdSe-ZnS-MAA, uncapped GaN, and PS-COOH nanoparticles are all highly
anionic due to the presence of carboxylic acid moieties and adsorbed hydroxyl groups.
Inherent biocompatibility of anionic, uncoated CdSe-ZnS, GaN, and PS nanoparticles
was determined by incubating them with COS-7 cells for 2 hrs, and characterizing the
results 24 hrs post-treatment (Fig 4.3). Cellular morphologies were analyzed using light
microscopy (left panel), and nanoparticle uptake was monitored by visualizing the
fluorescence (right panel). The cells treated with nanoparticles are extended and sprout
cellular processes, have distinct cellular and nuclear membranes, large nuclei, and dense
nucleoli. All these are indicators of cell viability, therefore demonstrating that the cells
are healthy and metabolically active after treatment with the nanoparticles. Analyzing the
fluorescence of the treated cells revealed differences in nanoparticle uptake by the cells;
those treated with CdSe-ZnS QDs demonstrated both, diffuse widespread fluorescence
and concentrated bright spots, indicating that while some QD may be spread throughout
the cells, others aggregated to form clumps. Cells treated with GaN particles showed blue
L
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fluorescence, indicating significant levels of non-specific uptake of the QDs. Cells treated
with PS nanoparticles exhibited discretized bright green fluorescence, demonstrating that
the endocytosed nanoparticles remained vesicle bound. The data demonstrated that
nanoparticles are not inherently cytotoxic, and are internalized by cells to varying
degrees.
Figure 4.3 COS-7 cells treated with CdSe-ZnS-MAA, GaN, and PS-MAA nanoparticles, characterized
using light (left panel) and fluorescence (left panel) microscopy. All cells appear elongated with distinct
organelles and intact membranes, and are therefore healthy. Fluorescence microscopy (right panel) reveals
that the GaN and PS are readily taken up by the cells, but the CdSe-ZnS particles show limited uptake
(scale bar 25 ipm).
Single-layer, cationic nanoparticle complexes were prepared by coating anionic CdSe-
ZnS, GaN and PS nanoparticles with cationic bPEI (25 kDa), PAA (19 kDa), PDMC (17
kDa), pLys (15 - 23 kDa), pArg (15 - 23 kDa), dextran (<100 kDa) and cellulose (17
kDa). Nanoparticles were introduced into the cationic polymer solutions, incubated on
the benchtop at room temperature for 30 mins, and purified from the excess unbound
polymer by spinning through an Amicon filter (100 kDa) twice. The surface potentials of
the assembled complexes suspended in water were determined by measuring their
respective zeta potentials (Fig. 4.4). All nanoparticles were positively charged, indicating
successful deposition of the cationic polymers33. The variations in zeta potentials between
different samples were within the experimental error of the instrument, and not
necessarily reflective of differences in the surface charge concentrations.
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Figure 4.4 Zeta potential of CdSe-ZnS-MAA, GaN and NP-COOH coated with cationic polymers (bPEI,
PAA, PDMC, pLys, pArg, dextran, cellulose). All the tested nanoparticles have highly positive surface,
indicating the successful deposition of cationic polymers (error bars between 2 - 8 mV).
Biocompatibility of the single layer, cationic complexes was determined by incubating
the heterostructures with COS-7 cells for 2 hrs, and determining the resulting cytotoxicity
24 hrs post-treatment. A visual assay was used to characterize cell viability; the treated
samples were stained with propidium iodide (PI), and visualized under the microscope. PI
is a cell impermeant dye that undergoes 50-fold enhancement in fluorescence when it
binds to single-stranded DNA, and is therefore an indicator of dead or dying cells with
compromised cellular membranes and dissociated DNA. Based on the apparent
cytotoxicity of the cationic complex treated cells, a value of 0, 0.5, or 1 was assigned to
the sample. If most of the cells were dead then a value of '0' was assigned, if the cells
looked similar to untreated controls with minimal toxicity, then a value of '1' was
assigned, and if the cytotoxicity was somewhere in-between, then a value of '0.5' was
assigned. The results (Fig 4.5) show that all the nanoparticles coated with bPEI, PAA,
PDMC, pLys, and pArg were highly cytotoxic and caused widespread cell death.
Nanoparticles coated with dextran caused some toxicity, while those coated with
I ---------
cellulose were non-toxic and did not result in significant cell death. Since the cellular
interactions are independent of the core material, and the nanoparticles are not cytotoxic,
the data demonstrates that biocompatibility of the nanoparticles depends primarily on the
polymer coatings. Surface material properties dominate, due to the high surface area to
volume ratios of the nanoparticles34
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Figure 4.5 Cytotoxicity of cationic polymer-coated CdSe-ZnS, GaN and PS nanoparticles determined
using visual assay. All nanoparticles coated with bPEI, PAA, PDMC, pLys and pArg are highly cationic,
those coated with dextran show intermediate levels of toxicity, while those coated with cellulose are not
toxic. Effect of polymer coating is independent of the nanoparticle core.
Cellular interactions of the cationic polymer coated CdSe-ZnS QDs were further probed
by characterizing the treated cells with microscopy (Fig 4.6). Cellular morphologies were
analyzed using light microscopy (left panel), cytotoxicity was determined by treating
with PI (red, right panel), and complex uptake was monitored by localizing the
fluorescence of the nanoparticles (green, right panel). Cells treated with bPEI, PAA,
PDMC, pLys and pArg coated QDs were small and rounded with fragmented
membranes, lacked distinct cellular organelles, and stained densely with PI, indicating
widespread cell death. They had significant green fluorescence in the cell debris,
indicating that the QDs likely assosciated with the cells, prior to cell death. Cells treated
with dextran-coated QDs demonstrated moderate levels of cytotoxicity; most of the cells
were healthy, but PI staining revealed higher levels of cytotoxicity than observed in the
untreated cells. There were low levels of green fluorescence in the cells, indicating
limited QD-complex uptake. Cells treated with cellulose-coated QDs appeared healthy,
and PI staining did not reveal higher levels of cytotoxicity than observed in the untreated
cells. These complexes demonstrated particulate green fluorescence inside the cells,
indicating high levels of QD-complex uptake. These data demonstrate that all cationic
QDs interact with the cells, but their cytotoxicity and cellular uptake depended on the
chemical composition of the coating polymer.
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Figure 4.6 Cells treated with cationic polymer-coated CdSe-ZnS QDs, characterized using light (left panel)
and fluorescence (right panel) microscopy. Cells treated with bPEI, PAA, PDMC, pLys and pArg coated
QD are curled up with fragmented membranes (left panels) and show intense PI staining (red, right panel),
which indicate widespread cell death. Residual QD-complexes (green) are localized in dead cell debris.
Dextran treated cells demonstrate low levels of toxicity and PI staining, and limited localization of QD-
complexes in cells. Cellulose coated complexes have very low levels of cytotoxicity, show virtually no PI
staining, and a lot of QD localization in healthy cells (scale bar 25 pLm).
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Biocompatibility of the cationic polymer coated CdSe-ZnS QDs was further
characterized by quantifying their relative cytotoxicity. Cells were treated with varying
doses of the polymer-coated nanoparticles for 2 hrs, incubated for 24 hrs., then treated
with PI, and their viability determined using fluorescence activated cell sorting (FACS).
The results (Fig 4.7) were expressed as percent normalized cell viability, relative to cell
viability of untreated cells maintained under the same conditions. The results show that
QDs coated with bPEI, PAA, PDMC, pLys, and pArg were highly cytotoxic at all doses,
dextran (DEAE) coated QDs demonstrated dose-dependent toxicity, while cellulose
treated QDs (HEC) were non-toxic at all doses. These results further demonstrate that the
cytotoxicity of the cationic QD-polymer complexes depends on the polymer coating.
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Figure 4.7 Cell viability of cationic polymer-coated CdSe-ZnS QDs. QDs coated with bPEI, PAA, PDMC,
pLys and pArg are highly cytotoxic at all doses, dextran coated QDs demonstrate dose-dependent toxicity,
while cellulose coated QDs are non-toxic at all the doses tested (error bars between 3 - 8 %).
The different biocompatibilities of the polymer-coated QD complexes are due to the
differences in chemical properties and structures of the coating polymers. Branched PEI,
PAA, PDMC, pLys and pArg have high charge densities and demonstrated the highest
cytotoxicities, dextran has low charge density and demonstrates moderate, dose-
dependent cytotoxicity, while cellulose has the lowest charge density and is relatively
non-toxic. Therefore, the higher the charge density of the coating polymer, the greater is
the evoked cytotoxicity. This direct correlation between the charge density and
cytotoxicity of the complexes is similar to the trends observed in co-polymer systems
with varying charge densities, and may be a result of increased cell-permeating efficiency
or increased endosomal escape of the cationic complex (Section 4.1.2.1)35. Another
reason for the high cytotoxicity of the polymer-coated QDs can be the physical
localization of the polymer on the QD surface, leading to increased effective charge
concentrations. The polymer is readily accessible to the cellular environment, and the
close proximity of the cation chains may promote synergistic electrostatic interactions.
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This is similar to the effective concentration enhancement observed when the cytotoxicity
of linear polymers is compared to that of their branched and dendrimer analogues, as
fewer charges are buried inside the polymer29 (Section 4.1.2.1). It is also analogous to the
increase in cytotoxicity of higher molecular weight polymers, compared to mass-
equivalent doses of their lower molecular weight counterparts.24
The data presented in this section demonstrate that biocompatibility of the nanoparticles
depends primarily on the polymer coating, and is relatively independent of the core. For
all subsequent investigations CdSe-ZnS QDs were used as the inorganic cores.
4.4.2 Multi-Layer Systems
Anionic, multi-layered complexes were prepared using PVSA (15 kDa), PAAc (16 kDa)
and DS (20 kDa) to coat cationic CdSe-ZnS QD-polymer complexes. Based on the results
presented in the previous section, dextran and cellulose coated QD complexes were used
as the cationic core, since they demonstrated moderate to low levels of cytotoxicity.
While both cationic cores were successfully coated with the anionic polymers, QD-
cellulose containing complexes aggregated during purification. This could be due to the
lower charge density of the cellulose polymer leading to deposition of thinner anionic
films around the cationic QD cores, resulting in nanoparticles that are not very stable 1"6.
Therefore QD-dextran complexes were used as the cationic cores for subsequent
modifications, unless noted otherwise.
Anionic PVSA, PAAc and DS coated QD-dextran complexes were characterized by
determining their surface zeta potentials (Fig 4.8). The surface charges of multi-coated
hybrids suspended in 50 mM NaCl were all highly negative, demonstrating the successful
adsorption of the anionic polymers on the QD-dextran surface33. These reversals in
surface charges are characteristic of layer-by-layer deposition, as discussed previously
(Section 3.4.2). The variations in the zeta potentials of the different samples are within
the instrument error, and not necessarily reflective of differences in the charge
concentrations.
Biocompatibility of the multi-layer. anionic complexes was determined by incubating the
heterostructures with COS-7 cells for 2 hrs, and determining the resulting cytotoxicity 24
hrs post-treatment (Fig 4.9). Cellular morphologies were observed using light microscopy
(left panel), cytotoxicity was determined by treating with PI (red, middle panel), and
complex uptake was monitored by localizing the fluorescence of the nanoparticles (green,
right panel). Treatment with both PVSA and PAAc containing heterostructures
demonstrated widespread cytotoxicity; the cell membranes were fragmented and merged
together, cellular morphologies distorted, discrete organelles were not readily visible, and
cells were intensely stained with PI. The cells also demonstrated bright green
fluorescence, indicating uptake of the QD-containing heterostructures. Cells treated with
DS coated complexes demonstrated much lower toxicity, as evidenced by the intact
cellular morphologies and limited PI staining, and showed less green fluorescence
indicating a decrease in QD-complex uptake. Therefore the cellular interactions of the
multi-layered complexes varied in the degree of cytotoxicity and cellular uptake. Since
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all three assemblies have the same cationic QD-dextran cores with limited cytotoxicity,
the differences in cellular responses are due to the different chemical functionalities of
the anionic polymer coatings.
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Figure 4.8 Zeta potential of anionic PVSA, PAAc and DS coated CdSe-ZnS-dextran QDs. All the
nanoparticles are highly negatively charged, indicating that the anionic polymer successfully coated the
surface of the cationic hybrid complex.
The morphologies and PI staining patterns of the anionic, multi-layered complex treated
cells (Fig 4.9) are different from those of the cationic, single-layer complex treated cells
(Fig 4.6). While both samples show fragmented cell membranes, discrete intense PI
staining, and QD-complex internalization, the former also demonstrates globular cellular
morphologies where cell membranes appear to merge together, and DNA (stained with
PI) is distributed throughout the cells, arrested in gelatinous networks. Therefore it is
likely that the two complexes mediate cell death via different mechanisms. The cell-
permeation and endosomal rupture mechanisms of cationic polymer-mediated cell death
were previously discussed2 1. It is possible that the anionic, multi-layer systems cause cell
death by displacing DNA from histones, sequestering the proteins, and then complexing
with the free DNA to form gelatinous cross-linking networks, as observed for other
anionic polymers .
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Figure 4.9 Cells treated with CdSe-ZnS-MAA-dextran complexes coated with PVSA, PAAc and DS,
characterized using light microscopy (left panel), PI staining (middle panel) and QD localization (right
panel). Cells treated with complexes containing PVSA and PAA have distorted cell morphologies and
intense PI staining, demonstrating that they are dying or dead, and show intense QD complex (green)
localization in the cell debris. Cells treated with DS containing complexes show low levels of cytotoxicity
and limited QD-complex uptake (scale bar 50 pLm)
The final step was to determine if the biocompatibility of the multi-layer QD-complexes
depended primarily on the outer anionic polymer layer, or on both the anionic and the
cationic polymer layers. Multi-layered complexes with different cationic polymers (bPEI,
PAA, PDMC and dextran), but the same anionic polymer coating (DS), were prepared.
Based on the results presented in Fig. 4.9, DS containing complexes demonstrated the
lowest levels of cytotoxicity, and therefore DS was selected as the anionic polymer.
Anionic DS coated, bPEI-, PAA-, PDMC- and dextran-containing, multi-layered
complexes were incubated with COS-7 cells for 2 hrs., and results were analyzed 24
hours post-treatment (Fig 4.10). Cellular morphologies were observed using light
microscopy (left panel), cytotoxicity was determined by treating with PI (red, middle
panel), and complex uptake was monitored by localizing the fluorescence of the
nanoparticles (green, right panel). Cells treated with bPEI containing complexes
demonstrated low levels of cytotoxicity, as evidenced by some distortion and
fragmentation of cellular morphology and limited PI staining. They also demonstrated
low levels of QD uptake, evidenced by limited green fluorescence. Cells treated with
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PAA containing complexes had highly fragmented cell membranes and PI staining
revealed high levels of cytotoxicity, with moderate levels of QD complex uptake. Cells
treated with PDMC demonstrated moderate levels of cytotoxicity, and QD complex
uptake. Compared to their cationic single-layered counterparts (Fig 4.6), multi-layered
complexes containing bPEI and PDMC demonstrated significantly reduced cytotoxicity.
The data demonstrate that the properties of the inner, cationic polymers in multi-layered
complexes may be partially shielded by the outer anionic polymer, but the composite
properties of the heterostructures depend on the properties of both the polyelectrolytes.
Since the anionic polymers do not form a tight shell around the cationic QD but assemble
into a loose mesh, it is likely that both the polymers are exposed to the cellular
environment, and therefore influence cellular interactions 3 . The degree to which the
behavior of one polymer dominates or shields the properties of the other depends on the
properties and chemical compositions of the constituent polymers.
Figure 4.10 Cells treated with CdSe-ZnS-MAA-cation-DS complexes containing bPEI, PAA, PDMC, and
dextran, characterized using light microscopy (left panel), PI staining (middle panel) and QD localization
(right panel). Cells treated with PAA containing complexes show widespread toxicity and diffuse QD
complex remains in dead cell debris. Cells treated with bPEI and PDMC-containing complexes
demonstrate moderate toxicity and some uptake of QD complexes. Those treated with dextran-containing
complexes have low toxicity and show limited QD-complex uptake (scale bar 25 pm).
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Here we demonstrate that cellular interactions of anionic and cationic QD complexes can
be specifically tailored by incorporating polymers with different functionalities. The
properties of both the cationic and anionic polymers affect the composite properties of
the system, and are relatively independent of the inorganic QD cores. Therefore,
rationally designed complexes with controlled properties can be prepared.
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4.5 Summary & Conclusions
4.5.1 Uncoated & Single Layer Systems
* Cellular delivery of uncoated, anionic CdSe-ZnS-MAA, PS-MAA and GaN
nanoparticles did not cause excessive cell death demonstrating that the nanoparticles
were not inherently cytotoxic.
* Cationic polymers with varying chemical structures were used to coat the anionic
nanoparticles, forming cationic single-layered complexes.
* Biocompatibility of the cationic single-layer complexes depended on the chemical
structure of the polymer, and was relatively independent of the inorganic core:
o QDs coated with high charge density polymers (bPEI, PAA, PDMC, pLys,
pArg) caused widespread cell death.
o Dextran coated nanoparticles demonstrated dose dependent toxicity.
o Quaternized cellulose nanoparticles were non-toxic at all ratios tested.
· Cationic QDs assosciated with the cells, and depending on their surface
modifications, were either localized in dead cell debris or in healthy, viable cells.
4.5.2 Multi-Layer Systems
· Dextran-coated QDs were coated with anionic PVSA, PAA and DS polymers to form
stable anionic multi-layered structures.
· Biocompatibility of anionic multi-layered complexes depended on the chemical
compositions of the anionic polymers.
o QD-dextran-PVSA and QD-dextran-PAAc were highly cytotoxic and
showed extensive cellular uptake leading to distortion of cellular
morphologies.
o QD-dextran-DS demonstrated limited cytotoxicity and low cellular uptake.
* Cellular interactions of multi-layered structures depended on the chemical structures
of both the cationic and the anionic polymers.
o QD-PAA-DS remain highly cytotoxic.
o QD-bPEI-DS and QD-PDMC-DS demonstrate decreased cytotoxicity and
low cellular uptake, as compared to their single-coated cationic
counterparts.
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Chapter 5: QD-Based Gene Delivery
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Chapter Synopsis
Objective
The aim of this section was to assemble and characterize multi-layered quantum dot
(QD)-cationic polymer-DNA heterostructures, investigate the effect of nanostructuring
on gene delivery properties, and visually track and characterize multi-gene systems.
Hypothesis
The use of multi-layered QD-polymer-DNA complexes with diverse chemical
functionalities and highly defined nanostructures may enable assembly of highly efficient
gene delivery vehicles capable of mediating high levels of protein production and
optically tracking the gene delivery complex.
Rationale
Polymer coated semiconductor QDs were used for assembling gene delivery
nanostructures since they (i) enable fine morphological control of the QD core, (ii)
possesses inherent fluorescence of the QDs, and (iii) allow easy integration of diverse
chemical functionalities. These properties are important for the assembly of finely tuned
delivery vectors for mediating efficient gene delivery and tracking.
Results
Diethylaminoethyl dextran (dextran)-coated QDs were selected as the DNA condensing
cores based on their gene delivery properties; when delivered to COS-7 cells they yielded
the highest levels of gene-product production and low levels of cytotoxicity.
Characterization of the electrophoretic mobilities demonstrated that QD-dextran
complexes condensed and over-compensated for the anionic DNA, elicited high levels of
protein production, and could be easily visualized using fluorescence.
Multi-layered heterostructures were assembled by integrating functionalized poly 3-
amino esters (C32) with the QD-dextran/DNA complexes, yielding approximately 2.5
fold enhancement in protein production. Characterization of hybrids using transmission
electron microscopy revealed ordered beads-on-a-string assemblies of QDs wrapped with
the polymers and DNA, analogous to naturally occurring nucleosomes. The
heterostructures were more effective at condensing DNA and mediated higher levels of
protein production than their unstructured and free polymer counterparts, at the same
mass ratios.
Heterostructured QD-dextran/DNA/C32 complexes were used to characterize DNA
delivery. Colocalization of QD and labeled DNA inside cells revealed that the nucleic
material remained bound to the QD, and could therefore be used for monitoring gene
delivery. Continuous imaging of a single cell tracked the intracellular route of the
heterostructures, from delivery to protein production. Multi-colored heterostructures (red
and blue) were used to monitor delivery of different genes (nuclear and mitochondrial
113
localizing GFP), and co-visualization with the gene products demonstrated that they were
effective labels for tagging gene delivery.
Conclusions
Multi-layered QD-dextran/DNA complexes demonstrate hierarchal nanostructuring
which leads to more effective DNA condensation and assembly of enhanced gene
delivery vehicles than their unstructured counterparts. Incorporation of the functionalized
C32 polymer further increases the gene delivery efficiency of the multi-layered
complexes. Hybrids also enabled the continuous tracking of the delivery complex inside
cells, and the simultaneous tagging of multiple genes.
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5.1 Background
Inorganic-organic complexes can be manipulated to allow design of diverse hybrid
platforms; integration of polymers with different functionalities allows chemical
diversity, while manipulation of the quantum dot (QD) size and morphology enables
control of the structural organization (Chapter 4). Assembly of highly tunable
heterostructures incorporating multiple functionalities may provide efficient solutions to
multi-faceted biological problems like gene therapy, the delivery of exogenous DNA to
manipulate endogenous protein levels -. To date, several specialized materials have been
developed for mediating gene therapy which should present high levels of gene-product
expression but low levels of non-specific cytotoxicity3. However, these synthetic systems
are not as efficient as viruses, the biological gene delivery vectors (Section 1.2.3)4-6 . The
difference in efficiency could be due to differences in structural organization and limited
material functionalities, leading to arrest by cellular barrier7 . In the following sections the
characterization of unstructured synthetic cationic polymer-DNA delivery systems, and
nanostructured hybrid systems for gene therapy, are discussed.
5.1.1 Unstructured Gene Delivery Systems
The use of different synthetic materials for mediating gene delivery has been extensively
investigated. These materials must (i) complex with DNA and facilitate cellular uptake of
the complex, (ii) protect DNA from enzymatic degradation while in transit within the
cell, and (iii) dissociate from DNA after nuclear localization, to enable gene transcription.
Some of the commonly used cationic polymers for gene delivery applications include
branched polyethyleneimine8 (bPEI), polylysine 9 (pLys), polyargininel ° (pArg) and
diethylaminoethyl dextran1l (dextran) (for discussion of chemical structures and
properties, see section 4.1.2.1). These materials electrostatically interact with the highly
anionic phosphate moieties of the DNA backbone, and lead to condensation of the
nucleic acid. While the use of these polymers can avoid some of the inflammatory and
immunogenic responses evoked by viruses, their application is limited by low
transfection efficiencies due to their arrest by cellular barriers to gene delivery7 . The
inability of these complexes to escape cellular impedances may be due to lack of both
materials with specialized chemical functionalities, and hierarchal nanostructuring of the
complex.
Functionalized materials specifically designed for mediating enhanced gene delivery,
target specific barriers that impede the delivery of the DNA complex (Section 1.2.2).
Nucleic acids complexed with bPEI covalently linked with arginine-glycine-aspartate
(RGD) residues or glucosyl units demonstrated increased levels of protein expression due
to increased cellular uptake of the polymer/DNA complex, mediated by association of the
ligand with cell surface receptors '3 . Thermo and pH responsive polymers, which
undergo a sharp coil-globule transition in water at 32 °C, being hydrophilic below this
temperature and hydrophobic above it, reversibly condense with DNA at lower
temperatures, and facilitate release of plasmid at physiological temperatures 5.
Biodegradable polymers with reducible disulfidesl6 or hydrolyzable bondsl7 facilitated
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the release of polymer-bound DNA, therefore mediating higher levels of gene
transcription.
The use of one particular class of hydrolyzable polymers, poly-3 amino esters, has
demonstrated very high levels of protein production as compared to other synthetic,
cationic polymers 17 18. These polymers are prepared via the conjugate addition of primary
amines to diacrylates, which results in the synthesis of cationic polyesters that are
hydrolyzed in aqueous environments 8 . These polymers can reversibly condense DNA; in
their undegraded form they are cationic enough to effectively condense DNA, but after
hydrolysis they fragment and dissociate from the nucleic acid, returning it to its original,
uncondensed state1 9. Libraries of different poly-3 amino esters were synthesized by
varying the constituent amines and diacrylates, with the resulting polymers demonstrating
varying levels DNA delivery efficiency'9'20 . Of the polymers tested, C32 (Fig 5.1)
demonstrated the best gene delivery properties2 1; it mediated the highest levels of protein
production while eliciting low levels of cytotoxicity, and was more effective than bPEI as
a gene delivery vector.
0
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Figure 5.1 Synthesis of C32 from constituent diacrylate and amine.
Structural morphology of several polymer-DNA complexes was investigated using
atomic force microscopy (AFM) and transmission electron microscopy (TEM).
Analyzing the morphologies revealed that the complexes formed rods, torroids and
spheroids, depending on the relative concentrations of the polymer and DNA, the
chemical structure of the condensing polycation, and the counter ion and the solvent used
for the complexing solution22-25. The size of the condensed complexes varied between -
50 and 300 nm, and lacked defined structuring on the nanometer length scale25. The size
and morphology of the polymer-DNA complexes was affected by the charge density of
the complexing polymers with highly charged polymers binding DNA more effectively.
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The geometric and structural organization of the cationic charge also influenced DNA
condensation; equivalent amounts of dendrimer, branched, and linear structural analogues
of polyethyleneimine, had different DNA condensation abilities, with the highly
branched, ordered dendrimers being the most effective2 6. Polymers that more efficiently
compacted DNA mediated higher levels of protein production.
Therefore previous investigations demonstrate that chemical composition, structural
organization, and hierarchal assembly of the delivery complexes affect their size and
morphology, which leads to differences in transfection properties.
5.1.2 Nanostructured Gene Delivery Vehicles
The use of alternate hybrid inorganic, polymer and DNA heterostructured complexes as
platforms for efficient delivery and optical characterization of multi-gene systems was
previously investigated. To date, examples of hybrid materials complexed with DNA
include cationic polymers grafted to gold nanoparticles27 , dendrimers attached to silica
nanoparticles2 8, amine-modified fluorescently labeled silica nanoparticles29 , fluorescent
silica nanotubes3 0, and fluorescently labeled Ni/Au nanorods31. These structured hybrids
show more efficient gene expression than their unstructured analogues. While the
delivery efficiencies of these structures are low, their properties may be manipulated by
controlling the hierarchal assembly and integration of multiple functionalities.
Herein the use of nanostructured polymer-coated quantum dots (QDs) to complex with
DNA is investigated. The use of QD-based platforms for gene delivery applications has
not been previously demonstrated, and confers several advantages on the hybrid complex.
Layer-by-layer deposition of different polymers enables the incorporation of multiple
functionalities that can systematically target escape from various gene delivery barriers.
The use of morphologically defined, nanostructured QD-cores may facilitate the
assembly of complexes with controllable hierarchal organization. The combination of
integrating multiple functionalities in an ordered heterostructure may lead to the
synergies in gene delivery efficiency. Finally the bright, resolved, stable fluorescence of
the QD core can enable continuous tracking of the gene delivery complexes, and
simultaneous characterization of multi-gene systems.
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5.2 Specific Aims
Nanostructural Enhancement
* Select cationic core for gene delivery
o Select biocompatible polymer coating for assembling cationic hybrid cores
o Characterize gene delivery properties of QD-polymer/DNA complex, and
select optimal QD to DNA mass ratio
o Integrate functionalized polymers to enhance protein production
* Characterize morphology of hybrid QD-polymer/DNA complexes and compare with
their unstructured and free polymer counterparts
· Determine effect of nanostructuring on gene delivery properties of the complex.
o Investigate DNA condensation & protection from enzymatic degradation
o Characterize levels of protein expression and cytotoxicity
Fluorescent Tracking
· Demonstrate continuous tracking of QD-polymer-DNA complexes inside single cells,
from delivery to protein production.
* Monitor multi-gene delivery by using different color QDs as platforms for
simultaneously delivering multiple plasmids.
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5.3 Materials & Methods
5.3.1 Experimental design
Materials
CdSe-ZnS core-shell QDs were purchased from Evident Technologies in red, green and
blue (4 nm, 2.1 nm and 1.9 nm diameters) preparations. Enhanced green fluorescence
proteins (EGFP, 3.4 kbp), rhodamine labelled plasmid (pGeneGrip/LUX) and nuclear and
mitochondrial localizing GFP (pCMV/myc/nuc and pCMV/myc/mito) plasmids were
obtained from BD Biosciences, Gene Therapy Systems, and Molecular Probes,
respectively. COS-7 cells were purchased from American Type Culture Collection, cell
culture supplies from Gibco BRL, and Nhe 1 enzyme from New England Biolabs. All
other materials were purchased from Sigma Aldrich.
QD surface modification and nanoassembly preparation
CdSe-ZnS core-shell quantum dots (QD) were modified with mercaptoacetic acid
(MAA), and coated with cationic polymers, as described previously. 12 Briefly,
trioctylphosphine oxide capped QDs were sonicated with MAA, purified twice by ethanol
precipitation, and suspended in 50 mM tris base buffer. The anionic QDs (30 - 50
[tg/mL) were mixed with two volume equivalents of cationic polymer solutions (10
mg/mL), incubated on benchtop for 20 mins, and purified twice by spinning through an
Amicon separating column (100 kDa cut off). To prepare nanostructured complexes
(NSC), cationic polymer-coated QDs (30 - 50 jig/mL) were mixed with DNA (1 mg/mL)
at QD to DNA mass ratio of 1.5:1 (unless specified otherwise) and incubated on benchtop
for 20 mins. To form heterostructured complexes (HSC), C32 (10 mg/mL) was mixed
with the NSC at C32 to DNA mass ratio of 10:1 (unless stated otherwise) and incubated
on benchtop for 20 mins. Unstructured complexes (USC) were prepared by adding
dextran (5 mg/mL) to MAA-capped QD (30- 50 pg/mL) and DNA mixture, at QD to
dextran to DNA mass ratio of 1.5:3:1. Free polymer complexes (FPC) were prepared by
adding dextran directly to DNA at dextran to DNA mass ratio of 3:1. The QD, dextran
and DNA mass ratios of all the complexes were equivalent.
OD-Cation/DNA cell transfiction
Monkey kidney COS-7 cells maintained at 37 °C and 5% CO2 were cultured in
DMEM/F- 12 medium supplemented with 10% fetal bovine serum and 1%
penicillin/streptomycin/amphotericin B. Cells were seeded at a density of about 75,000
cells per well in a 24-well plate, and 30,000 cells per well in an 8-well collagen treated
cover-glass chamber, and allowed to grow overnight. QD-polymer-DNA complexes with
1 g and 0.5 pg of DNA were delivered to cells in 24-well and 8-well, respectively, in
serum-free medium. Cells were treated for 2 hrs (unless stated otherwise), and then
loaded with fresh serum-supplemented medium.
Cell viability and transfection quantification
QD-polymer-DNA treated cells were analyzed 2 days post-treatment (unless stated
otherwise). Cells were washed with phosphobuffered saline (PBS), incubated on ice for
15 min with trypsin (2.5 mg/mL) and propidium iodide (PI, 5 pg/mL) supplemented-
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PBS, and analyzed using a FACScan (Becton Dickinson) flow cytometer, equipped with
an argon ion laser. PI treated cells were detected using a PE/PI band-pass filter (585/42),
and GFP expressing cells using a FITC band-pass filter (530/30). The cells were
appropriately gated by the forward and side scatter. Relative cell viability was determined
as the percent of viable cells, relative to untreated cells exposed to the same conditions.
Relative transfection was expressed as the percent of cells expressing the gene product,
relative to those treated with lipofectamine 2000, at an optimized LPF to DNA ratio of
1.5:1.
Zeta potential measurements
Surface electrophoretic mobilities of hybrid complexes were determined using a zeta
potential analyzer (ZetaPlus, Brookhaven) with a HeNe laser at 632 nm. Complexes were
dispersed in deionized water, and measurements were repeated three times. The
Smoluchowski method was used to calculate the zeta potentials.
Enzymatic cleavage & agarose gel electrophoresis
Equal amounts of free DNA, and DNA condensed in NSC, FSC and FSC* were cleaved
with Nhe 1 restriction enzyme for 1 hr at 37 C, according to manufacturer's protocols.
The enzyme was subsequently denatured by heating at 70 C for 5 mins. Equal amounts
of untreated and restriction enzyme treated complexes were loaded in 1% agarose gel
with 0.5 mg/mL ethidium bromide, and run at 100 mV for 60 mins in lx TAE buffer.
Images were obtained using UV BioRad transillumination imaging system, and
ChemiDoc software.
Thermogravimetric Analysis
QD-dextran in tris base buffer were lyophilized for 2 days, loaded in a platinum well, and
analyzed using the thermogravimetric analyzer (TG/DTA 320 Seiko). Temperature was
increased from 30 C to 400 C at 2 C/min.
Transmission electron microscopy characterization
Complexes were adsorbed on carbon coated copper grids (Ladd Research Industries) for
20 minutes, allowed to dry and imaged using a JEOL 2010 at an accelerating voltage of
200 kV.
Fluorescence microscopy imaging
Low magnification (40x) images were obtained using an inverted Olympus microscope
(IX51) with GFP (ex 450/40, em 525/50), TRITC (ex 535/50, em 610/75) and DAPI (ex
360/40, em 460/50) filters, using SimplePCI software. Cell tracking images (100x) were
obtained with a Zeiss Axiovert epifluorescence time-lapse systems using a GFP (ex
480/40, em 528/38) filter, with Metamorph software. Cells were maintained at 37 C and
5% CO2, using an environmental chamber. Confocal images were obtained using a Zeiss
LSM510 system with a 100x oil immersion objective, using FITC (bp 505 - 530) and
rhodamine (bp 565 - 615) filters with Argon (488 nm) and HeNe (543 nm) lasers. All
images were digitally enhanced.
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5.3.2 Experimental setup: Nanostructural Enhancement
(]) Prepare bPEI, PAA, PDMC, dextran and cellulose coated
QD complexed with DNA and deliver to cells at varying QD to
DNA mass ratios (1 to 10)
(2) Select QD-polymer system with highest cell transfection
and lowest cytotoxicity
(3) Optimize QD-polymer/DNA complex by monitoring (i) zeta
potential, (ii) agarose gel shifts, (iii) protein production, (iv)
cytotoxicity and (v) cell morphology at varying ratios
(4) Integrate functionalized polymer, C32, and characterize (i)
protein production, (ii) cytotoxicity and (iii) cell morphology at
varying ratios
(5) Analyze morphology by visualizing using transmission
electron microscopy
(6) Prepare nanostructured, unstructured and free polymer
complexes and deliver to cell
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(7) Characterize gene delivery efficiency by monitoring (i) zeta
potential, (ii) protection from enzymatic degradation, (iii) protein
production, and (iv) cytotoxicity I
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5.3.3 Experimental setup: Fluorescent Tracking
(1) Complex green QD-polymer with rhodamine labeled DNA
and observe colocalization 6 and 12 hrs post delivery
(2) Continuously track intracellular route of QD-polymer/DNA
complex from delivery to protein expression (14 hours)
(3) Observe colocalization of red QD and gene product green
fluorescent protein, inside cells
(4) Observe multiple gene delivery (nuclear and mitochondrial
localizing GFP) using different colored QDs (red and blue)
1
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5.4 Results & Discussion
In the subsequent sections, the selection, optimization, and characterization of QD-
polymer/DNA complexes, effect of nanostructuring on the gene delivery efficiency, and
the use of hybrids as fluorescent probes for tracking and characterizing multi-gene
delivery in COS-7 cells, were investigated. For all subsequent investigations, enhanced
green fluorescent protein plasmid (pEGFP) DNA was used as the reporter gene because
(i) the gene product can be easily detected and assayed due to its bright green
fluorescence, (ii) has high transcription efficiency, (iii) is a medium sized plasmid, (iv) is
completely characterized, and (v) can be easily engineered to integrate additional genes.
COS-7 cells are immortalized African green monkey kidney epithelial (fibroblast) cells
that grow in monolayers. They were selected because they are robust, have easily
characterizable morphologies, actively endocytose extracellular materials, and are very
well characterized.
5.4.1 Optimizing QD-polymer-DNA cores
The first step in assembling hybrid delivery vectors was to select a suitable cationic
polymer coating for the QD-MAA, to produce effective QD-cation complexes. Suitable
QD-cation complexes must (i) facilitate complexing of DNA, (ii) be capable of mediating
gene delivery and protein production, and (iii) demonstrate low cytotoxicity. Cationic
branched polyethyleneimine (bPEI, 25 kDa), Polyallylamine (PAA, 19 kDa),
polydiallyldimethylammonium chloride (PDMC, 17 kDa), diethylaminoethyl dextran,
(dextran, < 100 kDa) and hydroxyethylethoxy cellulose (cellulose, 25 kDa) were used to
coat Red CdSe-ZnS QDs (4.2 nm) QDs. These cationic QD-polymer cores were used to
complex with pEGFP DNA at varying QD to DNA mass ratios, and delivered to COS-7
cells for 2 hours. The cell viability and protein expression were quantified 48 hours post-
treatment. Cell viability was reported as the relative cell viability, relative to the viability
of untreated cells that were maintained under the same conditions. Cell viability was
determined by using fluorescence activated cell sorting (FACS) to quantify the number of
dead and live cells in propidium iodide treated cell samples. PI is a cell impermeant dye
that undergoes 50-fold enhancement in fluorescence when it binds to single-stranded
DNA, and is therefore an indicator of dead or dying cells with compromised cellular
membranes and dissociated DNA. Transfection efficiency was determined by measuring
the percentage of cells with green fluorescence (gene product) and relative transfection
efficiency was expressed relative to the transfection observed when equivalent amounts
of DNA were delivered using lipofectamine 2000 (LPF), a commercially available gene
transecting agent.
Analyzing cell viability results (Fig 5.2a) demonstrates that QD-polymer/DNA
complexes containing bPEI, PAA and PDMC were highly cytotoxic at all QD to DNA
ratios with their use resulting in almost complete cell death (< 5% viability). Cells treated
with dextran containing complexes displayed dose-dependent toxicity (30 - 100%
viability), displaying that these complexes become increasingly toxic at higher QD to
DNA ratios. Cells treated with cellulose-containing complexes were relatively non-toxic
at all QD to DNA ratios (> 95 % viability). The differences in cytotoxicity are likely due
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to differences in charge densities of the polymers (Section 4.1.2.1); bPEI, PAA and
PDMC have very high charge densities, and likely caused cytotoxicity by cell membrane
perforation and endosomal rupture (Section 4.4.1)8. Dextran has lower charge density
than the synthetic bPEI, PAA and PDMC, and therefore QD-dextran complexes
demonstrated varying levels of cytotoxicity. Cellulose has the lowest charge density, and
QD-cellulose complexes were non-toxic at all doses tested 32. Next, the corresponding
levels of transfection were analyzed (Fig 5.2b). Cells treated with dextran containing
complexes were the only ones that demonstrated significant levels of protein production
and were relatively independent of the QD to DNA ratios. The variations in the levels of
transfection are within the experimental error and are not necessarily reflective of
differences in gene expression. The lack of protein production in cells treated with
complexes containing bPEI, PAA and PDMC was likely due to the high cytotoxicity of
the complexes - most of the cells were dead and therefore unable to express the gene
product. Cells treated with cellulose-containing complexes did not demonstrate GFP
expression at any QD to DNA ratio, likely due to arrest of the delivery complex by
cellular barriers .
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Figure. 5.2 Gene delivery efficiency of cationic QD-DNA hybrid complexes, characterized by determining
the normalized (a) cell viability and (b) protein production of treated COS-7 cells. Complexes containing
bPEI, PAA and PDMC are highly cytotoxic and do not mediate gene product production. Complexes
containing dextran demonstrate dose-dependent cytotoxicity and mediate protein expression. Cellulose-
containing complexes do not evoke any cytotoxicity and do not mediate protein production.
The results indicate that dextran containing hybrid complexes mediated efficient gene
expression at low QD to DNA ratios. To further optimize delivery, QD-dextran/DNA
complexes were prepared at low QD to DNA ratios (<4), and their electrophysical
properties and gene delivery efficiency were characterized. The surface zeta potentials of
the complexes dispersed in deionized water were positive at all ratios (Fig 5.3a), and
similar (30 mV ± 4 mV) to those of uncomplexed QD-dextran cores (25 ± 5 mV). The
highly positive values demonstrate that the DNA was completely condensed by the
cationic QD. Gel shift assays were conducted in 1% agarose gels, and the results (Figure
5.3b) demonstrate that free DNA migrated towards the anode (bottom of the gel), while
DNA complexed with cationic QD-dextran moved slightly towards the cathode (top of
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the gel). This data also demonstrates that free DNA was negatively charged, while QD-
dextran/DNA complexes were positively charged. The low mobility of the QD-
dextran/DNA complexes was likely due their high mass, which may impede movement
of the complex through the agarose gel. These data demonstrate that the electrophoretic
mobilities of the QD-dextran DNA complexes prepared at QD to DNA ratios between
0.25:1 and 2.5:1 were positive, indicating complete, efficient condensing of the anionic
nucleic material33 .
50
40
35
30
25
20
15
10
5
0
0.25 0.5 0.75 1 1.5 2 2.5
QD-DEAE-DNA ration (mass:mass)
Figure 5.3 Characterizing the electrophoretic mobilities of QD-dextran-DNA complexes. (a) Zeta
potentials of complexes at all QD to DNA mass ratios are positive, indicating complete condensation of
DNA. (b) Gel shifts demonstrate that while free DNA migrates towards the anode (bottom of the gel), DNA
complexed with QD-dextran at all ratios, remains arrested in the wells.
Gene transfection properties of QD-dextran/DNA complexes at low QD to DNA mass
ratios were characterized by delivering the complexes to COS-7 cells for 2 hours, and
characterizing normalized cell viability and protein production 48 hours post-treatment.
Analyzing the relative transfection of the QD-dextran/DNA complexes (Figure 5.4, bars)
indicates that GFP levels are relatively independent of the QD to DNA ratios. While the
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levels of protein production vary at the different ratios, the error bars are large, and there
appears to be no systematic trend in GFP production with respect to variations in QD to
DNA ratio. Therefore these variations are likely due to systematic errors, and not
reflective of differences in transfection levels. Cell viability (Figure 5.4, line) was high at
all ratios tested, and also independent of the QD to DNA ratio. These data suggest that
protein expression and cell viability did not depend on the QD to DNA mass ratios at low
values (< 2.5:1).
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Figure 5.4 Characterization of gene delivery efficiency of CdSe-ZnS QD-dextran-DNA complexes at
varying ratios. High levels of normalized viability (line) indicate low cytotoxicity at all QD to DNA ratios.
High levels of protein production do not demonstrate a clear dependence on the QD to DNA ratio.
Cellular interactions of QD-dextran/DNA complexes were probed by fluorescent
characterization of treated cells 48 hours post-treatment. The cellular distributions of the
expressed green fluorescent protein (GFP, green) and QDs (red) were analyzed (Fig 5.5).
Since the QDs were delivered at very low doses, they were difficult to detect; the lowest
QD to DNA ratio at which red fluorescence was observed was 1.5:1. Therefore this ratio
was subsequently used for assembling QD-dexran/DNA gene delivery complexes.
5.4.2 Preparing and characterizing morphology of
heterostructured complexes
To further enhance gene delivery properties of the QD-dextran/DNA complex C32 was
integrated into the assembly, since previous use of C32 with DNA yielded high levels of
protein production 21. Heterostructured complexes (HSC) were prepared by assembling
QD-dextran/DNA and QD to DNA ratio of 1.5:1, and adding varying amounts of C32
polymer. These complexes were incubated on benchtop for 20 mins., and delivered to
cells for 2 hours. The percent relative cell viability and transfection were determined
using FACS, 48 hours post-treatment. Analyzing the cell viabilities of the treated cells
(Figure 5.6, line) demonstrated that cytotoxicity increased as the amount of C32 in the
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complexes increased, indicating that C32 was toxic at higher ratios. Protein production
(Figure 5.6, bars) initially increased with increasing C32, reaching a maximum value of
350% at a ratio of 25:1. At higher C32 ratios transfection decreased, likely due to the
elevated cytotoxicity levels.
Figure 5.5 Cells treated with CdSe-ZnS QD-dextran DNA complexes, characterized using fluorescence
microscopy. EGFP gene product (green) is visible at all QD to DNA ratios. QD complex (red) is visible at
higher QD to DNA ratios (> 0.75)
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Figure 5.6 Characterizing gene delivery properties of CdSe-ZnS QD-dextran-DNA complexes, mixed with
varying ratios of C32 polymer. Normalized cell viability (blue line) decreases with increasing amounts of
C32. Normalized transfection (bars) shows optimal enhancement at C32 to DNA mass ratio of 25:1.
Cells treated with HSC at varying C32 to DNA mass ratios were further characterized by
treating with propidium iodide (PI) and imaging using fluorescence microscopy (Fig 5.7).
Cellular morphologies were analyzed using light microscopy (left panel), cytotoxicity
was determined by treating with PI (red, right panel), and gene delivery efficiency was
monitored by localizing GFP fluorescence (green, right panel). Analyzing the
morphology of the cells demonstrates that as the C32 to DNA ratio was increased, the
cells became increasingly curled up, the cellular and nuclear membranes began to
fragment, and cellular organelles disappeared, all indicators of decreased cell viability.
The cells also demonstrated increased PI staining, an indicator of increased cytotoxicity.
GFP production of cells initially increased in number and intensity of color with
increasing amount of C32 until a ratio of C32 to DNA of 25:1 was reached, following
which protein production appeared to remain constant.
The results (Fig 5.6 and 5.7) demonstrate that there was an optimal C32 to DNA mass
ratio at which transfection was enhanced, while increase in cytotoxicity was limited. 10:1
was selected as the optimal C32 to DNA ratio since transfection is increased
approximately 2.5-fold, while cell viability decrease is limited to 72%. For all subsequent
preparations of heterostructured complexes, QD to DNA to C32 ratios of 1.5:1:10 were
used.
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Figure 5.7 Cells treated with QD-dextran-DNA-C32 complexes at varying C32 to DNA ratios,
characterized using light (left panel), and fluorescence (middle and right panels) microscopy. As the
amount of C32 used increases, cell viability decreases, as evidenced by the fragmented morphology of the
cells, and increased PI staining (red). The amount of protein expression (green) initially increases with
increased amounts of C32, and appears to plateau at C32 to DNA concentrations of 25:1.
Prior to analyzing the morphologies of the QD-dextran/DNA/C32 complexes, the relative
mass ratios of dextran polymer and the inorganic semiconducting materials were
determined using thermo gravimetric analysis. The sample was tested over a temperature
range of 30 - 400 "C , and the results showed three regions of weight loss (Figure 5.8)
The first was observed between 200 - 250 "C, accounted for approximately 12%
reduction in mass and was due to the loss of tris base (bp 220 "C). The second occurred
between 260 - 340 "C, accounted for approximately 58 % loss in mass, and was due to
the organic polymer burning off. The final loss in mass occurred after 370 "C, and was
due to loss of inorganic material, as reported for other inorganic/organic hybrid
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systems34 . Therefore, the mass ratio of the organic dextran polymer to QD was
approximately 2:1.
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Figure 5.8 Loss in mass of CdSe-ZnS-dextran complex as a function of temperature, determined using
thermogravimetric analysis. There re three regions of temperature drop, around 170 C, 325 C, and
following 350 C, which correspond to loss in weight due to loss of tris base, dextran polymer and the
inorganic material, respectively.
Next, the effect of polymer localization to the QD surface, on the overall morphology of
the hybrid was investigated (Fig 5.9). Adsorbed polymer chains cluster on the QD
surface, and can lead to an increased local concentration of the polyelectrolyte. This is in
contrast to unbound polymer chains that, in the absence of an adsorption substrate, are
freely dispersed in solution. This 'concentration localization' on the nanocrystal surface
may promote more efficient DNA condensation and hierarchal structuring of the QD-
polymer/DNA hybrids to form nanostructured complexes (NSC), that are different from
the rod and torroid structures observed when free polymer/DNA complexes are
assembled22" 25. The small size, high curvature and surface localization of cationic charges
of the polymer-coated QDs 35 are similar to those of histone proteins36 '37 and dendrimers 38
40, both of which, when complexed with DNA, form strings of dense, cationic DNA-
nanoparticle "beads" connected by anionic, uncomplexed "linker" DNA. The structure
of the NSC is expected to be similar to the beads-on-a-string morphology of nucleosomes
and dendrimers-DNA complexes. Furthermore, any hierarchal nanostructuring effects as
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a result of polymer localization to the QD surface should be lost if corresponding
amounts of QD/polymer/DNA are simultaneously mixed together to form unstructured
complexes (USC), without first adsorbing the polyelectrolyte on the QD core.
Conversely, incorporation of additional polymers to the NSC to assemble
heterostructured complexes (HSC) is unlikely to affect the bead-on-a-string morphology
of the hybrid, but may promote cross-linking of the constituent NSC and further
condensation of the hybrid.
Nanostructured complex (NSC) Unstructured complex (USC)
Heterostructured complex (HSC)
-------------
Figure 5.9 Characterizing self-assembly of hybrid complexes. (a) Schematic representation of hybrid
assemblies. Nanostructured complexes (NSC) comprise dextran (yellow) coated QDs (red) complexed with
DNA (green). Heterostructured complexes (HSC) have additional C32 polymer (purple). Unstructured
complexes include QD, DNA and dextran mixed at the same mass ratios as NSC, without first coating QD
with dextran.
Morphologies of structured and unstructured cationic polymer-coated CdSe-ZnS core-
shell QDs (4 nm diameter) and anionic DNA (3.4 kbp, pEGFP) complexes were
characterized using transmission electron microscopy (TEM, Fig. 5.10). NSC comprised
of dextran-coated QD complexed with DNA, and were assembled at an optimized QD to
DNA mass ratio of 1.5:1. HSC were prepared by mixing NSC with poly-3 amino ester
C32, at an optimized C32 polymer to DNA mass ratio of 10:1. USC were assembled by
simultaneously mixing QD, DNA and dextran in the same mass ratios as NSC, without
first coating QD with the polymer. The relative mass ratio of dextran to QD in dextran-
coated QD assemblies was 2:1, determined using thermo gravimetric analysis. Therefore
USC were prepared at QD to DNA to dextran mass ratios of 1.5:1:3. TEM
characterization of these complexes revealed that all three assemblies had dense,
spherical cores approximately 5 nm in diameter, and were surrounded by diffuse material
(Fig. 5.10a-c). Further characterization of the dense cores using high resolution TEM
revealed the presence of lattice fringes (Fig. 5.10d), characteristic of crystalline QD
cores4 1. Based on their size, shape and crystalline structure, the dense cores were
identified as QDs4 1, while the diffuse material comprised cationic polymer and DNA.
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However, the morphologies of the complexes was different from each other; NSC and
HSC form QD-polymer/DNA strings, while USC form large aggregates, 200 - 300 nm in
diameter. The QD-chains vary in size; NSC complexes are 50 - 100 nm in length while
HSC form larger, more elaborately branched structures. Previous characterization of
polymer-coated QDs without DNA revealed lack of hierarchal structuring and lower
amounts of the diffuse material 35. These data demonstrate that the localization of the
polymer on the QD surface has a significant effect on the morphology and nanostructure
of the QD-polymer/DNA hybrids, and results in the assembly of complexes with defined
hierarchal structures. This is likely due to enhanced DNA complexing ability of the
cationic QD core, caused by an increase in the local concentration of the polyelectrolyte
due to clustering of the polymer chains adsorbed on the QD surface.
Figure 5.10 Transmission electron microscopy characterization reveals that (a) NSC and (b) HSC form
complexes with defined secondary structures of linked QD chains, not found in their (c) USC analogues.
(d) High resolution lattice fringes reveal the crystalline QD core. Black and white scale bars are 20 nm and
5nm, respectively.
The data presented in this section demonstrates that QD-dextran nanoparticles formed
effective cores to condense and deliver DNA, and their efficiency was enhanced by
incorporating functionalized gene delivery polymers like C32. These hybrid
heterostructured systems demonstrated secondary ordering to form quantosomes,
biomimetic nucleosomes.
5.4.3 Determining effect of nanostructuring on gene delivery
properties
The effect of polymer localization to the QD surface, on the DNA complexing ability of
the dextran-coated QD core, was investigated. In addition to the NSC, HSC and USC,
free polymer complexes (FPC) which comprised unbound dextran polymer and DNA at
the same dextran to DNA mass ratio (2:1) as NSC, were also prepared. DNA
condensation was monitored by determining the electrophoretic mobilities of the QD-
dextran/DNA complex using gel electrophoresis. Free DNA and prepared complexes
were loaded in 0.5 mg/mL mM ethidium bromide (EtBr) agarose gels, run for 1 hour, and
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imaged. The positions of DNA complexes on the agarose gel were revealed by EtBr
staining, and were visible as fluorescent bands (Fig 5.11). Analysis of the migratory
patterns of the bands revealed that DNA complexed in various assemblies had altered
electrophoretic mobilities. Naked DNA migrated towards the positive electrode at the
bottom of the gel; uncomplexed DNA is anionic and freely dispersed in solution,
therefore demonstrating high mobility through the gel. DNA complexed in NSC and HSC
appeared to move slightly towards the negative electrode (top of the gel); the cationic
QDs appear to effectively overcompensate for charge neutralization of anionic DNA, and
the limited mobility is likely due to the high mass of the complexes. DNA incorporated in
the USC is partially arrested; free dextran condensed only some of the DNA which
remains in the wells, while the rest is uncomplexed and migrates the same distance
towards the negative electrode, as does naked DNA. Therefore free dextran in USC does
not facilitate complete DNA condensing. DNA in FPC remains arrested in the well and
does not appear to move toward either electrode; it is unclear whether the FPC is
positively charged or neutral. This data demonstrates that analogous assemblies
containing equal amounts of QD, polymer and DNA demonstrate different
electrophoretic mobilities as a result of nanostructuring the QD-dextran DNA complexing
core.
Figure 5.11 Gel electrophoresis results show anionic DNA migrates towards the anode, cationic NSC, HSC
and FPC* towards the cathode, and uncharged FPC remains arrested in the well.
The surface charges of the hybrid assemblies were further characterized by measuring the
zeta potential of the DNA-containing complexes (5.12). NSC and HSC are highly
cationic, and their surface charge is similar to that of dextran-coated QD without the
addition of DNA (27 +3 mV). This shows that dextran-coated QDs are effective at
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overcompensation of charge neutralization of DNA, forming cationic assemblies. USC
have highly negative surfaces which may be due to excess, uncomplexed DNA or
uncoated QDs (-43 ±6.9), which are not electrostatically neutralized by the free polymer
in the complex. The FPC are neutral which demonstrates that while the free polymer
complexes with DNA, it does not overcompensate for the anionic charge. The data
demonstrate that analogous assemblies containing equal amounts of QD, polymer and
DNA have very different complexing properties as a result of different nanostructures;
localization of polymer to QD surfaces makes it more effective at electrostatically
complexing with and overcompensating for charge neutralization of the DNA, than
equivalent amounts of free polymer.
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Figure 5.12 Zeta potentials of complexes reveal that NSC, HSC and free polymer complex (FPC*) at
optimized polymer to DNA mass ratio effectively condense DNA, while USC and FPC at original mass
ratios do not. Error bars represent standard error.
There may be several reasons that contribute to the enhancement of the DNA complexing
ability of the polymer, when it is localized on QD surfaces. The first is effect of polymer
chains clustering on the surface of the QD, leading to local physical increase in
concentration. Physical proximity of the cationic charges may also promote cooperative
coulombic interactions between the polymer and the oppositely charged DNA. These
effects are analogous to those observed when the molecular weight of DNA complexing
polymers is increased; at equivalent mass amounts, higher molecular weight cationic
branched polyethyleneimine are more effective at electrostatically condensing DNA and
forming smaller, more defined complexes, than their lower molecular weight counterparts
42,43. Complexing ability may also be enhanced because of minimization of steric
hindrance due to surface localization of the polymer, facilitating ready availability of the
cationic charge for electrostatic interactions. This effect is analogous to when dendrimers
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are used to complex DNA instead of their linear or branched counterparts; at equivalent
mass amounts, polyamidoamine dendrimers are more effective at condensing DNA and
forming complexes for gene delivery, than linear polyethyleneimine26
The effect of nanostructuring the QD-dextran core and integrating C32, on relative
transfection (Fig 5.13, white bars) and viability (Fig 5.13, hatched bars) of treated cells,
was determined. The transfection efficiency of NSC treated cells was 66%; dextran-
coated QDs mediated approximately two-thirds as much transfection as that obtained
using LPF. The transfection efficiency increased to 260% with the addition of C32 to the
complex; HSC mediated approximately 2.5-fold as much transfection as that obtained
using LPF. Transfection efficiency dropped to < 5% when USC and FPC were used to
deliver DNA; these unstructured and free polymer complexes were much less effective at
mediating gene delivery than LPF and their nanostructured counterparts (NSC). Analysis
of the relative viability demonstrates that 84% of NSC treated cells were alive; treatment
with QD-dextran/DNA complexes resulted in slight decrease in cell viability, as
compared to untreated cells. Cells treated with HSC demonstrate 71% effective viability;
addition of C32 to the complexes increases cytotoxicity of the DNA containing complex.
Treatment with USC and FPC demonstrate 86% and 98% effective viabilities,
demonstrating that treatment with QD-containing complexes causes slight increase in
cytotoxicity, while treatment with polymer/DNA complex is relatively non-toxic.
Therefore both relative transfection and viability increase due to nanostructuring of the
QD-dextran core prior to DNA complexing, and are further promoted by the
incorporation of C32 to form HSC.
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Figure 5.13 Gene product expression (white bar) and cell viability (hatched bar) demonstrate that NSC
treated cells yield more gene expression than USC and FPC, and similar expression levels as FPC*. HSC
mediated delivery results in further enhancement of gene expression. Error bars represent standard
deviation.
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The differences between the transfection and cytotoxicity properties of the different
DNA-containing complexes may be due to several reasons. The higher transfection
mediated by the NSC as compared to the unstructured and free polymer counterparts may
be attributed to more efficient DNA complexing by the QD-dextran core, as
demonstrated by TEM analysis and electrophoretic characterization. NSC are small and
electrostatically condense and overcompensate for anionic DNA, resulting in the
assembly of cationic complexes that can readily associate with, and be endocytosed by,
the negatively charged cell membrane. The negatively charged and neutral USC and FPC
are not electrostatically attracted to the anionic cell membrane. Furthermore, complete
condensation of the DNA within the NSC may protect it from enzymatic degradation and
arrest by intracellular gene delivery barriers7. Addition of C32 to the complex further
increases its transfection efficiency, due to the intrinsic gene delivery properties of the
polymer21. Decreased relative cell viability caused by the QD-containing complexes
(NSC and USC) as compared to those containing only the polymer (FPC) demonstrate
that there may be a slight increase in toxicity when QDs are delivered to cells. Several
studies have previously demonstrated that CdSe-ZnS core-shell QDs have limited
inherent cytotoxicity, and biocompatibility of the QDs depends primarily on the surface
coating of the QDs4 4 '4 5. However, delivery of large complexes to cells has previously
demonstrated elevated cytotoxicity levels, irrespective of the core material 6. Therefore is
it likely that the increase in cytotoxicity is not due to the delivery of QDs, but due to the
indiscriminate delivery of large complexes. Addition of C32 decreases cell viability
further, and could be due to increased cationic charge of the complex, or due to increased
uptake of the complex. There appears to be a trade-off between transfection and cell
viability, as observed for other cationic polymer-based gene delivery systems8 32.
However HSC appear to mediate higher levels of transfection and less toxicity as
compared to several commercially available cationic gene delivery polymers47 .
Analysis of gene transfection data clearly demonstrates that the addition of C32 polymer
and QD-dextran/DNA to form HSC results in increased transfection and decreased cell
viability, but the interaction mechanism between the polymer and NSC is unclear. Since
both the polymer and the composite NSC are cationic, C32 do not electrostatically adsorb
to the entire complex. Instead, the two may form physical blends, or C32 may attach to
anionic, uncomplexed DNA regions. Discussing the latter involves further probing the
binding mechanism between the cationic QD-dextran and the anionic DNA. It is unclear
whether contiguous segments of DNA complex with and wrap around cationic QD-
dextran cores, multiple strands interact with single QD-dextran core, or whether they
associate via other mechanisms. Whichever the case may be, it is likely that most of the
DNA is condensed by the dextran-coated QDs, forming cationic beads. However, there
may be exposed regions of anionic DNA between adjacent QD-dextran cores that are not
condensed. This structure is analogous to that of DNA condensed with histones to form
nucleosomes3 63 7 , and DNA complexed with dendrimers40. It is possible that cationic C32
attaches to these unbound DNA segments, resulting in further cross-linking and
complexing of the NSC. This mechanism of C32 incorporation would also explain the
more elaborate branching observed in HSC (Fig. 5.10b), as compared to NSC (Fig.
5.10a).
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5.4.4 Fluorescent Tracking
The ability of the dextran-coated QDs and DNA to remain associated inside cells post-
delivery was investigated, to validate the use of QDs as labels for tracking DNA delivery.
QD-dextran (green) and rhodamine labelled DNA plasmid (red, 5.1 kbp,) complexed as
NSC and HSC were delivered to cells for 1 hour, the cells were fixed 6 and 12 hrs post
treatment, and the cellular distribution of the QDs and labelled DNA characterized (Fig.
5.14). For NSC treated cells (top panel), the QD and DNA were either colocalized, or in
very close proximity to each other, distributed punctuately throughout the cell. With
increasing time, they appeared to localize towards the center of the cells, indicating
nuclear localization. HSC treated cells (bottom panel) also showed both QDs and DNA,
but with the QDs in excess. In the cytoplasm, most of the DNA is adjacent to (red-green),
or complexed with (yellow), QD-dextran. Their punctuated distribution indicates that the
complexes may be endosome-bound48 . In the nucleus, more free (red) than complexed
(yellow) DNA is observed, both diffusely spread and localized around the nucleoli. Since
protein production is first detected approximately 6 hrs after incubation of cells with HSC
(see Fig. 5.15), some DNA dissociation is expected at that time.
Figure 5.14 Confocal microscopy (100x, scale bar 10 pm) of QD-dextran (green) and rhodamine labelled
DNA plasmid in fixed cells 6 and 12 hrs after treatment with HSC. Both dissociated (red) and complexed
(yellow) DNA is observed in the nucleus and the cytoplasm.
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Optical tracking of QD-dextran/DNA complexes and the gene product, from delivery to
protein production, was demonstrated by visualizing HSC treated COS-7 cells. Cells
were treated for 15 mins with HSC comprising QD-dextran (green) and unlabelled
pEGFP DNA encoding for enhanced green fluorescent protein (EGFP). Post-treatment,
they were incubated in an environmental chamber and continuously visualized using
fluorescence microscopy. Since both the QD and expressed protein were green, they
could not be independently tracked inside cells based on color. Instead, their trajectories
were inferred by comparison (data not shown). The route of HSC within the EGFP
expressing cell was compared with that of HSC within other cells, treated under the same
conditions, but not expressing EGFP. The evolution of EGFP production was compared
to that of cells treated with red QD-containing HSC (red QDs were not distinctly
visualized using continuous imaging). Analyzing the fluorescence of the cells (Fig. 5.15)
demonstrates that the complexes are initially present diffusely over the entire cell (data
not shown), indicating attachment to the cell surface. Approximately 2 hr 20 mins post
treatment punctuate green vesicles begin to appear, likely due to endocytosis of the
complexes. 2 6 At 3 hrs post treatment, several such green vesicles are visible, localizing
around the perinuclear region (asterisk), suggesting continued endocytosis and nuclear
localization. By 3 hr 40 mins (arrow) green particulates begin to appear inside the
nucleus, where they continue to localize. At 5 hrs post treatment substantially more green
is observed in the cytoplasm and is distributed more diffusely than the endocytosed
quantosomes, likely indicating the beginning of EGFP production. The color becomes
more intense and widespread with time, and is stable for at least 3 days post treatment
(data not shown). These data demonstrate that QDs do not hydrolyze or photobleach over
the observed period, and may be repeatedly imaged to track gene delivery in individual
cells. Tracking the HSC intracellularly will help elucidate delivery routes and identify
cellular barriers impeding delivery. Understanding these mechanisms can subsequently
aid in the design of more efficient delivery vehicles.
Long term fluorescent labeling and semi-quantification of gene delivery complexes with
HSC was investigated by visualizing QD-dextran (red) and EGFP (green) in fixed cells
(Fig 5.16). The cells were treated with HSC for 2 hours, and results were obtained 36
hours post treatment. Projections (left panels) and their respective orthogonal sections
(right panels) show EGFP spread diffusely throughout the cytoplasm and concentrated
densely in the spherical nucleus49. QD particulates in the cytoplasm (red) and nucleus
(yellow) were brightly fluorescent, and resisted oxidative degradation even after extended
exposure to intracellular environments. This demonstrated that QDs can be visualized
simultaneously with the gene product.
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Figure 5.15 Continuous tracking of HSC (particulate green) cellular internalization and gene product
expression (bright, diffuse green), using time-resolved fluorescence microscopy (100x, scale bar 10 pm).
HSC are endocytosed (2 hr 20 min), trafficked to the nucleus (3 hr, asterisk) and enter the nuclear region (3
hr 40 min, arrow). EGFP expression is first observed 5 hrs post treatment, and remains stable for at least 14
hrs.
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Figure 5.16 Confocal projection and (b) orthogonal sections (00x, scale bar 10 pm) of HSC treated fixed
cells show EGFP (green) and QD-dextran (red). EGFP is distributed diffusely in the cytoplasm and
concentrated densely in the nucleus, while QDs are found in the nuclear/perinuclear region. Orthogonal
slices XZ (bl) and YZ (b2) show QDs localizing inside the cell.
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Multi-gene delivery was demonstrated and characterized using different color HSC, to
deliver DNA encoding for GPF variants. Live cells treated for 2 hours with red HSC (QD
4.5 nm) comprising DNA encoding for nuclear localizing GFP (5.7 kbp) were imaged 2
days post treatment (Fig. 5.17a). Results show intense GFP localization in the large
spheroid nucleus, and diffuse spread in the perinuclear region, indicating GFP en route to
the nucleus49. Red QDs are visible in and around the nucleus, indicating nuclear
localization of the HSC. Cells treated with blue HSC (QD 2.5 nm) delivering DNA
encoding for mitochondrial localizing GFP (5.7 kbp) were observed 2 days post treatment
(Fig. 5.17b). Results show GFP punctuately distributed in the cytoplasm, concentrating in
the perinuclear region and absent from the nucleus, indicative of mitochondrial
localization 49. Blue QDs are seen inside the cells, localizing in and around the nucleus.
Simultaneous delivery of red and blue HSC delivering nuclear and mitochondrial
localizing GFP, respectively, was also investigated (Fig. 5.17c). The results show GFP
localization in the nucleus, perinuclear region and mitochondria, with both red and blue
HSC visible in and around the nucleus. These data demonstrate the use of HSC as optical
labels to simultaneously characterize multi-gene delivery systems.
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Figure 5.17 Multi-gene labeling imaged using live cells (40x, scale bar 10 pm). (a) Cells treated with red
HSC delivering nuclear localizing GFP plasmid show protein (green) localizing in the nucleus and QDs
(red) in the nuclear/perinuclear region. (b) Cells treated with blue HSC comprising mitochondrial localizing
GFP plasmid show protein (green) localized in discrete organelles, and QDs (blue) in the
perinuclear/nuclear region. (c) Simultaneous delivery of red and blue HSC demonstrate nuclear, perinuclear
and mitochondrial protein localization (green), and the presence of multi-colored QDs (red, blue) in and
around the nucleus.
The data presented demonstrated that QD-based, fluorescent gene delivery assemblies
can be used to track DNA-containing vehicles to identify barriers to gene delivery, and
may be used to simultaneously visualize multi-gene delivery using different colored QDs.
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5.5 Summary & Conclusions
5.5.1 Nanostructural Enhancement
* Several cationic, single-layer QD complexes were used to condense DNA and
delivered to cells; based on high levels of protein expression and low levels of non-
specific cytotoxicity, dextran coated nanoparticles were selected as the delivery cores.
* Cationic dextran coated QDs effectively condensed DNA to form nanostructured
complexes (NSC), and when delivered to cells yielded higher levels of protein
expression than their unstructured and free polymer counterparts.
o Increasing the QD to DNA ratio increased the toxicity of the complexes
o Optimized QD to DNA mass ratio was at 1.5:1
· Integrating functionalized gene delivery polymers with NSC yielded heterostructured
complexes (HSC) which demonstrated significant enhancement in protein production
levels and increase in cytotoxicity, when delivered to cells.
o Optimized heterostructures were assembled at C32 to DNA ratio of 10:1
where protein production was enhanced to 250% and cell viability
decreased to 72%.
o Lower ratios did not yield as much enhancement in protein production,
while higher ratios yielded excessive cytotoxicity
· Hybrid NSC and HSC complexes had defined secondary nanostructures with beads-
on-a-string morphologies biomimetic of the nucleosomes, not observed in their free
polymer and unstructured counterparts.
5.5.2 Fluorescent Tracking
· HSCs were used to continuously track the intracellular route of QD-polymer-DNA
complexes inside single cells, from delivery to protein production.
o Colocalization with labeled DNA demonstrated that DNA was bound to
QD
o Continuous long-term visualization did not cause photobleaching of QDs
· Multi-colored HSCs were used to tag the delivery of multiple genes, using different
colors as labels for genes expressing different proteins.
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Chapter 6: Conclusions & Future Recommendations
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6.1 Main Results
Aim a: Synthesis of CdS QDs
The use of both cationic polymers and histidine oligopeptides mediated the synthesis of
optically active CdS QDs, as discussed below.
Cationic polymer-mediated synthesis
Optically active CdS QDs were successfully synthesized, using cationic polymers as the
capping agents, with the properties of the nanoparticles dependent on (i) chemical
structure, (ii) mass concentration, and (iii) chain length of the polymers used. Using bPEI
produced QDs with the most defined, split-peak absorbance spectra, and brightest
fluorescence. Using IPEI and PAA for QD capping resulted in the production of QDs
with single-peak absorbances, and reduced fluorescence as compared to bPEI produced
QDs. For all the polymers tested, there was an effective concentration range within which
the polymer formed optically active QDs. These polymer-mediated QDs had highly
cationic surfaces, and cause high toxicity when incubated with cells. Due to their
cytotoxicity they were not investigated for subsequent use in bioapplications.
Histidine oligopeptide-mediated synthesis
Histidine oligopeptides with 3 or more covalently linked residues were effective in
producing optically active CdS QDs. Varying the number of covalently linked histidine
residues affected the properties of the synthesized QDs; increasing the chain length
resulted in blue-shifting of the absorbance and the emission spectra. Varying the peptide
dose also affected the properties of the nanoparticle, but to a lesser extent. CdS QDs had
crystalline cores, with lattice spacing indicating wurtzite crystal structure. However the
emission peaks of these QDs were not very finely resolved, and when incubated with cell,
they aggregated in solution. Their subsequent use as bioprobes was not investigated.
Therefore despite being optically active, the use of aqueous-based QDs as bioprobes was
not pursued further, and the use of commercially available QDs was investigated.
Aim b: Modification of QDs with organic polymers
QD surface ligand exchange with mercaptoacetic acid (MAA) was optimized to make
hydrophobic, commercially available QDs miscible in water. These modified QDs were
negatively charged, and subsequently modified by layer-by-layer deposition of oppositely
charged polyelectrolytes. Cationic, single-layer and anionic, multi-layer complexes were
prepared using PAA and PVSA, respectively. The use of anionic GaN cores, and the
subsequent deposition of PDMC and PAAc demonstrated that this technique was robust
enough to allow integration of polyelectrolytes on semiconductor QDs, independent of
the core-polymer chemical compositions. The charged QD-polymer assemblies were
electrostatically assembled on oppositely charged, patterned substrates with high
selectivity and pattern integrity.
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Aim 2: Investigation of biocompatibility of polymer-coated QDs
Biocompatibility and cellular interactions of uncoated, cationic single-layer, and anionic,
multi-layer QD assemblies were investigated, as discussed subsequently.
Uncoated & Single Layer Systems
Cellular delivery of uncoated, anionic CdSe-ZnS-MAA, polystyrene-MAA and GaN
nanoparticles did not cause excessive cell death demonstrating that the nanoparticles
were not inherently cytotoxic. The anionic nanoparticle cores were coated with different
cationic polymers, forming cationic single-layered complexes. Biocompatibility of these
cationic complexes depended on the chemical structure of the polymer, and was
relatively independent of the inorganic core; polymers with high charge density (bPEI,
PAA, PDMC, pLys, pArg) caused widespread cell death, while bio-derived cationic
polymers with lower charge densities (N-dextran, N-cellulose) were more biocompatible.
Multi-Layer Systems
Dextran coated QD were subsequently coated with anionic polymers to form stable
anionic multi-layered structures; QD-dextran were selected due to their low cytotoxicity
and high surface charge and stability. Biocompatibility of anionic multi-layered
heterostructures predominantly depended on the chemical composition of the outermost,
anionic polymer; synthetic anions with high charge densities (PVSA, PAAc) caused cell
death and distortion, while bio-derived polymer with lower charge density (DS) was
more biocompatible. Cellular interactions of multi-layered structures depended on the
chemical structures of both the cationic and the anionic polymers; coating cytotoxic
cationic QD cores (bPEI, PAA, PDMC coated QDs) with biocompatible polyanionic DS
resulted in partial shielding of the cytotoxicity.
Therefore, the overall biocompatibility of the single-and multi-layered systems depends
primarily on the chemical compositions of the coating polymers, and is almost
independent of the nanoparticle core.
Aim 3: Assembly of QD-polymer-DNA hybrids for gene delivery
Nanostructural Enhancement
Several cationic, single-layer QD complexes were used to condense DNA and mediate
delivery to cells; based on high levels of protein expression and low levels of
cytotoxicity, dextran coated nanoparticles were selected as the delivery cores. Cationic
dextran coated QDs condensed DNA more effectively and when delivered to cells
yielded higher levels of protein expression than their unstructured and free polymer
counterparts. Integrating functionalized gene delivery polymers with NSC yielded
heterostructured complexes (HSC) with significantly enhanced protein production levels
with a slight increase in cytotoxicity when delivered to cells. Hybrid NSC and HSC
complexes had defined secondary nanostructures with beads-on-a-string morphologies
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mimetic of the nucleosomes, not observed in their free polymer and unstructured
counterparts.
Fluorescent Tracking
HSCs were used to continuously track the intracellular route of QD-polymer-DNA
complexes inside single cells, from delivery to protein production; the particles did not
photobleach or cause cytotoxicity, and were internalized inside the cell. Multi-colored
HSCs were used to tag the delivery of multiple genes, using different colors as labels for
genes expressing different proteins; red and blue QDs were used to assemble complexes
delivering GFP plasmids localized in the nucleus and the mitochondria, respectively.
Hybrid QD-polymer complexes demonstrated enhanced gene delivery with biomimetic
nanostructuring of DNA plasmid, and their efficiency could be further increased by
integrating specialized gene delivery polymers in the complex. These fluorescent probes
can be used to continuously track and characterize multi-gene delivery.
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6.2 Future Extensions
The QD-polymner coated complexes prepared using layer-by-layer deposition were used
for gene therapy, but their applications can be easily extended to other biological and
non-biological systems. Some of these potential applications are subsequently discussed.
6.2.1 Gene therapy
Optimize structural morphology of the complex
The nanoparticle core has a significant effect on enhancing the gene delivery properties
of the complex, by enabling more efficient interactions between the cationic QD and the
anionic DNA. These properties may be further enhanced by using QDs of different sizes
and shapes, and characterizing their effect on DNA condensation and gene delivery
efficiency.
Develop semi-quantification models for elucidating gene delivery
pathways, identifying cellular barriers, and designing functionalized
delivery platforms
The relative concentrations of the QD-polymer/DNA complexes can be optimized to
enable semi-quantification of the delivered plasmid, by using the fluorescence of the QD
cores as a marker for DNA concentration. Based on this fluorescence, the amount of
plasmid inside a cell can be quantified, and its cellular distribution be characterized. This
can enable elucidation of the gene delivery pathways, and help model the specific
bottlenecks of gene delivery systems; the relative amounts of plasmid arrested in cellular
barrier, en route to the nucleus, and present inside the nucleus can be determined. By
varying the chemical compositions of the QD-polymer complexes, their effects on
cellular distribution of delivered DNA may be characterized. This will allow
understanding how the structure of the polymer affects its transit inside a cell, and enable
identification of functionalities that are efficient at mediating escape from specific
cellular barriers. Integration of different functionalities into a multi-functional system that
can systematically by-pass the cellular barriers can lead to the design of a highly efficient
DNA delivery system.
Use semi-quantification methods to characterize multi-gene arrays
Semi-quantification of the delivered plasmid can also be used as an indicator for the
protein expression. By carefully controlling the amounts of DNA delivered, the minimum
levels required for effective therapeutic doses may be elucidated. The combinatorial
effects of delivering multiple genes can also be investigated, by using different color
QDs. Since most genetic disorders are complex manifestations involving several different
genes, hybrid QD-polymer delivery systems may help determine optimal combinations
and doses for subsequent therapeutic applications.
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6.2.2 Other applications
QD-polymer assemblies may be used for other bioapplications, in addition to gene
delivery. These include:
* Live-cell and in vivo imaging using modified QDs functionalized with ligands to
specifically recognize cells with characteristic morphologies.
* Tmmunolabelling and biological labeling of proteins, organelles and other biological
structures; since their surface chemistries can be easily manipulated, they are stable in
aqueous environments, and their optical properties are preserved, the QD-cores may
act as efficient bioprobes. Furthermore, successful DNA delivery indicates release of
QD-DNA complex inside the cellular cytoplasm, which is a barrier for several other
QD-labeling systems.
* Detection of biological species; the nanoparticle surfaces can be easily tailored to
express affinity for specific biological molecules. Nanoparticle cores (e.g. gold) can
be used that elicit specific changes as a result of the ligand binding to the nanoparticle
surface, therefore enabling quantification of the species in solution.
* FRET systems can be assembled by tailoring the surfaces of the nanoparticles to
facilitate quenching interactions. By varying the properties of the core and the surface
ligands, high throughput systems capable of detecting several different species may
be assembled.
Non-biological systems may also be developed. These include:
· Nanostructured microelectronics which can combine QDs, and similarly modified
nanotubes and nanorods, to produce patterned, structured arrays with controlled
electronic properties to produce nano-circuits.
· Photophysics systems that utilize the inherent optoelectronic properties of the QDs.
152
Acknowledgements
My advisor, Angela Belcher for everything - in particular the intellectual freedom to
pursue my ideas!
Everybody in the Belcher Lab for their time, knowledge and help! In particular, the
following people:
Ki Tae Nam for all his help with transmission electron microscopy and atomic force
microscopy, and for being one of the best collaborators ever!
Jifa Qi for his help and guidance with GaN and CdS quantum dot synthesis
Jia Xing & Rick Henrikson, for their work with layer-by-layer deposition and
quantum dot synthesis
I am grateful to my colleagues who made the intellectual journey more rewarding and
fruitful. In particular:
Gregory Zugates for the millions of intellectual discussion, particularly those related
to gene therapy
Andre Ditsch from the Hatton Lab for help with zeta potential
Agi Stachowiak from the Irvine Lab for her help with continuous microscopy
Nicki Watson for her training me on the confocal microscope
The funding sources that made this project possible:
EDAAD for a three-year graduate student fellowship
Packard Foundation for funding the projects
To my family and friends, thanks for putting up with me!!!
153
Appendices
154
Appendix I. Quantification of QD concentration based on
absorbance
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Appendix II. Figures of Polyelectrolytes
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Fig A2. 1. Structures of cationic polymers (a) bPEI, (b) IPEI, (c) PAA, (d) PDMC, (e)
pLys (f) pArg, (g) dextran (source: from reference 1), (h) cellulose (reference 2). For
detailed discussion of structure and charge density, see Section 4.1.2.1.
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Fig A2.2. Structures of anionic polymers (a) PVSA, (b) PAAc and (c) DS (source:
reference 3). For detailed discussion of structure and charge density, see Section 4.1.2.2.
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Appendix III. List of Acronyms
AFM
bPEI
C32
CA
COS-7
Cys
DAPI
Dextran
DLVO
DNA
DS
FITC
FPC
FPC*
FRET
GFP
HA
HEC
His-n
HSC
IPEI
LPF
MAA
MEA
MEtOH
NSC
PAA
PAAc
PAMAM
pArg
PBS
PDMC
PDMS
PE
PEG
pHis
PI
pLys
PVSA
QD(s)
QD-material
TEM
TOPO
Atomic force microscopy
Branched polyethyleneimine
Poly-3-amino ester, gene delivery polymer
Capping agent
Monkey kidney epithelial cells
Cysteine
4',6-Diamidino-2-Phenylindole filter (ex 360/40, em 460/50)
Diethyl aminoethyl dextran
Derjaguin-Landau-Verwey-Overbeek
Deoxy ribonucleic acid
Dextran sulfate
Fluorescein sothiocyanate
Free polymer complex
Optimized free polymer complex
Fluorescence resonance energy transfer
Green fluorescence protein, filter (ex 450/40, em 525/50)
Hyaluronic acid
Quatemized hydroxylethyl ethoxy cellulose
Histidine oligopeptide with 'n' covalently linked units
Heterostructued complex - C32 integrated with NSC
Linear polyethyleneimine
Lipofectamine
Mercaptoacetic acid
Mercaptoethyl amine
Mercaptoethanol
Nanostructured complex - dextran coated QDs assembled with DNA
Polyallyl amine
Polyacrylic acid
Polyamidoamine dendrimers
Poly arginine
Phosphobuffered saline
Polydiallyldimethyl ammonium chloride
Polydimethylsi loxane
Polyelectrolyte
Polyethylene glycol
HIistidine polypeptide with 70 - 90 covalently linked units
Propidium iodide
Poly lysine
Polyvinyl sulfonic acid
Quantum dot(s)
Outermost layer of the QD-organic complex
Transmission electron microscopy
Tlrioctylphosphine oxide
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